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Introduced in 1976, continuous ambulatory peritoneal dialysis
(CAPD) is an effective and increasingly popular form of long-term
dialysis. Infective peritonitis is its main drawback. This can be
caused by a wide variety of micro-organisms, but usually by
bacteria from the skin or gut. The commonest and most troublesome
causative organism is the coagulase-negative staphylococcus.
Although improvements in methods of diagnosis, treatment and
prevention were made during the first five years of its use, CAPD
continued to be plagued by peritonitis in most centres.
This study was carried out between 1982 and 1984 in the Queen
Elizabeth Hospital, Birmingham. A CAPD service began there in 1981
and peritonitis quickly became the main threat to its success. It
was soon evident that the methods then in use for the
microbiological diagnosis of CAPD peritonitis were inadequate. A
simple method of culture was developed which greatly increased the
chances of a positive microbiological diagnosis. This method
became the cornerstone of a more effective and economical
laboratory service to the CAPD progranme.
The antibiotic sensitivities of organisms causing CAPD
peritonitis were studied with the aim of establishing a more
effective initial treatment policy. Vancomycin was found to be the
most consistently active of the antibiotics tested against Gram
positive isolates in general and the coagulase-negative
staphylococcus in particular. Aminoglycosides were the most
consistently active against Gram negative isolates. A trial of
intra-peritoneal vancomycin and tobramycin showed that this
combination was much more effective in the initial treatment of
CAPD peritonitis than cefuroxime, previously the antibiotic of
first choice. However, potentially ototoxic levels of tobramycin
were encountered.
With the aim of making initial treatment both simpler and
safer, a modified protocol involving once-daily intra-peritoneal
vancomycin and gentamicin was developed. One hundred episodes of
CAPD peritonitis were treated, of which 88 were cured without
recourse to other antibiotics. This study showed for the first
time that most episodes of CAPD peritonitis could be safely treated
at home using intra-peritoneal antibiotics self-administered once-
daily. The problem of aminoglycoside toxicity was not solved,
however.
Many episodes of CAPD peritonitis follow contamination of the
administration set with organisms on the patient's hands.
Contamination usually occurs during the dialysate exchange
procedure. We studied how effectively bacteria were removed from
the patients' hands by washing with povidone iodine detergent or
70% ethyl alcohol. Surprisingly, povidone iodine was often found
to be counter-productive. Ethyl alcohol was much more effective
and convenient.
Despite improvements in the diagnosis and treatment of CAPD
peritonitis, its incidence at the Queen Elizabeth Hospital has
recently increased. This may in part be due to a steady decline in
the amount of time staff can devote to training and supervising
individual patients: staffing of the programme has failed to keep
pace with the rapid rise in patient numbers. The thesis ends with
a review of a variety of recently developed techniques and
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strategies which aim to prevent CAPD peritonitis.
INTRCCXJCTI ON
"All progress is precarious and the solution of one problem brings
us face to face with another problem."
Martin Luther King jnr
Until around thirty years ago, chronic renal failure was as
fatal as rabies, only less hurriedly so. Then haemodialysis made
its faltering debut and the next decade saw the first tentative
experiments in human renal transplantation. These techniques have
since been progressively refined and as a result, most patients
with chronic renal failure should, in principle, be able to elude
death for many years. Unfortunately, however, both haemodialysis
and transplantation are expensive and highly sophisticated
techniques. Their application has been restricted in most
countries by limited dialysis facilities and an inadequate supply
*
of kidneys suitable for transplantation. Many patients, and
especially those over 60 years of age, have thus been denied
treatment. Furthermore, haemodialysis in particular offers its
recipients a way of life which falls far short of the ideal. For
example, patients must spend many hours each week attached to their
dialysis machines; they must submit to a very restricted diet and
fluid intake; they are subject to wild swings in body biochemistry
resulting in major fluctuations in their sense of well-being.
It was against this imperfect background that continuous
ambulatory peritoneal dialysis (CAPD) was launched in 1976. CAPD
seemed to avoid many of the difficulties inherent in haemodialysis.
It dispensed with the need for regular attachment to a machine; it
provided continuous rather than fluctuant control of blood
biochemistry; it permitted a much more liberal diet and fluid
intake; it required a minimal capital outlay and promised to be
cheaper to run than haemodialysis. It also nicely matched the mood
of an American (and later British) public, keen to embrace any type
of therapy which seemed less dehumanising than the high technology
medicine which was seen as dominating health care.
CAPD quickly became established as a major form of dialysis
and in many centres in the United Kingdom and North America it
became the dialysis technique of choice. However, CAPD has one
major drawback. Because the technique requires the creation and
maintenance of an artificial communication between the peritoneum
and the exterior, the CAPD patient is constantly haunted by the
spectre of infective peritonitis. When it strikes, peritonitis can
threaten the success of the dialysis technique and, if inadequately
treated, place the patient's very survival at risk.
Man has suffered from peritonitis since the beginning of
history. It is usually caused by some intra-abdominal catastrophe
leading to the leak of gastro-intestinal or genito-urinary contents
into the peritoneum. As a rule, its course is violent and
ultimately fatal unless both the infection and the underlying
disorder can be corrected. CAPD peritonitis, on the other hand, is
only as old as CAPD itself and differs in many respects from
classical peritonitis. Consequently, it has presented new problems
of diagnosis, treatment and prevention, the solutions of which have
proved surprisingly elusive.
All dialysis centres using CAPD have had to deal with an
epidemic of CAPD peritonitis. This thesis starts by outlining the
scale and nature of this iatrogenic scourge and the attempts to
master it which were made during the first five years of CAPD. It
then describes the work I carried out with the renal unit at the
Queen Elizabeth Hospital, Birmingham, between 1982 and 1984. We
attempted to rationalise our methods of diagnosing peritonitis;
develop treatment that was effective, safe, convenient and cheap;
and explore the problem of prevention. As the reader will
discover, we were thus able to tame the beast without persuading it
to go away. The thesis finishes with an examination of the methods
currently under development which hold the most promise of
peritonitis-free CAPD.
On the surface, this thesis is about dialysate, bacteria and
antibiotics. At bottom, however, it describes a small part of a
major world-wide effort to secure a healthier and happier future
for those of us unfortunate enough to lose the use of our kidneys.
PRCLDQUE
CAPD PBRITOSIITIS
Five Years in t>c World, One Year in Birmingham
1. What is CAPD?
The birth of continuous ambulatory peritoneal dialysis (CAPD)
was announced without ostentation in an abstract submitted to the
American Society for Artificial Internal Organs by Popovich et al
in 1976. The infant was initially called "the equilibrium
peritoneal dialysis technique" but two years later its progenitors
rebaptised it with the name by which it is now known (Popovich et
al, 1978). In brief, two litres of dialysate were infused into the
peritoneal cavity via a permanent intraperitoneal catheter and left
there for four to five hours. The dialysate was then drained and
replaced. There were five dialysate exchanges per day, seven days
per week. The two radically new features of this technique were
firstly that while dialysis was in progress patients could pursue
their normal activities; and secondly that because dialysis was
virtually continuous, biochemical stability could be achieved.
CAPD is the first-born of the third generation of peritoneal
dialysis techniques. Peritoneal dialysis relies on the fact that
substances of relatively low molecular weight can diffuse from the
blood across the peritoneal membrane into fluid instilled into the
peritoneal cavity. The first member of this therapeutic dynasty
was developed by Ganter in 1923 (Boen 1981). He instilled 1.5
litres of saline solution into the peritoneal cavity of a patient
with uraemia. Over the next forty years, the technique was used
more and more widely to treat patients in acute renal failure.
During the first two decades, patients treated with peritoneal
dialysis rarely recovered but, thereafter, survival rates gradually
improved. This was due to the development of more reliable
intraperitoneal catheters, to improvements in the composition and
use of the dialysate and to more successful prevention and
treatment of peritonitis. Peritoneal dialysis remains a standard
treatment for acute renal failure.
In the late fifties and early sixties, Boen (1961) and
Tenckhoff (1965) calculated and then confirmed in practice that if
the volume and flow of dialysate were sufficiently high, peritoneal
dialysis could be used for the long term treatment of patients in
chronic renal failure. However, their first attempts using a
permanent intraperitoneal catheter all failed due to peritonitis or
catheter blockage. A major advance was made by Tenckhoff and
Schecter (1968) who developed an intraperitoneal catheter made of
silicon rubber. The intraperitoneal portion was 20 cm long and
perforated with many holes to reduce the chance of blockage. The
extraperitoneal portion was designed to lie within a subcutaneous
tunnel some 12 cm long. Dacron cuffs were attached to the catheter
just below the skin and just outside the peritoneum. These
improved the catheter seal, preventing the leakage of dialysate
from the distended peritoneum and, crucially, the passage of micro¬
organisms from the skin into the peritoneum. This catheter, now
called the Tenckhoff catheter, proved to be suitable for long term
use and made chronic intermittent peritoneal dialysis a practical
proposition. Patients were treated for ten to twelve hour periods
two to three times each week. While dialysing, they had to remain
attached to a machine which instilled and drained the dialysate in
a controlled manner. Peritonitis still occasionally occurred, as
did other complications such as dialysate leaks, catheter blockage
and abdominal pain. Also, some patients could not be adequately
dialysed by this method. Consequently, in the eyes of many
nephrologists, chronic intermittent peritoneal dialysis seemed less
suitable than haemodialysis for most patients and now accounts for
only a very small proportion of dialysis patients in most
countries.
Intermittent peritoneal dialysis had shown, however, that the
peritoneal membrane could be used as an artificial kidney for long
periods. The key step that led to the development of CAPD was the
recognition by Popovich and his colleagues that once the dialysate
was instilled into the peritoneum, the patient could be detached
from the dialysate source. Satisfactory dialysis could continue
for several hours before blood and dialysate concentrations began
to equilibrate. If the dialysate was replaced every four or five
hours and was continued every day, the improvement in blood
biochemistry proved to be comparable to that achieved by
haemodialysis. However, unlike haemodialysis, CAPD, being
continuous, resulted in the achievement of a steady biochemical
state.
Following their initial announcement of the technique in
1976, Popovich and his colleagues reported in 1978 on its use in
nine patients. They found that CAPD could control blood
biochemistry at least as well as could other dialysis techniques.
They were also impressed by the considerable improvement in the
sense of well-being experienced by the patients and by their
enthusiasm for the freedom the technique allowed. Many patients
became appreciably more active than they had been on haemodialysis
or intermittent peritoneal dialysis.
The major complication of CAPD that they encountered was
bacterial peritonitis. Thirteen episodes occurred during the 138
patient-weeks of the study, or about one episode every ten patient-
weeks. Organisms commonly found on the skin were usually
responsible and included staphylococci, streptococci, an
acinetobacter and an Enterobacter cloacae. All episodes were said
to have responded rapidly to antibiotics added to the dialysate.
The authors felt that most episodes of peritonitis followed
contamination of the dialysate during the dialysate exchange
procedures.
A description of the technique of dialysate exchange makes
the risk of contamination easy to understand. In between
exchanges, the patient's Tenckhoff catheter was sealed with a cap.
To begin the exchange, the patient removed the cap and attached the
catheter to a plastic infusion line leading to an empty two litre
glass bottle. The bottle was placed on the ground and the
dialysate effluent was allowed to drain from the peritoneum into
the bottle. When the drainage was complete, the bottle was
replaced with one containing fresh dialysate which was then
instilled into the peritoneum. Finally, the bottle and infusion
line were disconnected from the catheter which was resealed with a
sterile cap. Thus, the system was opened three times during each
exchange, and hence, with five exchanges daily, 105 times each
week. Even assuming that all episodes of peritonitis were caused
by contamination during the dialysate exchange, an incidence of one
episode every ten weeks would occur if the dialysate was
contaminated only once in every 1,000 times the system was opened.
The incidence of peritonitis seems in fact creditably low in
the face of the technique's extreme vulnerability to contamination.
This is particularly so when "many patients changed fluids in
automobiles, parks or restrooms so that they did not need to return
home at inconvenient times" (Popovich et al, 1978). Thus, the
freedom offered by CAPD compared with other forms of dialysis was
offset by the need for patients to devote the utmost care to their
fluid exchanges. It was apparent from the outset that CAPD could
only succeed if patients were thoroughly trained in the technique
of aseptic fluid exchange and were seen to be capable of achieving
this before they were allowed home. Such training remains an
integral part of all CAPD programmes to this day.
Major progress towards reducing the risk of peritonitis was
made by Oreopoulos and his colleagues in 1978 when they replaced
the glass bottles with collapsible plastic bags (Figure P.1). Now,
instead of removing the bottle and administration tubing and
capping the catheter, the bag and tubing could be left attached to
the catheter, rolled up and kept in a pouch until the next
exchange. This meant that the system was opened only once at each
exchange. It was also found that most patients could be adequately
dialysed using four and occasionally only three exchanges daily.
Together, these modifications reduced the number of disconnections
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Figure P.l CAPD dialysate inflow
per week from ICS to 28. Another important cause of contamination
then emerged: accidental disconnection of the administration tubing
from the Tenckhoff catheter. This was solved by the introduction
of a titanium connector which provided a very secure seal between
the catheter and the tubing (Oreopoulos et al, 1981).
The result of these modifications was substantially to reduce
the incidence of peritonitis. The Toronto group, headed by
Dimitrios Oreopoulos, reported an incidence of one episode every
7.9 months in 1978 (Williams, 1981). With the apparent taming of
peritonitis, CAPD suddenly became a much more attractive
proposition and the message was broadcast with missionary zeal by
the pioneers in Texas and Toronto. CAPD was seen to be
particularly suitable for elderly and diabetic patients and others
with cardiovascular disease for whom haemodialysis was not a
practical proposition. CAPD also seemed likely to cost less than
haemodialysis. Virtually no capital outlay is required to start a
CAPD service, the main costs being incurred in the provision of the
dialysate and in staff salaries. Thus, for health authorities
eager to cut costs, the arguments in favour of CAPD were also
seductive. Consequently, 1978-80 saw a remarkable growth in the
number of patients using CAPD in North America, Europe and
Australasia. For example, in the United States, it increased from
20 in 1977 to 1,700 three years later (Moncrief and Popovich,
1981a). Between 1978 and 1980, 219 patients were trained in CAPD
in Australia (Thompson et al, 1981) and 325 in the United Kingdom
(Gokal and Ward, 1981).
By 1980, several centres had accrued considerable experience
in CAPD. The leading exponents of the technique from three
continents assembled in Melbourne in the autumn of that year for a
major re-appraisal of CAPD in the light of this experience. The
proceedings of this conference (Atkins et al, 1981a) and several
other contemporaneous publications made it abundantly clear that
peritonitis remained the main threat to successful CAPD despite the
technical improvements that had been made. In the following
sections, I shall describe the problem of CAPD peritonitis in more
detail. Emphasis will be placed on the difficulties of diagnosis
and treatment which still remained in 1981 when the CAPD programme
with which I was associated began.
2. The Incidence of Peritonitis
Table P.l shows the incidence of peritonitis reported by ten
CAPD centres, expressed as months of CAPD per episode. While in
most centres the average was about one to two episodes per patient
per year, there was a remarkable ten-fold difference between the
highest and lowest incidences. A number of factors may account for
this.
Technical improvements undoubtedly play an important part.
The dramatic fall in the incidence at Centre 1 from one episode
every two months to one every seventeen months coincided with their
changing from glass bottle to plastic bags. However, plastic bags
and equipment provided by the same firm, Travenol Laboratories,
were used by most centres from 1978 onwards, suggesting that other
factors are also important. Centre 7 in Toronto reduced its
incidence of peritonitis appreciably from 1979 to 1980 without
introducing any major technical changes (Table P.l) (Oreopoulos et
TABLE P.l






la Rubin et al 1980 United States 185 2
2 Atkins et al 1981 Australia 1,090 3.5
3 Gokal et al 1980 United Kingdom 138 5
4 Chan et al 1981 United Kingdom 497 5.5
5 Lindholm et al 1981 Sweden 242 7
6 Lameire et al 1981 Belgium 673 7.5
7a Williams et al 1978 Canada 776 8
8 Morrison et al 1981 New Zealand ? 8
9 Mergerion et al 1981 West Germany 375 8.6
7b Williams et al 1979 Canada 1,588 9.2
7c Williams et al 1980 Canada 1,797 13.3
lb Prowant et al 1981 United States 1 17
10 Mion et al 1981 France 715 20
alr 1981). Could patient selection and training play a part? Many
authors noted that the incidence of infection was not evenly spread
among their patients. C. Williams and her colleagues (1981) found
that 44% of 315 patients had never had peritonitis, including many
who had been using CAPD for more than one year. On the other hand,
59% of all episodes occurred in only 18% of the patients, with a
"hard core" of 6% of patients experiencing 25% of all episodes.
Fenton et al (1981) asked their nursing staff to assess the degree
of co-operation shown by each patient. Whilst stressing they did
not wish to attach too much importance to such a subjective
evaluation, they nevertheless found that 80% of the patients who
had three or more episodes of peritonitis were considered "unco¬
operative" compared with only 10% of patients who had had no
peritonitis. Oreopoulos et al (1981b) felt that poor dialysate
exchange technique probably led to peritonitis in 46% of 93
episodes and possibly in a further 26%. They concluded that
motivation and cleanliness were key factors in determining a
patient's risk of developing peritonitis and should be taken into
account when assessing his or her suitability for CAFD. Moncrief
and Popovich (1981b) stated that patients in their centre who had
more than three episodes of peritonitis within the first six months
were advised to change to haemodialysis where practicable.
Criteria for acceptance for and removal from a CAPD programme will
clearly vary from centre to centre as will the quality of the
training offered to patients. It is inevitable that the incidence
of peritonitis will be influenced by these factors.
The centre reporting the lowest incidence of peritonitis
(Mion et air 1981) was the only one where a bacterial filter was
placed in the administration line between the bag and the Tenckhoff
catheter to prevent bacteria introduced during the bag exchange
from reaching the peritoneum (Figure P.2) (Slingeneyer et al,
1981). After excluding episodes caused by accidental disconnection
of the administration tubing from the catheter, they calculated
that the incidence of peritonitis at their centre was only one
episode every 31 patient months. They cultured 114 filters used by
16 patients, each worn for 10 to 14 days. Organisms were isolated
from the bag side of the filter in 25%, but from the catheter side
in only 3%. Most of the isolates belonged to species known to
cause CAPD peritonitis. It thus seemed plausible that the filter
was preventing peritonitis, although no attempt was made to compare
the incidences of CAPD peritonitis with and without the filter.
However, in an earlier long-term study on patients using
intermittent peritoneal dialysis, they found that the incidence of
peritonitis was equally low - one episode every 4.7 patient years -
whether or not the filter was used. Consequently, they were unable
to provide unequivocal evidence that the use of the filter was the
key to their success.
The incidence of peritonitis in a given CAPD centre is
undoubtedly multifactorial in origin. As things stood at the end
of 1981, the principal onus lay upon the patient to carry out his
or her dialysate exchanges precisely as instructed. It was clear
that until technical modifications removed the risk of patient
error, CAPD peritonitis would continue to occur.
Whilst many authors attributed most episodes of peritonitis
to contamination occurring during the dialysate exchange or to
Figure P.2 Dialysate infusion system incorporating a
bacterial filter (Adapted from Slingeneyer
et al, 1982)
accidental disconnection of the administration tubing from the
Tenckhoff catheter, several other sources of infection were
mentioned. These included infection of the Tenckhoff catheter exit
site? cracks or holes in the administration tubing or dialysate
bag; leak of bowel contents via an intestinal perforation; and
blood-borne oral organisms. These will be considered in more
detail in later sections.
3. Hie Clinical Presentation of CAPD Peritonitis
CAPD peritonitis is usually easy to diagnose. Uninfected
dialysate effluent is normally crystal clear with a yellowish
tinge. Its white cell content is low. For example, the white cell
content of 149 samples of uninfected dialysate ranged from O-85/mm3
with a mean of 23/mm3 (Prowant and Nolph, 1981). Peritonitis
usually results in a rapid rise in the dialysate white cell count
to at least 300/mm3 (Rubin et al, 1980). A white cell count of
more than 100/mm3 results in the dialysate becoming visibly cloudy
(Moncrief and Popovich, 1981b). Cloudy dialysate effluent is thus
the cardinal feature of CAPD peritonitis.
The clinical features at presentation in two studies covering
259 episodes of peritonitis are shown in Table P.2. In two-thirds
of the episodes, the patient complained only of cloudy effluent
with or without abdominal pain. The two main determinants of the
patient's clinical state when first seen by a doctor were (1) the
duration of the infection and (2) the causative organism. What
began as a symptomless condition, evident only as a "cloudy bag",
would progress to one of increasingly severe abdominal pain
TABLE P.2
SYMPTOMS AT PRESENTATION IN 259 CASES OF CAPD PERITONITIS
Principal Author






Cloudy dialysis effluent 97 99
Abdominal pain or discomfort 86 p < 0.01* 97
Pyrexia 29 35
Nausea or vomiting 20 p < 0.02* 35
Chills 16 23
Drainage problems 15 ?
Diarrhoea ? 7
2* X with Yates' correction
accompanied by the other familiar symptoms of bacterial peritonitis
- nausea and vomiting, fever, hypotension and collapse. It is
notable that symptoms were more often severe in the cases studied
by Fenton and his colleagues (Table P.2) perhaps suggesting that
their patients took longer to seek medical attention.
Because peritonitis is such a frequent and potentially
serious complication of CAPD, all CAPD patients are instructed to
report to their CAPD centre as soon as the dialysate becomes cloudy
or other symptoms suggesting peritonitis develop. Consequently,
patients should rarely be seriously ill when first seen. The
relationship between the nature of the causative organism and the
clinical condition of the patient will be discussed in the next
section.
4. The Organisms Causing CAPD Peritonitis
By the end of 1981, a number of CAPD centres had published
details of the micro-organisms they had found to cause peritonitis
in their patients. The findings of nine centres from seven
countries and covering 843 episodes of CAPD peritonitis are
summarised in Table P.3. Several features are immediately
apparent
(1) A very similar range of organisms was found to cause
peritonitis in North America, Europe and Australasia;
(2) The majority of causative organisms were Gram positive
cocci with the commonest single species in most centres
being Staphylococcus epidermidis;

















































































































































































(4) In most centres, organisms were not recovered in 20 to
40% of episodes whilst in three, organisms were
isolated in all but 4% of episodes.
The causative organisms can be considered in four groups:-
(1) Resident skin flora;
(2) Transient skin flora;
(3) Organisms of intestinal origin;
(4) Organisms of uncertain origin.
Resident skin flora: Staph, epidermidis, a coagulase-negative
staphylococcus, was incriminated in 39% of the culture-positive
episodes, more than twice as often as any other organism. The
taxonomy of the coagulase-negative staphylococci has undergone
major changes during the past decade (Kloos and Schleifer, 1975).
Previously, the name Staph, epidennidis or Staph, albus had been
generally applied to all coagulase-negative staphylococci.
Subsequently, however, the definition of Staph, epidermidis became
much more precise and a number of other species of coagulase-
negative staphylococci were recognised. As none of the authors of
the reports summarised in Table P.3 defined what they meant by
Staph, epidermidis, it cannot be accepted that all the isolates
were Staph, epidermidis, sensu stricto. For the moment, these
organisms will be described as coagulase-negative staphylococci.
Their true identity will be discussed in Chapter 3.
Coagulase-negative staphylococci are constant residents of
the human skin and in normal circumstances do not cause infection.
During the past fifteen years, however, they have been shown to
cause low-grade infections subsequent to their colonisation of
inert material, particular plastics, used as intravascular
catheters, prosthetic joints, heart valves, cerebrospinal fluid
shunts etc (Lowy and Hammer, 1983). It thus comes as no surprise
that they should cause peritonitis in a plastic system which is
vulnerable to contamination with skin organisms several times each
day. Peritonitis due to coagulase-negative staphylococci was
generally found to be a mild condition with abdominal pain being
the only major symptom at presentation (Oreopoulos, 1981b).
Other skin commensals were rarely isolated from infected
dialysate. Diphtheroids were isolated in 13 of the 843 episodes
(1.5%). Nine of these episodes occurred in one centre which
employed a variety of culture methods requiring complex
manipulation (Atkins et al, 1981b). Human skin diphtheroids have
rarely been implicated in human infection (Noble, 1984). Their
role in these episodes must therefore remain uncertain.
Acinetobacter calcoaceticus was isolated on nine occasions (1%).
This organism is found on the skin of about 10% of the population
(Gill and Gill, 1979). In recent years, it has been shown to cause
septicaemia and infection of burns and surgical wounds,
particularly in patients who are debilitated or have received broad
spectrum antibiotics. The source of septicaemia is often found to
be a colonised intravascular catheter. Acinetobacter calcoaceticus
is therefore an organism of known pathogenic potential in the
circumstances created by CAPD.
Transient skin organisms: Staphylococcus aureus was found to
cause CAPD peritonitis in all nine centres and accounted for 17% of
all isolates. Unlike the coagulase-negative staphylococci, Staph,
aureus is not a permanent resident of the skin. It colonises the
anterior nares of 8 to 30% of adults but is generally found on the
skin of less than 5% (Smith, 1981). No data concerning the
percentage of CAPD patients colonised with Staph, aureus were
available in 1981. However, Vas (1981) noted that patients with
Staph, aureus peritonitis often had a concurrent Staph, aureus
infection of the catheter exit site which could act as source of
recurrent peritonitis until eradicated. Whether the infecting
organisms in such cases reached the peritoneum by making their way
down the outside of the Tenckhoff catheter or by contamination of
the fluid during the bag exchange had not been established.
Predictably, this relatively virulent organism often caused
more severe peritonitis than did coagulase-negative staphylococci.
Vas (1981) found that dialysate infected with Staph, aureus usually
had a high white cell and fibrin content and patients required a
long course of.treatment, often culminating in removal of the
intraperitoneal catheter. Oreopoulos et al (1981b) believed that
peritonitis due to Staph, aureus required more intensive treatment
than that caused by most other organisms. Atkins et al (1981c)
reported that patients with Staph, aureus peritonitis were febrile
and remained in hospital for longer than those with coagulase-
negative staphylococcal peritonitis.
Organisms of bowel origin: All centres reported isolating
Enterobacteriaceae from infected dialysate (Table P.3). These
included Escherichia coli, Proteus spp, Enterobacter cloacae and
Serratia marcescens. As a percentage of total isolates, they
ranged from 6% (Atkins et al, 1981c) to 27% (Chan et al, 1981).
Four centres also reported isolating Streptococcus faecalis (Vas et
al, 1981a, Atkins et al, 1981c, Chan et al, 1981, Mergerian, 1981),
These organisms are all part of the bowel flora but can also be
found transiently on the skin especially of the groin, lower
abdominal wall and hands (Sandusky, 1979). Peritonitis could thus
follow either external contamination or leakage of bowel contents
directly into the peritoneal cavity. The latter route would be
especially probable if a mixed intestinal flora, including
anaerobes was found. Vas et al (1981), one of only two groups to
isolate anaerobes, reported several cases of "faecal peritonitis"
in patients on CAPD who were found to have severe diverticular
disease.
Organisms of uncertain origin: Pseudomonas: Most centres
reported isolating members of this genus from infected dialysate
but none made it clear if species other than Pseudomonas aeruginosa
were involved. All the pseudomonads are normal inhabitants of
water, vegetation and moist soil (Sanford, 1979). They rarely
cause human infection except for P. aeruginosa which is an
important cause of infection in debilitated patients in hospital.
P. aeruginosa can be found in the nose, throat or faeces of 5 to 9%
of healthy individuals (Cross, 1979). It is very readily isolated
from sinks, damp cloths, mops, etc, and can also survive and
multiply in a wide range of antiseptics and "sterile" fluids such
as dialysate and distilled water. As CAPD patients necessarily
spend a lot of time hand-washing and using antiseptics, there is a
high chance their hands will occasionally become contaminated with
pseudomonads. A subsequent technical error during a bag exchange
would then allow the organism to enter the system.
Streptococci other than enterococci: All centres reported
isolating streptococci from infected dialysate. Five did not
identify them any further. Atkins et al (1981c) found that 21 of
25 isolates were viridans streptococci (Strep, mitior 14; Strep,
milleri 2; Strep, mutans 2; and haemolytic streptococci 3), three
were Strep, faecalis and one a microaerophilic streptococcus. Of
their 16 streptococcal isolates, Vas et al (1981a) found ten were
viridans streptococci and six were Strep, faecalis. Mergerian
(1981) reported isolating seven "haemolytic" streptococci and two
Strep, faecalis and Chan et al (1981) isolated two viridans
streptococci. Oreopoulos et al (1981b) found that patients with
viridans streptococcal peritonitis were often acutely ill at
presentation. Fenton et al (1981) described two fatal cases of
CAPD peritonitis, one caused by Strep, pneumoniae, the other by
Strep, agalactiae.
Streptococci other than Strep, faecalis are rarely found on
the skin, but transient viridans streptococcal bacteraemia occurs
throughout the day in the course of chewing or tooth brushing
(Durack, 1979). This bacteraemia Is believed to lead to a large
proportion of cases of infective endocarditis. Vas (1980)
therefore suggested that most episodes of peritonitis caused by
viridans streptococci resulted from organisms borne in the blood
from the mouth to the peritoneal cavity. A similar mechanism was
recently proposed to explain the rare association between
pneumococcal peritonitis and intra-uterine contraceptive devices
(Gruer et al, 1983).
Fungi: Five of the nine centres reported CAPD peritonitis due
to organisms described as fungi or yeasts. Rubin et al (1980)
reported two cases of peritonitis caused by Candida albicans and
one by Nocardia asteroides (strictly speaking, a branching
bacterium and not a fungus). They noted that the dialysate white
cell count in these cases was lower than in those caused by
bacteria. In one of the cases due to C. albicans, there was a very
heavy growth of the organism but only 15 leukocytes/mm-^ in the
dialysate. They contrasted this with a case due to P. aeruginosa
where the dialysate white cell count was 14,400/mm-^ but only 2.5
bacteria/ml were present. Prowant and Nolph (1981) found that
fungal CAPD peritonitis often produced a number of non-specific
symptoms, days or even weeks before the dialysate became cloudy.
These included difficulties in draining and infusing dialysate,
fluid overload, gastro-intestinal symptoms, fatigue, malaise,
abdominal distension and diffuse abdominal soreness. In none of
their five cases was there fever at presentation.
Miscellaneous: Neisseria were occasionally found to cause
peritonitis in three centres (Atkins et al, 1981c; Prowant and
Nolph, 1981; Vas et al, 1981a). Neisseria are normal residents of
the human oropharynx. Peritonitis due to these bacteria is most
likely to have been caused by organisms blood-borne from the mouth.
Other organisms isolated once by one or two centres included
Alkaligenes spp, Bacillus spp, Flavobacterium spp, Gaffkya sp, and
Listeria monocytogenes.
5. The Laboratory Diagnosis of CAED Peritonitis
If a case of CAPD peritonitis is to be satisfactorily
managed, it is clearly desirable that the causative organisms are
quickly and correctly identified. Nevertheless, Table P.3 shows
that in most centres no organism was isolated in 20 to 40% of
episodes. Several of the authors reporting from these centres
described such culture negative episodes as "sterile" peritonitis
(Atkins et al, 1981b) and implied that at least some were not due
to micro-organisms at all. However, the fact that three centres
were able to isolate organisms in almost all episodes suggests that
their less successful colleagues were using inadequate culture
techniques. In this section, the various laboratory diagnostic
methods employed are evaluated.
White Cell Count
As described in section 3, a constant feature of CAPD
peritonitis is a raised dialysate white cell count. The white cell
density in uninfected dialysate is 0-80/mm^ (Prowant and Nolph,
1981). With the onset of peritonitis, the white cell density rises
rapidly to over 300/mm^ and often much more (Rubin et al, 1980).
In most instances, the great majority of white cells in infected
dialysate are polymorphonuclear leukocytes. Vas et al (1980)
stated that a dialysate polymorph count of 100/mm^ or more strongly
suggested infection. This nice, round figure has since become
widely accepted (Moncrief and Popovich, 1981b).
As discussed earlier, the "cloudy bag" is a cardinal feature
of CAPD peritonitis, but there are other causes of cloudy
dialysate. Slight intraperitoneal bleeding, such as may result
from retrograde flow during menstruation is one (Moncrief J W, in
Atkins et al, 1981a, p295); lipid and fibrin are, rarely, others
(Prowant and Nolph, 1981). Peritoneal eosinophilia of unknown
origin has also been reported (Oreopoulos et al, 1981b).
Consequently, the clinical diagnosis of CAPD peritonitis should
always be confirmed by a dialysate white cell count, preferably
using a haemocytometer (Moncrief and Popovich, 1981b).
The Gram Stain
Instinctively, the bacteriologist will then want to perform a
Gram stain, in the hope of seeing the causative organisms.
However, this is generally unsuccessful. Rubin et al (1980) found
the Gram stain revealed organisms in only 9% of 87 specimens, even
when a centrifuged deposit was studied. Vas (1981) reported that
organisms were seen on the dialysate Gram stain in 35% of all
episodes of CAPD peritonitis. Other authors did not indicate that
they found the Gram stain helpful.
Culture
The frequent failure to see organisms on the Gram stain
suggests that they are either present in very small numbers, cannot
be conventionally stained or do not exist. That the first
explanation is likely to be correct in most cases was shown by
Rubin et al (1980). They carried out colony counts on ten samples
of infected dialysate and found a density of only 0.25 colony
forming units/ml or less in half the samples. The organisms
isolated in such small numbers were Staph, epidermidis, P.
aeruginosa, Ekiterobacter agglomerans, Strep, faecalis and Candida
albicans. Such a low density of organisms contrasts sharply with,
for example, that found in a urinary tract infection where the
normal diagnostic threshold is 105 organisms/ml of urine.
Further circumstantial evidence that the culture negative
episodes were caused by bacteria was provided by Atkins et al
(1981b). Comparing 109 episodes of culture positive peritonitis
with 45 episodes of culture negative peritonitis, they found that
the clinical presentations in the two groups were indistinguishable
except for the mean duration of symptoms prior to admission:
culture positive - 25 hours, culture negative - 19 hours. The mean
dialysate white cell count was very similar in both groups.
However, 40% of the culture negative episodes resolved following
peritoneal lavage without antibiotics compared with only 5% of the
culture positive episodes and the mean duration of symptoms was
significantly shorter in the culture negative group. This suggests
that many, if not all, the culture negative episodes were caused by
less pathogenic or less well-established organisms than those
causing the culture positive episodes.
In a search for a more sensitive means of culture, Rubin and
his colleagues (1980) tested three methods: -
(1) Inoculation of 5 ml of dialysate into supplemented
peptone broth;
(2) Passage of 100 ml of dialysate through a 0.45 nm pore-
diameter membrane filter in an anaerobic "glove box".
The filter was divided and incubated both aerobically
and anaerobically on sheep blood agar;
(3) Addition of 17 ml of dialysate to a plastic cylinder
containing a dessicated nutrient agar pad overlain by a
0.45 nm pore-diameter filter. As dialysate was drawn
through the filter to rehydrate the nutrient pad, any
bacteria present would be trapped on the filter. The
filter and pad were then incubated together.
These methods were compared using dialysate from 97 episodes
of CAPD peritonitis. Broth culture was positive in 73% of samples,
the filter in 81% and the filter-nutrient pad in 61%. The
differences were not statistically significant. The authors did
not indicate if certain species were more readily isolated by one
method than another.
Atkins and his colleagues (1981b) compared several methods.
They found that culture of the deposit of 150 ml of centrifuged
dialysate yielded organisms in 75 of 100 episodes compared with 63%
of 54 episodes when only 15 ml of dialysate was centrifuged (X^ =
1.9, p > 0.10). They then compared 150 ml deposit culture with
culture of 100 ml of dialysate in 900 ml of 0.1% soy agar and
culture of 0.2 iim pore-diameter filters through which up to one
litre of dialysate had been passed. Using samples from only 23
episodes of peritonitis, they concluded that centrifuged deposit
culture and large volume broth culture were equally sensitive and
both more sensitive than the filtration technique. The number of
samples tested was, however, too small for any statistically valid
conclusion to be drawn from their results. Overall, despite their
efforts, 29% of episodes proved to be culture negative.
Chan et al (1981) did not describe their methods but found
that by adding dialysate to thiol enriched broth, they improved
their positive culture rate from 31 to 79%. The other centres
reporting low culture rates did not describe their culture methods.
Of the three centres reporting successful culture in 96% of
cases (Table P.3), only two described their methods. Vas et al
(1981a) used the Addichek system (Millipore Inc), designed for
checking the sterility of pharmaceutical products. This consisted
of a plastic cylinder containing a 0.45 urn pore-diameter filter.
After passing 100 mis of diaylsate through the filter, the cylinder
was filled with thioglycollate broth and incubated. Growth
thereafter could usually be detected visually. Although this
method was very sensitive, they found the filter often became
blocked with white cells and fibrin. In such cases they
centrifuged the fluid and cultured the deposit. However, they felt
that contamination was more likely to occur during centrifugation.
Mergerian (1981) inoculated 5 ml of dialysate into each of
the following four liquid media:-
(1) Thioglycollate broth, incubated anaerobically at 37°C;
(2) Glucose broth, incubated aerobically at 37°C;
(3) Two Sabouraud broths, incubated at 37°C and 22°C
respectively.
He reported that in only two of 44 episodes were organisms
not isolated, but did not indicate the relative usefulness of the
different media.
Only tentative conclusions can be drawn from these very
limited studies. Where dialysate was filtered or centrifuged and
the filter or deposit then transferred to solid media, the culture
negative rate was high. Greater success was achieved when the
dialysate or its filtrate was cultured in a rich liquid medium,
capable of growing both aerobic and anaerobic organisms. None of
these studies showed conclusively that the isolation rate was
increased by increasing the volume of dialysate processed.
However, as the number of organisms present appears often to be
small, it would seem sensible to culture the largest volume
practicable.
If the culture negative episodes are caused by micro¬
organisms, what are they? Only Vas et al (1981) - 4/103 episodes -
and Moncrief and Popovich (1981) - 1/25 episodes - isolated
anaerobes, suggesting that some of the undiagnosed infections in
other centres could have been caused by anaerobes. Coagulase-
negative staphylococci caused a higher proportion of the infections
diagnosed by Vas et al than in other centres, suggesting that
infections caused by these organisms may also have been
underdiagnosed. However, the proportion of infections caused by
coagulase-negative staphylococci in the studies by Mergerian (1981)
and Moncrief and Popovich (1981), both of whom reported an
isolation rate of 96%, was lower than that of Lameire et al (1981)
whose diagnostic rate was only 78%. Consequently, examination of
these studies does not specifically incriminate any one organism as
the cause of undiagnosed infections.
Atkins et al (1981b) used a wide range of methods in an
attempt to isolate fastidious organisms such as mycoplasmas,
viruses or lipophilic yeasts. None were found. They also found no
evidence that endotoxin caused peritonitis in their patients, a
possibility suggested by a Canadian report (Kovanicolas et al,
1977). They concluded that "sterile" peritonitis probably had
several causes, with the freshness, temperature and volume of the
dialysate sample all being important. Antibiotics or antiseptics
in the dialysate might also occasionally be responsible.
Of these authors, only Vas et al (1981) attempted to provide
clear guidelines to assist other laboratories in the daily task of
culturing dialysate. While their results were impressive, their
methods could be criticised on several grounds. The Addichek
system was expensive and required expert manipulation. The filter
was readily blocked and in such cases another less satisfactory
method had to be used. If the sample was taken outside normal
laboratory hours, its culture would be delayed unless an emergency
on-call technician was available.
6. The Treatment of CRPD Peritonitis
Hospital Admission and Peritoneal Lavage
By 1981, there was general agreement that CAPD peritonitis
should be treated as soon as it has been clinically diagnosed
(Oreopoulos et al 1981c; Moncrief and Popovich, 1981). It was
agreed that to wait for the results of culture would be to risk the
transformation of a minor nuisance into a life-threatening illness.
A review of the methods of treatment used by different centres
shows, however, that in other respects treatment differed markedly
from centre to centre. Only two centres (Rubin et al, 1980;
Moncrief and Popovich, 1981) did not admit all patients with
peritonitis to hospital. Once in hospital, all patients in most
centres underwent peritoneal lavage and were given intraperitoneal
antibiotics. Peritoneal lavage is a technique whereby dialysate is
flushed in and out of the peritoneal cavity at frequent intervals.
The aim is to remove "the inflammatory mediators of tissue injury,
such as the vasoactive amines as well as debris, fibrin, bacteria
and exotoxin" (Atkins et al, 1981c). The duration of lavage varied
from centre to centre. Lameire et al (1981) continued until
symptoms had disappeared; Chan et al (1981) continued for at least
24 hours; Atkins et al (1981c) for three days. Rubin et al (1980)
and Moncrief and Popovich (1981) maintained, however, that lavage
was not necessary unless the peritonitis was severe. That lavage
might even be counter-productive was shown by a series of in vitro
experiments carried out by Vas et al (1981b). They found that
peripheral blood leukocytes phagocytosed and killed Escherichia
coli most efficiently in dialysate that was isotonic and at pH 7.4.
Fresh dialysate, which is hypertonic and at pH 5.2, significantly
inhibited both phagocytosis and intracellular bacterial killing.
Bacterial killing was also slowed considerably if the density of
bacteria and white cells was decreased. Vas and his colleagues
thus argued that frequent peritoneal lavage would prevent natural
defence mechanisms from acting effectively. They felt that lavage
was beneficial in the early treatment of severe peritonitis because
it removed inflammatory products and hence relieved the acute
symptoms. They believed that thereafter bacterial killing would be
enhanced if the dialysate remained in the peritoneal cavity for
long periods. The pH and osmolality of the dialysate would then
become more physiological, thereby allowing the phagocytes
effectively to function in concert with the antibiotics.
Clinical evidence against the need for lavage came from P.
Williams and his colleagues (1981). They studied 24 patients with
peritonitis, all treated with the same intraperitoneal antibiotics.
Twelve were given peritoneal lavage and twelve continued CAPD
normally. They found that all the patients recovered, but culture
of the dialysate remained positive for much longer in the lavage
group (mean 8.7 days) than in the normal CAPD group (mean 2.4
days). Patients receiving lavage also spent longer in hospital
(mean 12.25 days versus 6.7 days).
If lavage was unnecessary, then there was little reason to
treat patients with mild peritonitis in hospital. So argued Rubin
et al (1980), who treated 49 of 97 episodes of peritonitis at home.
In only six of the 49 cases was infection not successfully
controlled. Moncrief (quoted in Atkins et al, 1981a, p341) pointed
out that patients who knew that peritonitis was always treated in
hospital were often reluctant to contact their dialysis centre
until symptoms became severe. In his experience, patients who knew
they were likely to be treated at home promptly reported the
development of cloudy dialysate. This may explain the observation
that the patients of Fenton et al (1981) (who treated all
peritonitis in hospital) had on average more severe symptoms than
those reported by Prowant and Nolph (1981) who treated mildly ill
patients at home (see Section 3).
There was thus both experimental and clinical evidence that
peritoneal lavage was not a necessary part of the treatment of mild
or moderately severe peritonitis; and clinical evidence that such
episodes could be satisfactorily treated at home. Hie high cost of
hospital treatment was stressed in two reports. Rubin et al (1980)
calculated that the average cost per episode of treating a patient
with peritonitis in hospital was $1,600. They found that in-
hospital treatment virtually annulled the cost advantage of CAPD
compared with haemodialysis. Atkins et al (1981c) found that in¬
patient treatment ranged from $1,085 for an uncomplicated infection
to $6,885 for one caused by antibiotic resistant Staph, aureus.
Thus, although a reduction in the incidence of peritonitis was
rightly seen by all authors as a principal objective, effective
home treatment of peritonitis emerges as a means of substantially
reducing the disruption and extra costs caused by peritonitis.
Hie Choice of Antibiotics
Because treatment of CAPD peritonitis is usually started
before the causative organism is known, it is sensible to start
with antibiotics active against most of the likely bacteria. As
discussed in Section 4, the range of organisms is similar in all
centres. Nevertheless, the choice of antibiotics for the initial
treatment of CAPD peritonitis varied considerably. In North
America, the first generation cephalosporin, cephalothin, was
generally used. Rubin et al (1980) and Moncrief and Popovich
(1981b) added 125 mg/1 of cephalothin to every bag of fresh
dialysate. Cephalothin is active against most staphylococci and
streptococci but inactive against Strep, faecalis, P. aeruginosa
and many strains of the Enterobacteriaceae (Garrod et al, 1981).
Consequently, Oreopoulos et al (1981a) combined cephalothin with
tobramycin (8 mg/l/bag), and, Vas (1981) reported that this
combination was active against 98% of bacteria isolated from
infected dialysate.
In the United Kingdom, cefuroxime was favoured (Bint et al,
1980). This is a second generation cephalosporin which is less
active against Gram positive cocci than cephalothin but more active
against some Gram negative bacilli (Garrod et al, 1981). It was
used singly by Gokal et al (1980) in a dose of 200 mg/1 of
dialysate but combined with the antistaphylococcal agent
flucloxacillin, also given intraperitoneally, by Chan et al (1981).
In Belgium, either gentamicin or cotrimoxazole was the most popular
first choice (Lamiere et al. 1981), their dosage or route of
administration not being specified. In France, Mion et al (1981)
used the aminoglycoside, kanamycin, adding 20 mg/1 to each bag.
Only Oreopoulos et al (1981b) explicitly stated that their
initial treatment, cephalothin and tobramycin, was based on an
analysis of the antibiotic sensitivities of organisms they had
isolated from infected dialysate. Very few centres attempted to
describe the results of treatment with any given antibiotic. The
data of Rubin et al (1980) are ambiguous but suggest that of 49
episodes of peritonitis treated initially at home, only 32 (65%)
responded satisfactorily to cephalothin alone. Their data are
insufficient to assess the results of treatment in hospital.
Moncrief and Popovich (1981) did not detail their results but
stated that 85% of episodes responded to three days of
intraperitoneal cephalosporin followed by five to seven days of
oral cephalosporin. Chan et al (1981) found that an initial
combination of flucloxacillin and cefuroxime cured 75% of episodes.
It was not possible to determine the success of treatment with any
given antibiotic from the data presented by other authors.
Two groups reported that treatment had been complicated by
the emergence of antibiotic resistant staphylococci. Chan et al
(1981) reported that eight of 21 strains of coagulase-negative
staphylococci were resistant to flucloxicillin (their antibiotic of
choice) and many other antibiotics. Atkins et al (1981c) found
that 16 of 38 isolates of coagulase-negative staphylococci and
seven of twelve isolates of Staph, aureus were resistant to the
following antibiotics: penicillin, methicillin, cephalothin,
kanamycin, gentamicin, tobramycin, cotrimoxazole, chloramphenicol,
tetracycline and erythromycin. All isolates were, however,
sensitive to vancomycin. They reported that antibiotic resistance
led to the mean length of hospital admission per episode increasing
from 5.6 to 10.7 days when caused by coagulase-negative
staphylococci, and from 6.6 to 35.8 days (sic) when caused by
Staph, aureus.
Catheter Removal
By 1981, criteria for the removal of the intraperitoneal
catheter in the event of infection had been published by two
centres. Moncrief and Popovich (1981) and Oreopoulos and others
(1981b) both recommended removal of the catheter and drainage of
the peritoneal cavity when there was failure to respond to
peritoneal lavage and appropriate antibiotics. Specific criteria
for removal shared by both groups were: fungal or tuberculous
peritonitis; peritonitis accompanied by severe catheter tract
infection; and peritonitis due to bowel perforation. In the event
of fungal peritonitis, Oreopoulos recommended that the catheter
could usually be replaced after two or three weeks. In no report
was there a comprehensive analysis of the episodes of peritonitis
which resulted in catheter removal. Several authors indicated that
some patients successfully restarted CAPD a few weeks after
catheter removal (Rubin et al, 1980; Oreopoulos et al, 1981c;
Moncrief and Popovich, 1981). However, the long term outlook of
these patients was not discussed.
Moncrief and Popovich (1981) stated that patients who had had
more than three episodes of peritonitis in their first six months
of CAPD were generally advised to switch to haemodialysis if
practical. Other centres did not make explicit their criteria for
discontinuation of CAPD because of peritonitis. However, it would
seem inevitable that policies would vary considerably from centre
to centre under the influence of a multitude of factors, ranging
from the availability of haemodialysis time to the personalities of
the renal physicians.
7. Discontinuation of CAPD or Death Due to Peritonitis
The two most serious consequences of CAPD peritonitis are the
discontinuation of CAPD and death. By 1981, several reports had
been published showing that both outcomes occurred with worrying
frequency. Most centres had been using CAPD for only two or three
years and therefore many of their patients had been using the
technique for only a few months. Nevertheless, over 8% of all
patients who had been trained in the pioneering centres had already
discontinued CAPD because of peritonitis and at least 26 of the
patients covered by the reports had died from peritonitis (Table
P.4).
Some centres appeared more successful than others at avoiding
discontinuation and death. Mion et al (1981) in France, who
reported an extremely low peritonitis rate, discontinued CAPD
because of peritonitis in only two of 94 patients compared with
seven of 50 discontinued by Heale et al (1981) in Australia (X2 =
5.95, p < 0.02). However, the average duration of CAPD per
patient in the French report was little more than half that
reported by the Australians (Table P.4). The higher rate of
discontinuation in the latter centre may simply reflect a longer




















































































































Very little information was available about the major factors
contributing to discontinuation of CAPD or death. These could
include
(1) The general condition of the patient, including his or
her age and the nature of any underlying disease;
(2) The nature of the infecting organism(s);
(3) The delay between the onset of infection and the start
of treatment;
(4) The type of treatment given;
(5) The centres' policy for removal of the intraperitoneal
catheter and temporary or permanent discontinuation of
CAPD.
Oreopoulos et al (1981b) reported five patients who had died
of peritonitis. One had dementia, one a cerebral infarct, one
severe wasting and one developed abscesses secondary to
diverticulitis and treatment was withheld because of his general
condition. The two episodes of fatal peritonitis in the series
described by Fenton et al (1981) were both caused by virulent
organisms: Strep, pneumoniae and Strep, agalactiae. Both were in
septic shock on admission to hospital, more than 24 hours after the
onset of symptoms. As these organisms are virtually always highly
sensitive to the penicillins, it is quite likely these patients
would have survived if treated earlier.
No details of the other fatal episodes of peritonitis were
given, and thus the possibility that some were due to ineffective
treatment cannot be explored. However, it is clear that the
antibiotics used by many centres for the initial treatment of
peritonitis are inactive against some potentially dangerous
bacteria. For example, cephalothin alone would be ineffective
against P. aeruginosa, Enterobacter cloacae, many strains of
Proteus spp and Bacteriodes fragilis. Both gentamicin (Lameire et
al, 1981) and kanamycin (Mion et al, 1981) would leave the patient
unprotected against streptococci in particular. As culture and
antibiotic sensitivity results are rarely available within 24
hours, in such circumstances effective treatment may be long
delayed, with possibly disastrous consequences.
8. Antibiotic Toxicity
Most authors giving details of their antibiotic treatment of
CAPD peritonitis stated that they used aminoglycosides. Some, such
as Mion et al (1981) and Oreopoulos et al (1980) used them to begin
treatment. Others used them only when they were specifically
indicated (Rubin et al. 1980). All aminoglycosides are normally
renally excreted and are potentially ototoxic. Ototoxicity is thus
a major hazard of their use in patients in renal failure. Does the
manner in which they are used in treating CAPD peritonitis place
the patient at risk of ototoxicity?
Intraperitoneal administration appears a logical way of
ensuring that the bacteria causing CAPD peritonitis are exposed to
lethal concentrations of aminoglycoside, whilst the patient is
relatively shielded from its toxic effects. It quickly became the
route of choice, with most centres opting for either gentamicin or
tobramycin. However, the intraperitoneal dose per litre varied
considerably.
Chan et al (1981) used 3.3 to 6.6 mg/1; Moncrief and
Popovich, 5 mg/1; Gokal et al (1980), 8 mg/1; Oreopoulos et al
(1981b), 8 mg/1, preceded by a loading dose of 1.7 mg/kg
bodyweight; Atkins et al (1981c), 10 mg/1. Oreopoulos et al
(1981b) stated that their dosage schedule led to a serum
concentration of 6-8 mg/1 "which is not otoxic". De Paepe et al
(1981) studied three patients treated with intraperitoneal
gentamicin at a concentration of 7.5 mg/1 of dialysate. They found
that serum concentrations reached 3-5 mg/1 within five days. , Mawer
et al (1974) described vestibular toxicity in five patients treated
with gentamicin, in three of whom the peak serum concentration did
not exceed 8 mg/1. They concluded that there was a high risk of
ototoxicity if the product of the trough serum concentration in
milligrams per litre and the number of days of treatment exceeded
45. Thus, by their reckoning, ten days of treatment resulting in a
persistent serum concentration of gentamicin of 6-8 mg/1 would
carry a high risk of ototoxicity. Smith et al (1980) compared the
nephrotoxicity and ototoxicity of gentamicin and tobramycin in a
prospective randomised double-blind study. They found that
although tobramycin was significantly less nephrotoxic than
gentamicin, both drugs caused ototoxicity in about 10% of patients.
Peak serum concentrations of both antibiotics in their patients
were below 7 mg/1 and trough concentrations only 2.5-3.5 mg/1.
Thus, although no reports of aminoglycoside induced toxicity
occurring in CAPD patients had been published by 1981, it was
apparent that the intraperitoneal doses commonly used were
potentially ototoxic. Toxicity would seem particularly likely to
occur in patients receiving several courses of aminoglycosides in
succession.
9. At the conclusion of 1981, CAPD had emerged as an effective
form of dialysis, particularly suitable for treating certain types
of patient, and was already being widely used. However, despite
important technical improvements, bacterial peritonitis remained
the major complication of CAPD, although its incidence varied
considerably from centre to centre. Patient error during the
dialysis exchange was most often blamed as the source of the
infection. It seemed unlikely that peritonitis could be eliminated
until technical developments had substantially reduced the risk of
contamination during the bag exchange.
Peritonitis was caused by a limited range of bacteria, most
of which can be found on the human skin. However, in many centres,
causative organisms were not isolated in a large proportion of
cases. Inadequate culture methods seemed most often responsible.
A cheap, simple and effective culture technique had yet to be
designed. Most patients with peritonitis were treated in hospital,
an approach that was clearly costly and disruptive. Two centres
had, however, shown that some patients could be effectively treated
at home.
Antibiotics were generally given intraperitoneally but the
choice of antibiotic varied considerably. Several of the
antibiotics used to start treatment were inactive against organisms
commonly causing peritonitis. Aminoglycosides were used in some
centres at doses likely to be ototoxic in some patients. The rates
of discontinuation of CAPD and death due to peritonitis also
suggested that the treatment used by some centres at least was
suboptimal. The ideal of safe, effective, home treatment of
peritonitis for most patients had not yet been achieved.
10. CAPD Peritonitis at the Queen Elizabeth Hospital* in 1981
The first patient to use CAPD at the Queen Elizabeth
Hospital, Birmingham, was trained early in 1981. By the ertd of
that year, twelve patients had been established on CAPD, a full-
time nursing sister had been assigned to their care and a room set
aside for their exclusive use. As the hospital's haemodialysis
facilities were being fully used and patients in chronic renal
failure continued to be referred to the hospital, it seemed likely
that the number of patients using CAPD would increase steadily.
My association with the renal unit at the Queen Elizabeth
Hospital began at the end of 1981. By then, it was already clear
that peritonitis was the main threat to the success of the CAPD
service. Ten of the twelve patients on CAPD had already developed
peritonitis, including two who had had three episodes. The overall
incidence of peritonitis was one episode every 3.3 patient-months.
This was similar to that initially reported by the North American
centres which had pioneered CAPD (Rubin et al. 1980) but much
higher than that reported more recently by experienced centres (C.
Williams et al, 1981; Mion et al, 1981).
The high incidence of peritonitis had led to a growing number
of requests for the bacteriological examination of dialysate and
consequently to an appreciable increase in the workload of the
microbiological laboratory. However, there had as yet been no
attempt to establish a rational policy for such requests or to
assess the effectiveness of the microbiological diagnostic methods
in use.
During 1981, CAPD peritonitis was treated in hospital until
the infection was felt to be under control. The antibiotic of
first choice was cefuroxime, given as an initial intravenous
loading dose of 500 mg followed by 160 rag added to each new bag of
dialysate for two weeks. This approach was successful in most
cases but had two main drawbacks. Firstly, the high incidence of
peritonitis meant that hospital beds were often occupied by CAPD
patients with peritonitis, thereby disrupting or delaying the
investigation and treatment of other patients. Secondly, on
several occasions the bacteria causing peritonitis were resistant
to cefuroxime. Furthermore, in three patients the infection was
not eradicated by the initial course of cefuroxime, although the
causative organisms were apparently sensitive to cefuroxime.
RESEARCH AH) DEVELOPMENT OBJECTIVES
Our initial assessment (Prologue, Section 10) showed that
CAPD peritonitis at the Queen Elizabeth Hospital was comparable in
incidence and nature to that occurring in other centres. With a
view to reducing its impact upon the patients, the renal unit and
the bacteriological service, a research and development programme
was sketched out early in 1982. It consisted of four main
objectives
(1) To establish an effective routine service for the
microbiological diagnosis of CAPD peritonitis;
(2) To analyse the antibiotic sensitivities of bacteria
causing CAPD peritonitis with a view to finding the
most reliable antibiotics for its initial treatment;
(3) To simplify treatment, so that as many patients as
possible could be treated at home with the minimum
disruption to their routine;
(4) To reduce the incidence of peritonitis.
The following chapters describe our attempts to meet these
objectives, placing them in the perspective of work published by
other centres since the beginning of 1982.
CHAPTER 1
Establishment of a System for the Routine Bacteriological
Examination of CAPO Dialysate
Summary: After considering the various steps needed to make the
microbiological diagnosis of CAPD peritonitis, a more efficient and
economical system was developed. Normally, only cloudy dialysate
was examined. The renal unit staff injected dialysate effluent
into special culture bottles containing concentrated nutrient
broth. These could be incubated immediately without intervention
by a technician. They were then subcultured onto solid media after
24 hours incubation. A second sample of dialysate was also sent to
the laboratory for a white cell count and, after centrifugation, a
Gram stain and culture on solid media. The broth culture method
proved both sensitive and convenient and the system has now
operated smoothly for over three years. Great emphasis is placed
on ensuring effective communication between the laboratory and the
renal unit.
Introduction
With the advent of CAPD at the Queen Elizabeth Hospital, the
hospital microbiology laboratory was faced with increasing numbers
of requests for the bacteriological examination of dialysate.
During the first year of CAPD, there were no guidelines as to when
dialysate should be examined. Samples were often sent not only




treatment and at regular out-patient consultations, irrespective of
the patient's condition. Not infrequently, patients presented with
peritonitis at night or during the weekend. The duty physician
would then ask the on-call bacteriology technician to examine the
dialysate as an emergency. Soon, 15% of all out-of-hours
bacteriological requests and one third of those made after midnight
were for the examination of CAPD dialysate. CAPD peritonitis had
thus quickly become a major generator of laboratory work. It was
clearly necessary to establish criteria for sending specimens of
dialysate and to assess critically the techniques used to process
the dialysate in the laboratory. Otherwise, there was every
likelihood that this unbudgeted influx of specimens would disrupt
other aspects of laboratory work without the needs of the renal
physician necessarily being met. We thus considered in turn the
various steps leading to the microbiological diagnosis of CAPD
peritonitis. Following detailed consultation with the staff of
both the renal unit and the laboratory, it was then possible to
establish a service that was satisfactory to both parties.
the White Cell Count
As discussed earlier (p 20), it had been well established
that the onset of clinical peritonitis was almost always heralded
by the development of cloudy dialysate, due to the greatly
increased density of inflammatory cells (Moncrief and Popovich,
1981). It was found that dialysate became visibly cloudy when the
white cell count exceeded approximately 100/mnP. The white cell
count of uninfected dialysate is usually less than 50/mm^ and that
of infected dialysate greater than 300/mm^ (Prowant and Nolph,
1981). Consequently, cloudy dialysate is a very good indicator of
infection except in those rare cases where the cloudiness has some
other cause (p 30). It was thus decided that a white cell count
should be performed only when the dialysate was cloudy, enabling
the diagnosis of peritonitis to be affirmed and providing a
baseline against which the effect of treatment could be measured.
Under normal circumstances, a white cell count on clear dialysate
was not justified.
The white cell count would be performed on fresh dialysate
using a Fuchs-Rosenthal haemocytometer. A differential count of
polymorphonuclear leukocytes and other white cells would be made
and the count reported as the number of cells per cubic millimeter.
Gram Stain
As discussed earlier (p 31), a Gram stain of cloudy dialysate
reveals bacteria in only a minority of cases even when a
centrifuged deposit is used. However, it was felt that this cheap
and rapidly performed test should be carried out on all specimens,
at least until satisfactory culture techniques had been developed.
The results of the Gram stain and culture could then be compared.
It was also thought that the Gram stain might prove helpful in
cases of severe peritonitis, when the density of bacteria might be
high, and in the early diagnosis of fungal infection, which
requires totally different treatment.
The Gram stain would be performed on a smear of the deposit
obtained after centrifuging 20 ml of dialysate in a plastic
universal container at 3,000 rpm for 15 minutes.
Dialysate Culture
Studies of the culture of infected dialysate published before
1982 had shown that the presumably infective bacteria were often
present in the dialysate in very small numbers (p 31).
Consequently, it seemed that the chances of successful culture
would be enhanced by processing a relatively large volume of
dialysate. During the first year of CAPD at the Queen Elizabeth
Hospital, a simple centrifugation method was used. This method led
to successful culture in only 12 of the 21 episodes of peritonitis
during that period, a rate of positive culture similar to those
reported by other centres using centrifugation.
We have already seen (p 33) that in only two adequately
described studies were causative organisms isolated in more than
90% of cases. In both, the organisms were cultured in liquid
medium. In one, dialysate was passed through a filter and the
filter then submerged in broth. In the other, 5 ml of dialysate
were added to each of four tubes of liquid medium. It was clear,
however, that filtration has several disadvantages. The dialysate
cannot be cultured until it has been carefully processed by a
skilled technician: this will lead either to delay or extra expense
if the samples are taken outside laboratory hours. The filter is
readily blocked when the dialysate contains a lot of white cells
and fibrin. Special precautions are necessary if anaerobes are to
be successfully cultured. Filters are expensive.
To permit the culture of a large volume of dialysate without
the need for centrifugation or filtration, the following technique
was adopted. Twenty millilitres of nutrient broth prepared at four
times the normal culture concentration were added to a standard
100 ml blood culture bottle, and then sterilised. By adding 60 mis
(the contents of the largest standard syringe) of dialysate to the
bottle, the broth was diluted to the correct concentration. The
culture bottle could then be treated exactly like a blood culture
bottle. In particular, if the bottle was inoculated outside
laboratory hours, it could be incubated immediately in the out-of-
hours blood culture incubator. There was thus no need for
intervention by laboratory staff until the following day.
A suitable nutrient broth had to have two main
characteristics. It had readily to permit the growth of a wide
range of aerobic and anaerobic organisms including staphylococci,
streptococci, Enterobacteriaceae, Bacteriodes fragilis and fungi.
It also had to be fully soluble at four times its normal
concentration. A broth which appeared to satisfy these
requirements was Oxoid no 2.
From 1 March 1982 onwards, dialysate was processed using both
liquid culture and culture of a centrifuged deposit. It was soon
evident that liquid culture was indeed the more sensitive method.
During the first three months, dialysate from 21 episodes of
peritonitis was cultured and organisms were isolated from all
samples. However, organisms were isolated by liquid culture in 19
of the 21 episodes compared with only 12 of 21 by deposit culture
(X^ = 4.43, p < 0.05). Table 1.1 shows that the majority of
organisms isolated by liquid culture alone were coagulase-negative
staphylococci. A Staph, aureus and an Acinetobacter calcoaceticus
were isolated only by deposit culture. In the light of these
encouraging results, it was decided to continue to use both methods
TABLE 1.1
METHOD OF CULTURE OF BACTERIA FROM 21 CONSECUTIVE EPISODES OF
CAPD PERITONITIS MARCH - MAY 1982
Method of Culture




Staphylococcus aureus 0 0 1
Streptococcus spp 1 1 0
Gram negative bacilli 3 2 1
Total 10 9 2
routinely. The results of a comparison of the two methods over two
years are given in the following chapter.
As discussed above, it had been judged that a white cell
count on macroscopically clear dialysate could not normally be
justified. To determine whether there was any value in culturing
clear dialysate, we cultured a series of 88 specimens taken at
random over a two month period from patients who, clinically, did
not have peritonitis, and in which the white cell count was less
than 100/mm^. On only seven of the 88 occasions (8%) was an
organism isolated (coagulase-negative staphylococci (3),
diphtheriods (2), Serratia marcescens (1), and Strep, faecalis
(1)). On none of these occasions did peritonitis due to the
organism isolated subsequently develop. These results indicated
that the culture of clear dialysate in asymptomatic patients would
rarely if ever hasten the diagnosis of peritonitis. The culture of
clear fluid could thus not normally be justified. A fuller
discussion of the significance of the organisms isolated from clear
dialysate appears on page 67.
The results of this assessment of the various facets of the
bacteriological examination of dialysate were discussed with the
staff of the renal unit and the laboratory and agreement reached.
The arguments against the need for an out-of-hours service are set
out in Appendix 1. Appendix 2 is a summary of the instructions
issued to renal unit and laboratory staff at the Queen Elizabeth
Hospital. Appendix 3 is a summary of similar proposals adopted by
staff at the Centre D'Hemodialyse des Hospices Civils de Lyon.
58
Discussion
This bacteriological policy has now been in use for over
three years. As well as being effective microbiologically, it has
also proved extremely satisfactory economically and economically.
The culture bottles are prepared in batches in the laboratory media
room and stocks maintained in the CAPD room in the renal unit.
Because the analysis of clear fluid has ceased, the number of
specimens received has been kept within manageable limits, despite
the rapid increase in the number of patients treated: 12 in 1981,
108 in 1984. The elimination of out-of-hours requests has also
meant considerable savings. Once the culture bottles reach the
laboratory, they are treated exactly like blood cultures and
consequently can be processed by all levels of laboratory staff
without special training. A satisfactory system has thus been laid
down. A key element in-its success, however, has been, and
remains, the close contact that exists between the renal unit and
the laboratory. This ensures that results are transmitted to the
renal unit staff as soon as they are available, allowing
therapeutic decisions to be made without undue delay.
o™ 2
A COMPARATIVE STUDY OF TWO METHODS OF CULTURE OF CAPO DlALYSATE
Summary: Two methods of culture of dialysate effluent were compared
using samples from 148 episodes of CAPD peritonitis. Addition of
60 mis of dialysate to concentrated nutrient broth yielded growth
in 89% of cases; culture on solid media of a centrifuged deposit
from 20 mis of dialysate in only 65%; and the two methods combined
in 95%. Coagulase-negative staphylococci and streptococci were
isolated much more readily by broth culture. Several strictly
aerobic Gram-negative bacilli were isolated only on solid media.
These results show that the microbiological diagnosis of most cases
of CAPD peritonitis can be made without recourse to expensive or
complex techniques.
Introduction
In this chapter, I present the results of a two year
prospective study comparing the two methods of dialysate culture
routinely used at the Queen Elizabeth Hospital: culture of 60 mis
of dialysate in nutrient broth, and culture on solid media of a
centrifuged deposit of 20 mis of dialysate.
Patients and Methods
All patients presenting with CAPD peritonitis at the renal
unit of the Queen Elizabeth Hospital between 1 March 1982 and 29
February 1984 were included in the study. Patients had been
instructed to attend the hospital renal unit if their dialysis
effluent became cloudy or if they developed abdominal pain, nausea,
vomiting or fever. A diagnosis of infective peritonitis was made
if the polymorphonuclear leukocyte count in the dialysate exceeded
100/mm3.
After the patient's clinical condition had been assessed by
the duty doctor, 80 mis of dialysis effluent were removed from the
dialysate bag by the injection port (previously cleaned with an
alcohol soaked swab) using a sterile syringe and needle. Using a
fresh sterile needle, 60 mis were injected into a 100 ml blood
culture bottle containing 20 ml of sterile nutrient broth (Oxoid
No 2) at four times normal culture concentration. The remaining
20 ml were placed in a sterile plastic universal container. During
normal laboratory working hours, all samples were sent directly to
the laboratory. At other times, the dialysate culture bottle was
kept in the out-of-hours incubator at 37°C and the universal
container in a refrigerator at 4°C until the laboratory opened.
In the laboratory, the fluid in the universal container was
gently shaken and several drops removed for a cell count in a
Fuchs-Rosenthal haemocytometer. The remainder was centrifuged at
3,000 rpm for 15 minutes. All but a drop of the supernatant was
discarded and the deposit resuspended. A small portion was used to
make a Gram smear and the remainder inoculated onto blood and CLED
agar for aerobic incubation and blood agar for anaerobic
incubation. The culture bottle was incubated aerobically.
Subculture onto solid media for both aerobic and anaerobic
incubation was performed routinely after 24 hours incubation and at
any time during the next eight days if growth was seen. Isolates
were identified using conventional techniques.
Results
There were 155 episodes of CAPD peritonitis during the study
period. In seven, only one of the two methods of culture was used.
The study is therefore based on 148 episodes.
In 87 episodes (59%), bacteria were isolated by both methods.
In 82 of these, both methods yielded the same organism (one species
in 80 and two in two); in two, each method yielded a different
organism; and in three, bottle culture yielded two organisms and
deposit culture only one. In 44 episodes (30%), isolation was by
bottle culture only (one organism in 43 episodes and two in one).
In nine episodes (6%), isolation was by deposit culture alone. In
eight episodes (5%), no organism was isolated. Thus, bottle
culture led to the isolation of bacteria in 131 episodes (89%),
plate culture in 96 (65%) and the two methods combined in 140
(95%).
The method or methods by which each strain was isolated are
shown in the Table. This shows that coagulase-negative
staphylococci and streptococci were isolated much more readily by
bottle culture than by deposit culture. Staph, aureus, Pseudomonas
spp and Acinetobacter spp were isolated with equal facility by both
methods. However, an Agrobacterium sp (yellow group) and two
unidentified aerobic Gram negative bacilli were only isolated by
deposit culture, the former repeatedly. On the two occasions that
anaerobes were isolated, they were isolated by bottle culture only.
TABLE 2.1
METHOD OF CULTURE OF 148 BACTERIAL ISOLATES FROM DIALYSATE
IN 140 EPISODES OF CAPD PERITONITIS
Method of Isolation




S. aureus 10 0 1
Streptococcus spp 5 12 0
Diphtheriods 1 4 2
Acinetobacter spp 4 1 1
Enterobacteriaceae 13 5 1
Pseudomonas spp 7 0 0
Agrobacterium sp 0 0 1




Yeast 1 0 0
Total 87 50 11
Culture and the Gram Stain
Organisms were seen on Gram stain of the deposit in 39
episodes (27%). In coagulase-negative staphylococcal peritonitis,
the Gram stain was positive significantly more often when the
organism was isolated by both methods (17 of 45 episodes) than when
it was isolated by bottle culture alone (3 of 26 episodes) (X2 =
5.58, p < 0.02). This suggests that liquid culture was the more
sensitive method for isolating organisms present in small
concentrations.
Culture and the White Cell Count
There was no correlation between the dialysate white cell
count and the likelihood of isolation of bacteria by both methods
or by either method alone. For example, the mean dialysate white
cell count in the 45 episodes where coagulase-negative
staphylococci were isolated by both methods was 2,500/mm2
(SD+2,700/mm2) compared with 2,400/mm2 (SD+3,400/mm2) in the 26
episodes where coagulase-negative staphylococci were isolated by
liquid culture alone.
Culture and the Response to Treatment
The clinical severity of the peritonitis had no bearing on
whether organisms were subsequently isolated by both methods or by
one method alone. Gram positive organisms were treated with
intraperitoneal vancomycin and Gram negative organisms generally
with an aminoglycoside, also intraperitoneally (see chapters 5 and
6). The response to treatment was equally satisfactory in cases
where organisms were isolated by both methods and in those where
they were isolated by liquid culture alone.
Culture Negative Cases
In five of the eight episodes where there was a raised
dialysate white cell count but negative culture, the patient was
asymptomatic. Two of the five patients had had recent culture
positive peritonitis and had stopped taking antibiotics two and six
days before the sample was taken; a third had received
intramuscular cefamandole until three days before; one had stopped
CAPD for 48 hours before the sample was taken and the dialysate may
thus have been unusually concentrated, thereby giving a misleading
high white cell count; one was seen on a Saturday and samples were
not incubated until two days later. A sixth patient with
symptomatic culture negative peritonitis was seen on Christmas Day,
again suggesting the possibility of delayed culture. The seventh
patient who had severe symptoms of peritonitis had received dental
treatment two days before. This points to a streptococcal
infection (Vas, 1981), possibly due to a vitamin Bg deficient
strain. The eighth patient also had symptomatic peritonitis.
Although intracellular Gram positive cocci were seen on the deposit
Gram stain, culture was negative.
All eight patients responded rapidly to intraperitoneal
vancomycin and gentamicin.
Discussion
This study showed clearly that liquid culture is a more
sensitive method than deposit culture for the isolation of bacteria
from infected dialysate. Our liquid culture method led to the
isolation of organisms in 89% of cases compared with only 65% by
deposit culture. This difference was largely due to the more
frequent isolation by liquid culture of coagulase-negative
staphylococci and streptococci. Liquid culture also led to the
only two isolations of anaerobes. There was evidence that, in
part, this superiority lay in the greater ability of liquid culture
to permit growth of organisms present in very small numbers: if
coagulase-negative staphylococci were isolated by liquid culture
alone, the initial Gram stain was significantly less likely to have
been positive than if they were isolated by both methods.
The earlier study of the culture of clear dialysate (p 57)
showed that organisms can sometimes be isolated from dialysate in
the absence of peritonitis. Some of these isolates could have been
the result of contamination during sampling or processing. In this
respect, liquid culture would appear less vulnerable than deposit
culture, as the former requires less manipulation prior to
incubation. Alternatively, the isolates could have represented
non-pathogenic organisms present in the dialysate during sampling.
Slingeneyer and others (1981) studied the use of bacterial filters
fitted to the administration tubing with the aim of preventing
micro-organisms passing from the dialysate bag or the bag connector
to the peritoneal cavity. They cultured 114 filters each of which
had been used for between 40 and 60 dialysate exchanges. Organisms
were cultured from the bag side only in 26 of the 114 filters, the
most common isolates being staphylococci, Bacillus spp and yeasts.
Their results indicate that organisms find their way into the
dialysate relatively frequently but cause peritonitis in only a
minority of occasions, even when a filter is not used. Presumably,
the organisms are eliminated by the peritoneal cavity's natural
defences. It is thus possible that such non-pathogenic organisms
may occasionally be isolated from the dialysate of patients with
peritonitis, whilst the true cause escapes detection. The more
sensitive the method of culture, the more frequent are such false
positive isolates likely to be. The present study suggests,
however, that the organisms isolated by liquid culture alone had
the same clinical significance as those isolated by both methods.
The clinical features, dialysate white cell count and response to
treatment of episodes associated with coagulase-negative
staphylococci were similar, irrespective of whether the organisms
were isolated by both methods or by liquid culture alone. It thus
seems certain that the great majority of organisms isolated by
liquid culture alone were genuine pathogens.
Use of the two methods in parallel led to the isolation of
organisms in 95% of episodes. The nine isolates which were only
cultured from the deposit included three strictly aerobic bacteria.
Of these, an Agrobacterium sp was repeatedly grown only from the
deposit. This suggests that the bottle was insufficiently
oxygenated to permit the growth of some fastidious aerobes. Rather
than attempting to provide satisfactory conditions for the
isolation of all types of bacteria in one medium, greater success
might be had if two different liquid media are used. Trials are at
present underway in Les Hospices Civils de Lyon using brain heart
infusion broth for aerobes and Schaedler broth for anaerobes.
Fifty millilitres of cloudy dialysate are injected into each of the
two culture bottles, each containing 50 ml of broth at twice normal
culture concentration. Should these trials prove successful,
deposit culture will become superfluous and the processing of
dialysate further simplified.
In only two of the 148 episodes did it seem likely that more
complex techniques would have improved the chances of isolating
bacteria. One of the eight culture negative cases developed
shortly after dental treatment. A viridans streptococcus would
thus be the most likely causative organism (p 28) and a pyridoxine
containing medium might therefore have revealed a vitamin Bg
deficient strain. In another culture negative case, intracellular
organisms were seen. Here, disruption of leukocytes prior to
culture might have been helpful. In the other culture negative
cases, however, it appeared more likely that antibiotics in the
dialysate or delayed culture were to blame.
No major advances in the microbiological examination of
dialysate have been published since the start of this study.
Knight and others (1982) inoculated 2-3 mis of dialysate into a
bottle containing thioglycollate broth under 5% C02 and reported a
positive culture in 42 of 50 episodes. The Gram stain was positive
in only eight episodes. Beardsworth and others (1983) used similar
methods and reported a positive culture in 90% of 130 episodes.
The Gram stain was positive in 30%. Fenton (1982) described a
pour-plate method in which 1 ml of dialysate was mixed with 10 mis
of molten nutrient agar and poured into a sterile Petri dish.
After the agar had set at room temperature, the plate was incubated
for 72 hours at 37°C in air plus C02. Organisms were thus isolated
in 11 of 14 episodes of peritonitis. However, because the number
of episodes considered was so small, the method could not properly
be assessed. The method also had two practical disadvantages: the
volume of dialysate may be insufficient if few organisms are
present; and the medium must be inoculated by skilled laboratory
staff, making the method unsuitable for use outside normal
laboratory hours.
Filtration continued to be widely used. Both Vas (1983) and
Prowant and Nolph (1982) reported that filtration led to the
successful isolation of organisms in nearly all episodes. Neither,
however, offered a detailed analysis of their results. However,
Gokal and others (1982) reported that their filtration method
yielded organisms in only 80% of episodes. The expense and
inconvenience of filtration, previously discussed (p 54), were
generally glossed over by its advocates.
It is thus clear that isolates of organisms in at least 80%
of episodes should be readily attainable by all laboratories.
Several recent reports indicate, however, that many laboratories
continue to fall short of this target. In a survey of 41 dialysis
units using CAPD in the United Kingdom, only one half reported they
could culture the infecting organism in at least 70% of episodes
(Gokal and Marsh, 1984). Only one in five claimed positive
cultures in at least 90% of episodes. Whilst the majority of
laboratories used methods involving centrifugation, filtration or
liquid culture, 25% merely cultured uncentrifuged dialysate using
routine laboratory techniques. More recently, Gray and others
(1985) in London, using culture of a centrifuged deposit, isolated
bacteria in only 48% of cases; Read and others (1985) in Leeds
isolated organisms in 60% of cases but did not describe their
methods of culture. Poor results were not confined to this side of
the Atlantic. Rubin and others (1983) in Missouri also reported
that 40% of their episodes were culture negative. They used two
methods of culture: 0.5-1 ml of dialysate was inoculated into
thioglycollate broth and 0.01 ml of dialysate was streaked onto
blood agar plates. Three years earlier, the same principal author
had been unable to detect more than 25 organisms/100 ml of
dialysate in many episodes of peritonitis (Rubin et al, 1980).
Thus, by his own reckoning, the culture methods subsequently used
by his collaborators would often have little chance of success.
Most recently, Vas and others (1985) have described further
refinements in their methods- They appear to have abandoned
filtration in favour of centrifugation; they use resins or washing
by repeated centrifugation to remove antibiotics present in the
dialysate; and they use the Bactec system to detect bacterial
growth early. However, their results do not suggest that these
modifications offer any advantage except in the case of the patient
already on treatment. Their paper closes with the following
sentence: "Although the cost of the above-described methods is
considerable, one has to weigh the cost of laboratory diagnosis
against the possibility of unnecessary therapy and prolonged
hospitalisation." The present study has shown that high laboratory
costs can be avoided without endangering the quality of the
service.
Chapter 3
The Organisms Causing CAPD Peritonitis and their Antibiotic
Sensitivities
1. The Coagulase-Negative Staphylococci*
Summary: Forty-three strains of coagulase-negative staphylococci
were obtained from dialysis effluent during 41 episodes of CAPD
peritonitis. Eighty per cent of these were found to be Staph,
epidermidis but several other species also occurred. A recurrent
infection lasting 15 weeks was caused by Staph, haemolyticus.
Multiple antibiotic resistance was found to be common. Of 13
antibiotics tested, only vancomycin was active against all strains
although most strains were also sensitive to rifampicin, netilmicin
and cefamandole. Vancomycin was therefore selected as the most
suitable antibiotic for the initial treatment of CAPD peritonitis
caused by coagulase-negative staphylococci.
Introduction
Even with efficient methods of culture, the identification of
the organisms causing CAPD peritonitis and their antibiotic
sensitivities will not be known for at least 24 hours after the
patient is first seen. Treatment, however, should normally be
begun without delay to bring the infection quickly under control.
* Much of the data in this chapter was included in a paper
published in the Journal of Antimicrobial Chemotherapy. See
Appendix 4.
Consequently, the initial treatment should include antibiotics
active against most if not all the likely causative organisms.
This is particularly vital if it is hoped to treat most patients at
home. Frequent failure of the initial treatment would render such
a policy unworkable. We therefore felt it was essential to
determine the antibiotics most likely to control the infection from
the outset. We aimed to do this by studying the antibiotic
sensitivities of a large number of isolates from the infected
dialysate of CAPD patients at the Queen Elizabeth Hospital.
As we saw earlier (p 23), virtually all CAPD centres have
found that coagulase-negative staphylococci are the most common
cause of CAPD peritonitis. Two reports also showed that these
organisms could often be resistant to many antibiotics (Chan et al,
1981; Atkins et al, 1981c). We quickly found that the situation
was similar at the Queen Elizabeth Hospital. Twelve of the 21
episodes seen in early 1982 were caused by coagulase-negative
staphylococci. These included three of the four episodes which did
not respond to cefuroxime, the antibiotic of choice at that time.
Each of the three strains was reported as sensitive to cefuroxime
but resistant to flucloxacillin and several other antibiotics.
However, staphylococci that are resistant to flucloxacillin
consistently show reduced sensitivity to the cephalosporins (Lowy
and Hammer, 1983). It thus seemed possible that the antibiotic
content of the disc used to test for cefuroxime sensitivity was too
high to detect reduced sensitivity and that the result of the
cefuroxime test could thus be misleadingly optimistic.
It was therefore clear that a detailed study of our isolates
of coagulase-negative staphylococci was required due both to the
frequency with which they caused peritonitis and to their uncertain
sensitivity to antibiotics.
As discussed earlier, all the authors of reports of CAPD
peritonitis published before 1982 had described their isolates of
coagulase-negative staphylococci as Staph, epidermidis. They did
not indicate how such isolates had been identified and it must
therefore be assumed that they had done no more than confirm that
the isolates were staphlococci which did not produce coagulase. It
has for long been known that the coagulase-negative staphylococci
are a heterogenous group of organisms (Baird-Parker, 1965).
However, it was not until 1975 that a manageable classification was
proposed (Kloos and Schleifer, 1975). This recognised nine
distinct species based on an extensive series of biochemical tests.
The species Staph, epidermidis was retained but its definition
became much more precise. With the acceptance of this
classification by the International Journal of Systematic
Bacteriology (Schleifer and Kloos, 1975), it henceforth became
strictly incorrect to describe all coagulase-negative staphylococci
as Staph, epidermidis without recourse to further tests. However,
because such tests are expensive and time-consuming and the results
generally have little if any clinical relevance, the old ways have
persisted.
More recently, a rapid micromethod based on the Kloos and
Schleifer classification has been developed (Brun et al, 1978).
This permits the identification of coagulase-negative staphylococci
within 24 hours and has been available in commercialised form for
several years. Precise identification of coagulase-negative
staphylococci is now possible in all routine microbiological
laboratories. A further, as yet imperfect, means of
differentiating coagulase-negative staphylococci for
epidemiological purposes is phage typing (de Saxe et al, 1981).
As coagulase-negative staphylococci causing CAPD peritonitis
had not been studied in any detail before, it seemed useful not
only to test their antibiotic sensitivities but also to
characterise them as precisely as possible. I thus collected all
coagulase-negative staphylococci isolated from the infected
dialysate of CAPD patients during the twelve months from 1 May
1982.
Materials arid Methods
Initial Isolation and Identification: Dialysate from patients
with peritonitis was sampled and processed as previously described
(p 60). All isplates of Gram positive cocci resembling
staphylococci were purified on Columbia agar base (Oxoid Ltd) by'
twice plating out from a single colony. Isolates were subjected to
the following primary identification tests: catalase, coagulase and
oxidation or fermentation of glucose (Hugh and Leifson, 1953). All
catalase-positive, coagulase-negative, fermentative isolates were
then characterised further.
API Staphylococcus identification galleries (API, Montalieu,
Vercieu, France) were used according to the manufacturer's
instructions. Tests included in the galleries were the fermentation
of glucose, fructose, mannose, maltose, lactose, trehalose,
mannitol, xylitol, melibiose, raffinose, xylose, saccharose, a-
methyl glucoside and N-acetyl-glucosamine; the reduction of nitrate
to nitrite; the production of acetyl-methyl-carbinol (V-P test);
and the production of alkaline phosphatase, arginine hydrolase and
urease. On the basis of the results each isolate was assigned a
numerical profile which could then be used to identify the isolate
from an index provided by the manufacturer and based on the
classification of Kloos and Schleifer (1975).
Biotyping using conventional methods and phage-typing (de
Saxe et al, 1981) were carried out by the Central Public Health
Laboratory (CPHL), Colindale, London. The tests used were the
fermentation of fructose, maltose, lactose, trehalose, mannitol,
xylitol, xylose, arabinose, ribose and sucrose; the reduction of
nitrate to nitrite; and the production of acetion and alkaline
phosphatase. Each isolate was then assigned a biotype according to
a modification of the Baird-Parker classification which could then
be converted to the Kloos and Schleifer classification (Marples,
1981; Marples and Richardson, 1982).
Antibiotic Sensitivity Testing: Thirteen antibiotics with
known anti-staphylococcal activity were tested. The minimum
inhibitory concentration (MIC) of each antibiotic for each isolate
was found by a standard agar plate dilution method (Waterworth,
1978) with Iso-Sensitest agar (Oxoid Ltd). Control strains of
coagulase-negative staphylococci were provided by the Antibiotic
Research Laboratory, Dudley Road Hospital, Birmingham and were
included on each plate. All MICs were determined after 24 hours
incubation except for flucloxacillin, cefuroxime and cefamandole
where the determination was made at 48 hours.
A short antibiogram was obtained for each isolate using five
antibiotics (gentamicin, erythromycin, clindamycin, flucloxacillin
and fusidic acid) to each of which resistance was common and
apparently independent. The production of p-lactamase was detected
by the method of Park, Lopez and Cook (1978).
Results
A total of 61 isolates of coagulase-negative staphylococci
were obtained from 52 specimens of dialysis effluent during the
period 1 May 1982 to 30 April 1983. These specimens were collected
during 41 episodes of acute peritonitis in 25 patients. A
coagulase-negative staphylococcus was twice cultured concurrently
with an acinetobacter, once with a Staph, aureus and once with a
p-haemolytic streptococcus. On seven occasions, two or three
colonial types of coagulase-negative staphylococci were obtained
from a single specimen. On five of these occasions futher
characterisation showed that they were all colonial variants of the
same strain, but on two occasions the isolates had different
biotypes and antibiograms.
Identification: After considering the source, biotype, phage
type and antibiotic sensitivity of each of the 61 isolates, we were
able to distinguish only 43 strains. These are classified
according to species in Table 3.1 which shows that most were Staph,
epidermidis. There was close agreement between API and CPHL
biotyping as to which strains were Staph, epidermidis but several
of the other strains were speciated differently by the two methods.
Hie same strain was isolated more than once from each of nine
patients. In five, all the isolates were cultured during the
TABLE 3.1
SPECIATION OF 43 DISTINCT STRAINS OF COAGULASE NEGATIVE




Staph, epidermidis 36 34
Staph, haemolyticus 2 2
Staph, warneri 1 2
Staph, cohnii 1 1
Staph, capitis 1 0
Staph, simulans 0 2
Staph, hominis 1 2
Untypeable 1 0
* Tests carried out by Central Public Health Laboratory,
Colindale
initial course of antibiotics and were not re-isolated thereafter.
In three, the same strain was re-isolated between one and three
weeks after the first course of treatment but did not recur after
the second course. In one patient the same strain of Staph,
haemolyticus was isolated from the dialysate on four different
occasions over a period of 15 weeks. On each of these occasions
the patient had peritonitis and no other organism was isolated.
During the 12 months of the study, four patients had two
separate episodes of peritonitis caused by different strains of
coagulase-negative staphylococci, three patients had three and two
had four.
Phage Typing: Only 26 of the 59 isolates tested showed lysis
by one or more phages and lysis was often weak. On two occasions,
phage typing clearly differentiated isolates from the same patient
which had identical biotypes and antibiograms. Phage typing also
sometimes confirmed that isolates cultured on different occasions'
from the same patient were identical.
MIC^q and MlCgg: All but six of the 43 distinct strains
produced p-lactamase. The MICs of each of the 13 antibiotics for
50% and 90% of the strains are shows in Table 3.2. Also included
in the Table are the antibiotic concentrations which can be readily
but safely achieved in dialysis fluid and blood. Only six of the
13 antibiotics - vancomycin, rifampicin, netilmicin, cefamandole,
fusidic acid and clindamycin achieved an adequately low MICgg. All
strains were sensitive to 1 or 2 mg/1 of vancomycin and only one
strain was resistant to rifampicin. All but two strains were
sensitive to netilmicin and cefamandole at 2 and 4 mg/1,
respectively, but the MICs of both these antibiotics varied between
TABLE 3.2
MIC50 AND MICgo OF 13 ANTIBIOTICS FOR STRAINS OF COAGULASE NEGATIVE
STAPHYLOCOCCI FROM PATIENTS WITH CAPD PERITONITIS COMPARED WITH












Vancomycin 41 2 2 15 20
Rifampicin 41 0.004 0.008 - 5*
Netilmicin 41 0.125 1 6 4
Cefamandole 39 1 4 30 10
Fusidic Acid 41 0.125 2 25 20
Clindamycin 42 0.06 0.125 25 5
Flucloxacillin 43 2 >32 50 10
Cephradine 35 16 32 - 10+
Cefuroxime 35 16 >32 30 10
Erythromycin 42 0.125 >32 - 1.5 +
Gentamicin 41 0.125 16 4 4
Tobramycin 35 0.125 >16 4 4
Trimethoprim 35 >16 >16 - 3+
* Approximate mean inter-dose level following standard intra-peritoneal dose
(Oreopoulos et al, 1981b)
t Approximate mean inter-dose level following standard intravenous dose (or
oral dose where marked) suitable for patient with severe renal impairment
(Garrod et al, 1981)
+ Given orally
strains by a factor of up to 64 suggesting that strains with
greater resistance might readily emerge. There were three strains
resistant to clindamycin (all > 32 mg/1) and four to fusidic acid
(> 8 mg/1).
We concluded that vancomycin appeared to have the most
consistent activity of all the antibiotics tested. Rifampicin,
netilmicin and cefamandole also seemed worthy of further
consideration for clinical use.
Antibiograms: Sixteen of the 61 isolates tested were
sensitive to all five antibiotics but each of the other 45 isolates
was resistant to between one and four. Table 3.3 shows the
percentage of strains which were resistant to each of the five
antibiotics compared with those from seven other recent studies of
coagulase-negative staphylococci isolated from a variety of
clinical specimens.
There were 14 different patterns of resistance to the five
antibiotics among our isolates, several patterns being unique to
isolates from a single patient. On all but one occasion, isolates
with identical phage types also had identical antibiograms.
Conversely, only twice did an isolate have a different phage type
but the same antibiogram. Thus, phage typing and the antibiogram
had similar usefulness.
Discussion
Only about 25% of the coagulase-negative staphylococci found
on normal human skin are Staph, epidermidis, sensu stricto (Kloos























































































































coagulase-negative staphylococci show that from 63 to 81% are
Staph, epidermidis (Marsik and Brake, 1982; Gemmell and Dawson,
1982; Sewell et al, 1982) whilst as many as 93% of clinically
significant coagulase-negative staphylococcal infections may be
caused by Staph, epidermidis (Sewell et al, 1982). The present
study of 43 distinct strains of coagulase-negative staphylococci,
all of which were thought to be clinically significant, showed that
about 80% were Staph, epidermidis. Thus, the apparently greater
pathogenicity of Staph, epidermidis compared with other coagulase-
negative staphylococci includes a greater propensity to cause CAPD
peritonitis. Nevertheless, the infection can also be caused by
other coagulase-negative staphylococci. Most notably, Staph,
haemolyticus was responsible for a recurrent infection lasting 15
weeks.
A beginning has been made in elucidating the mechanisms of
pathogenicity of Staph, epidermidis. It causes infection almost
exclusively following colonisation of implanted plastic materials
(Lowy and Hammer, 1983). As catheters, artificial joints and
valves and other prosthetic devices have become more and more
widely used, so have the opportunities afforded to Staph,
epidermidis increased. Electromicrographic studies have shown that
Staph, epidermidis can adhere to and form microcolonies on the
surface of synthetic polymers (Peters and Pulverer, 1984). Growth
often begins on areas of surface irregularity. The microcolonies
secrete extracellular slime which ultimately covers the bacteria
completely. This slime, which is thought to be a glycoconjugate
complex may have several important functions. It may allow the
organisms to adhere firmly to plastic and it may act as a barrier
against antibiotics (Peters and Pulverer, 1984). Most recently it
has also been shown that the slime can interfere with the immune
system (Gray et al, 1984). The lymphoproliferative response of
peripheral mono-nuclear cells was shown to be markedly inhibited by
the slime. It is not yet clear, however, whether or not the
pathogenicity of coagulase-negative staphylococci depends entirely
on the production of slime.
Biotyping was found to be helpful in determining which
isolates represented persisting and which fresh infection. As
other authors have shown, the API Staph, system gave results which
correlated well with those of conventional methods, yielding
numerical profiles which could be readily compared (Marples and
Richardson, 1982; Gemmell and Dawson, 1982; Ellner and Myrick,
1982). Further differentiation of some strains was made possible
by phage typing or antibiotic sensitivity testing, but both
approaches had disadvantages. The phage-typing system could type
only 50% of isolates and extensive antibiotic sensitivity testing
is too expensive and laborious for routine, clinical use. The
short antibiogram, on the other hand, proved capable of
differentiating some strains, as well as providing clinically
useful information.
Antibiotic Sensitivities: Resistance to flucloxacillin,
cefuroxime, cephradine, gentamicin, tobramycin, trimethoprim and
erythromycin was sufficiently frequent among our isolates of
coagulase-negative staphylococci to make these agents unsuitable
for routine use. Although apparently not universal, resistance to
these and other antibiotics is widespread (Table 3.3) and may be
increasing. Richards and Marples (1982) have noted that the
proportion of gentamicin-resistant strains of coagulase-negative
staphylococci has risen from 7% in 1976-77 to 33% in 1980.
Cefamandole and netilmicin were both notably more active than
the other cephalosporins and aminoglycosides we tested, a feature
also noted by Smith and others (1982). However, we found their
MlCs varied greatly from strain to strain, suggesting that a
progressive decrease in the sensitivity of coagulase-negative
staphylococci to both antibiotics might occur if they were used
extensively. The activity of cefamandole against coagulase-
negative staphylococci has been shown to be virtually identical to
that of cephalothin, the antibiotic most frequently used for
treating CAPD peritonitis caused by coagulase-negative
staphylococci in North America (Price and Flournoy, 1982).
However, several studies have shown that the activity of both these
antibiotics is markedly reduced against the frequently encountered
methicillin-resistant strains (Archer, 1978; Laverdiere et al,
1978; John and McNeill, 1980). Such reduced sensitivity can be
most readily revealed using a heavy inoculum of organisms with
incubation at 30°C for 48 hours (John and McNeill, 1980). These
authors found that the mean MIC of cefamandole against 28 strains
of methicillin-sensitive coagulase-negative staphylococci was 1
mg/1 with a maximum value of 8 mg/1. In contrast, its mean MIC
against 54 methicillin resistant strains was 31 mg/1 with some
strains being resistant to greater than 250 mg/1. They also found
that whilst cefuroxime was active against all methicillin-sensitive
strains, its mean MIC against methicillin-resistant strains was
greater than 1,000 mg/1. These results reinforce our conclusion
that cefuroxime is totally unsuitable for treating methicillin-
resistant coagulase-negative staphylococci. As these strains
accounted for more than one-third of our isolates, cefuroxime
clearly had no place in the initial, blind treatment of such
infections. Likewise, they confirm our impression that the
relative resistance of some strains to cefamandole and cephalothin
meant that these antibiotics were less than ideal. Despite the
excellent activity of rifampicin against all but one strain, we
felt that its special role in the treatment of tuberculosis
precluded its routine use in CAPD peritonitis.
All the isolates tested in the present study were sensitive
to vancomycin. In most published studies of the sensitivity to
vancomycin of coagulase-negative staphylococci, all isolates tested
have been sensitive to 4 mg/1 of vancomycin or less
(Watanakunakorn, 1984). A few reports have pointed to the
existence of occasional resistant strains (Sewell et al, 1979;
Marsik and Brake, 1982) but these have never been adequately
characterised. There is no evidence that the emergence of
coagulase-negative staphylococci resistant to vancomycin is a
problem at present. Vancomycin therefore emerged as the most
reliable of the antibiotics tested in vitro against coagulase-
negative staphylococci causing CAPD peritonitis.
chapter
IhE Organisms Causing CAPD Peritonitis and their Antibiotic
Sensitivities
2. Bacteria other than Coagulase-Negative Staphylococci*
Summary: We tested the antibiotic sensitivities of 32 strains of
bacteria other than coagulase-negative staphylococci isolated from
infected dialysate. Gram positive isolates were tested against
vancomycin, rifampicin, netilmicin and cefamandole and Gram
negative isolates against netilmicin, tobramycin, gentamicin,
cefamandole, cefuroxime and cefotaxime. Vancomycin and rifampicin
were active against all ten Gram positive isolates. Netilmicin was
active against 19 of the 22 Gram negative isolates; gentamicin and
tobramycin were each active against 18; and cefuroxime was active
against only seven. We determined that a combination of vancomycin
and either netilmicin, tobramycin or gentamicin would be the best
initial treatment of CAPD peritonitis from the bacteriological
point of view.
Introduction
In the previous chapter, evidence was presented that
vancomycin was the most consistently active antibiotic against the
most common causative organism, the coagulase-negative
staphylococcus. Other generally active agents were rifampicin,
netilmicin and cefamandole. Cefuroxime, the drug of choice for the
* Part of the data in this chapter has been published in Nephron.
See Appendix 4.
initial treatment of CAPD peritonitis at the Queen Elizabeth
Hospital, emerged extremely badly, with more than half the strains
tested being resistant to it. On this evidence alone, it was clear
that cefuroxime would have to be replaced.
The next step in choosing the best available antibiotics for
initial treatment was to consider in turn the antibiotic
sensitivities of the other Gram positive and Gram negative
isolates.
Materials and Methods
Samples of infected CAPD dialysate were obtained and cultured
as previously described (p 60). Isolates were identified using
conventional techniques. Antibiotic sensitivities were determined
using the Stokes disc diffusion method (Stokes and Ridgway, 1980).
The Gram positive isolates other than coagulase-negative
staphylococci were only tested against the four antibiotics
consistently active against the'coagulase-negative staphylococci
viz, vancomycin, rifampicin, netilmicin and cefamandole. The
antibiotics tested against the Gram negative isolates were
netilmicin, gentamicin, tobramycin, cefamondole, cefuroxime and
cefotaxime. (Neither vancomycin nor rifampicin has satisfactory
activity against many Gram negative bacteria.)
Results
During the twelve months from 1 May 1982 to 30 April 1983,
there were 75 episodes of CAPD peritonitis. Organisms were
isolated from dialysate on 71 of the 75 occasions (95%). One
species was cultured on 65 occasions and two on five occasions.
There were 43 isolates of coagulase-negative staphylococci, whereas
no other organism was cultured on more than four occasions (Table
4.1).
Gram Positive Isolates Other Than Coagulase—Negative Staphylococci
Vancomycin and rifampicin were both active against all ten
isolates; cefamandole was active against all except the three
Strep, faecalis isolates; netilmicin, however, was only active
against the Staph, aureus and diphtheroid isolates. These findings
were combined with those of the previous chapter. Overall activity
of the four antibiotics against all the Gram positive isolates was
therefore vancomycin, 100%; rifampicin, 98%; cefamandole, 91%; and
netilmicin, 85%.
Gram Negative Isolates
Netilmicin was the most consistently active antibiotic
tested, inhibiting all but three of the 22 isolates (Klebsiella
aerogenes, Agrobacterium sp and an unidentified aerobic Gram
negative bacillus). Gentamicin and tobramycin were both active
against 18 of the 22 isolates and cefotaxime against 16.
Cefuroxime and cefamandole were each only active against seven
isolates.
Overall Antibiotic Sensitivities
These are shown in Table 4.2. The best single agent was
netilmicin, active against 86% of isolates. However, combinations
of vancomycin with netilmicin and vancomycin with tobramycin or
gentamicin provided activity against 96% and 95% of isolates
respectively. Cefuroxime, the drug of choice at the start of the
study, was active against only 47% of isolates.
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Netilmicin 65 11 86
Cefamandole 56 20 74
Cefuroxime 36 40 47
Discussion
This analysis showed that no single antibiotic had a spectrum
of activity wide enough for it to be used alone with confidence in
the initial treatment of CAPD peritonitis at the Queen Elizabeth
Hospital. Netilmicin emerged as the best agent overall but, like
all aminoglycosides, it has very little activity against
streptococci. As streptococci can cause severe peritonitis (p 44),
it is essential that they should be effectively treated from the
outset. Cefamandole (and hence the similar cephalothin) emerged as
a fair choice against Gram positive isolates, although poorly
active against Strep, faecalis. However, it was inactive against
most of the Gram negative isolates. The third generation
cephalosporin, cefotaxime, was not considered for use against Gram
positive isolates as it is poorly active against staphylococci. It
faired better against the Gram negative isolates but was
nevertheless inactive against P. aeruginosa and Acinetobacter spp.
Cefuroxime was no more effective against Gram negative isolates
than against coagulase-negative staphylococci.
The logical conclusion of this survey was to combine
vancomycin, which has outstanding activity against Gram positive
organisms with netilmicin, tobramycin or gentamicin, each of which
would be active against most Gram negative organisms, including P.
aeruginosa. Such a combination would be active against about 95%
of organisms causing CAPD peritonitis. It would also be
synergistic against many Gram positive strains (Garrod et al,
1981).
The number of isolates of most species other than coagulase-
negative staphylococci tested in this analysis is small. However,
the isolates tested are representative of the organisms causing
CAPD peritonitis everywhere (p 23) and their sensitivities agree
closely with those found in much larger studies of the same species
(Garrod et al, 1981). The present analysis is thus likely to hold
good for the treatment of CAPD peritonitis elsewhere.
Nevertheless, several recent reports indicate that treatment of
CAPD peritonitis is still often begun with antibiotics which have
little or no activity against many likely causative organisms. A
survey of renal units using CAPD in the United Kingdom at the end
of 1982 highlighted this (Gokal and Marsh, 1984). Table 4.3 shows
the antibiotic (s) used to start treatment by the 41 renal units
surveyed. Only five of the protocols would be likely to achieve a
high degree of success. It was therefore not surprising that Gokal
and Marsh found that "often treatment of peritonitis was
unsuccessful" and "50% of units reported 5-15% of episodes of
peritonitis had become intractable".
Keogh and others (1983) used netilmicin alone and found that
netilmicin resistant streptococci caused three of the 14 episodes
of peritonitis they studied. Krothapulli and others (1983) began
treatment with intravenous vancomycin alone. They did not discuss
the outcome of the 23% of their infections caused by Gram negative
organisms. Raman and Maskell (1985) report that only 68% of 168
episodes of CAPD peritonitis were cured by cephradine, a
cephalosporin with a spectrum of activity somewhat narrower than
that of cefuroxime.
TABLE 4.3
ANTIBIOTICS USUALLY GIVEN BY INDIVIDUAL RENAL UNITS FOR PERITONITIS BEFORE
KNOWLEDGE OF INITIAL DIALYSATE CULTURE RESULTS
(ADAPTED FROM GOKAL AND MARSH, 1984)
Single Agents Combinations
Cefuroxime 12 Cefuroxime + Gentamicin 5
Cefotexime - 3 *Cefuroxime + Netilmicin 1
Gentamicin 2 Cefuroxime + Tobramycin 1
Cephradine 1 Cefuroxime + Cotrimoxazole 1
Vancomycin 1 Cephradine + Tobramycin 1
*Cephalothin + Gentamicin 1
Amoxycillin + Flucloxacillin 1
*Vancomycin + Gentamicin 1
+*Vancomycin + Tobramycin 1
Cefamandole + Flucloxacillin 1
Flucloxacillin + Gentamicin 1
Cefuroxime + Ampicillin + Flucloxacillin
*Cefuroxime + Netilmicin + Vancomycin 1
Amoxycillin + Flucloxacillin + Tobramycin 1
Other Combinations 3
* Treatment judged to give adequate initial cover
t* Treatment at Queen Elizabeth Hospital
Having made our selection of antibiotics on the basis of in
vitro tests, the next step was to design a treatment protocol which
would combine maximum effectiveness with minimum risk and
inconvenience to the patient. This will be considered in the
following chapter.
CHAPTER 5
The Treatment of CAPD Peritonitis: A Comparison between Cefuroxime
am) Vancomycin plus Tobramycin
Summary: Of 27 episodes of CAPD peritonitis initially treated with
intraperitoneal cefuroxime, only 14 (52%) were cured without
recourse to other antibiotics. Eight of the 13 failures were
caused by coagulase-negative staphylococci. Three patients
developed Clostridium difficile colitis during treatment.
Subsequently, treatment was started with intraperitoneal vancomycin
and tobramycin. Normally, treatment was continued with only the
more appropriate of the two antibiotics once the causative organism
was known. Thirty-eight episodes of CAPD peritonitis were thus
treated. Thirty-one (82%) were cured, including 21 of the 22
infections caused by coagulase-negative staphylococci, but only
five of the nine infections caused by Gram negative organisms.
Intraperitoneal vancomycin plus tobramycin thus appeared a more
effective initial treatment of CAPD peritonitis than cefuroxime.
However, serum concentrations of tobramycin were sometimes
potentially ototoxic and the regimen was judged too complicated for
routine use at home.
Introduction
In the previous chapter, we saw that the combination of
vancomycin and an aminoglycoside was active in vitro against almost
all the organisms commonly causing CAPD peritonitis. Both
vancomycin and the aminoglycosides are potentially ototoxic and are
normally excreted almost exclusively by the kidneys. As they are
poorly dialysed, they must be used with caution in patients in
renal failure. It was quickly recognised that intraperitoneal
administration is the most effective way of ensuring that the
bacteria causing CAPD peritonitis are exposed to lethal
concentrations of the aminoglycosides, whilst the patient is
relatively shielded from their ototoxic effects (p 45). Evidence
for the potential ototoxicity of intraperitoneal aminoglycoside
regimens in current use has already been presented (pp 45-48).
However, no reports of ototoxicity occurring in patients treated
for CAPD peritonitis had been published by mid-1982. Vancomycin
has also been reported to cause ototoxicity. Cases are, however,
rare and have only been associated with serum concentrations of
vancomycin in excess of 50 mg/1 (Moellering et al, 1981). There is
no evidence that vancomycin potentiates the ototoxicity of the
aminoglycosides.
A satisfactory intraperitoneal aminoglycoside regimen must be
a compromise between the conflicting requirements of antimicrobial
efficacy and safety. Most aminoglycoside-sensitive organisms are
inhibited by 2 mg/1 or less of gentamicin or tobramycin (Garrod et
al, 1981). Whilst ototoxicity may occur when peak serum
concentrations are as low as 5-8 mg/1 (Smith et al, 1980), data on
the pharmacokinetics of intraperitoneal aminoglycosides in patients
with CAPD peritonitis were still sparse in 1982. De Paepe and
others (1981) treated three patients with gentamicin 7.5 mg/1 of
dialysate for three weeks. The concentration of gentamicin in the
drained dialysate remained above 2 mg/1 whereas serum
concentrations rose to a maximum of 4-5 mg/1 after several days.
Williams and others (1982) studied serum concentrations of
tobramycin in 20 patients with CAPD peritonitis. Each received an
intravenous "loading dose" of 1.7 mg/kg bodyweight followed by
8 mg/1 of dialysate. They found that the mean serum concentration
after seven days of treatment was 6 mg/1. The range of
concentrations was not given. As bacteraemia associated with CAPD
peritonitis is very rare unless the infection is extremely severe,
we saw no great virtue in the loading dose as a routine measure.
We therefore elected to give the aminoglycoside only by
intraperitoneal injection, in the hope of achieving the rather
lower serum concentrations reported by De Paepe and his colleagues.
Gentamicin and tobramycin have virtually identical
antibacterial activity, except that gentamicin is slightly the more
active against Staph, aureus and tobramycin against P. aeruginosa
(Garrod et al, 1981). Tobramycin has proved less ototoxic in
laboratory animals but the evidence in human studies is
inconclusive (Smith et al, 1980). Netilmicin appears somewhat more
active and less ototoxic than either gentamicin or tobramycin but
in 1982, it cost twice as much as the other two. On balance,
therefore, we selected tobramycin as it was cheaper than gentamicin
in the Queen Elizabeth Hospital at that time.
Most Gram positive bacteria are inhibited by 4 mg/1 of
vancomycin or less, whereas vancomycin ototoxicity is unlikely
unless serum concentrations exceed 50 mg/1. Vancomycin thus seems
to offer a wider margin of safety than the aminoglycosides. The
organisms most likely to cause rapidly fatal peritonitis are Staph,
aureus and streptococci (Fenton et al, 1981). To ensure immediate
cover against these organisms, we elected to give an intravenous
loading dose of 500 mg of vancomycin followed by 15 mg/1 of
dialysate intraperitoneally thereafter. At the time the study was
initiated, no data were available on the serum concentrations
likely to result frcm this regimen.
It was envisaged that both antibiotics would normally be
given only until the results of culture were known. Thereafter,
the more appropriate antibiotic would be continued alone for a
period (arbitrarily chosen) of 12-14 days. As the majority of
isolates were Gram positive, most infections would be treated with
vancomycin, the less toxic antibiotic. As very few episodes were
now culture negative, treatment with both antibiotics for 14 days
would be exceptional.
Given the very poor showing of cefuroxime, both clinically
and in our laboratory studies, we felt that we could not justify
starting a prospective randomised controlled trial comparing
cefuroxime with vancomycin and tobramycin. This chapter thus
describes the results of treating 38 consecutive episodes of CAPD
peritonitis with vancomycin and tobramycin and retrospectively
compares these with 27 episodes treated with cefuroxime.
Patients and Methods
All the episodes of CAPD peritonitis seen between March 1982
and February 1983 were included in the study except for ten
episodes randomly allocated for treatment with Augmentin during
August-September 1982 (Gruer et al, 1983a). Samples of dialysate
were taken and processed as previously described, with antibiotic
sensitivities being tested by the Stokes method (p 86). Treatment
was started as soon as bacteriological samples had been taken.
Regimen 1 : March - September 1982
After an initial intravenous dose of cefuroxime 500 mg,
cefuroxime 150 mg was added to every 2 litre bag of dialysate for
12 days. If isolates were resistant to cefuroxime, another
appropriate antibiotic was given.
Regimen 2 : October 1982 - February 1983
After an initial intravenous infusion of vancomycin 500 mg,
vancomycin 30 mg and tobramycin 16 mg were added to every bag of
dialysate until the results of bacteriological culture and
antibiotic sensitivities were known (usually 48-72 hours).
Thereafter, treatment was continued as follows:-
(1) vancomycin sensitive organisms: vancomycin 30 mg added
to each bag of dialysate;
(2) vancomycin resistant, tobramycin sensitive organisms:
tobramycin 16 mg added to each bag of dialysate;
(3) organisms resistant to both vancomycin and tobramycin:
treatment with another appropriate antibiotic started;
(4) if no organisms cultured despite other evidence of
peritonitis, treatment with vancomycin and tobramycin
continued.
Treatment was normally given for a total of 12-14 days.
Under both regimens, patients were only treated in hospital
if they were systemically unwell. Patients admitted to hospital
were treated as above, unless they had severe abdominal pain which
did not settle quickly. In such circumstances, rapid peritoneal
lavage (see p 36) was started and continued until symptoms
improved. Patients treated at home were carefully instructed by
renal unit staff how to inject antibiotics into fresh dialysate.
They were reviewed in the CAPD clinic after two and ten days
treatment and in all cases their administration tubing was changed
after two days of treatment.
Treatment failure: Treatment was considered to have failed if
the causative organism was not eradicated after the course of
treatment or if peritonitis due to the same organism recurred
within 28 days of the end of treatment.
Antibiotic concentrations: Serum vancomycin concentrations
were assayed using an Abbott TDX immunoassay system (Abbott
Diagnostics Divisions, Queensborough, Kent, UK). Serum tobramycin
concentrations were assayed using an EMIT immunoassay system (Syva
UK Ltd, Maidenhead, Berkshire, UK).
Statistical analysis: The statistical significance of
differences was tested by the Chi squared test with Yates'
correction.
Results
Treatment with cefuroxime: The 27 episodes of CAPD
peritonitis treated with cefuroxime are summarised in Table 5.1.
Only 14 (52%) were cured. Eight of the 13 failures were caused by
coagulase-negative staphylococci. Only two of these eight failures
were caused by organisms reported to be resistant to cefuroxime
whilst all eight were resistant to flucloxacfllin (methicillin).
All of the seven successfully treated episodes caused by coagulase-

































































but two were resistant to flucloxacillin. Thus, disc sensitivity
to flucloxacillin seemed a better indicator of the outcome of
treatment with cefuroxime of infections caused by coagulase-
negative staphylococci than did disc sensitivity to cefuroxime
itself (13/15 vs 9/15). The reasons for this have been discussed
on page 71. All eight infections caused by coagulase-negative
staphylococci which did not respond to cefuroxime were ultimately
cured by vancomycin.
Only four of the eight infections caused by Gram negative
bacilli were cured by cefuroxime. Two of these four failures were
subsequently cured by tobramycin.
Treatment with Vancomycin and Tobramycin
The 38 episodes treated with vancomycin and tobramycin are
summarised in Table 5.2. Thirty-one episodes (82%) were cured by
the vancomycin/tobramycin regimen. All the isolates of coagulase-
negative staphylococci were sensitive to vancomycin and all but one
of the 22 infections they caused were cured by vancomycin. The
single failure also did not respond to clindamycin and the organism
only disappeared when the patient developed peritonitis due to
Klebsiella pneumoniae! Two infections involving vancomycin
sensitive diphtheroids did not respond to vancomycin. One
responded when ampicillin was added but the other was only cured
by removal of the intraperitoneal catheter.
Only five of the nine infections involving Gram negative
organisms were cured without recourse to other antibiotics. The
unsuccessfully treated infections were caused by P. aeruginosa (2),

































































































was resistant to tobramycin and was eradicated by a combination of
amikacin and cefotaxime. The infections caused by the Proteus and
one of the Pseudomonas isolates were cured by combining tobramycin
with azlocillin. The second Pseudomonas infection was only cured
by removal of the intraperitoneal catheter.
Canparison of the TYjo Regimens
Overall, treatment with vancomycin/tobramycin appeared much
more successful than that with cefuroxime (31/38 vs 14/27).
However, both regimens registered only moderate success against
Gram negative organisms (5/9 vs 4/8). The main difference lay in
the results of treatment of coagulase-negative staphylococci (21/22
vs 7/15; X2 =9.03, p < 0.005).
Twenty-seven of the 38 patients receiving
vancomycin/tobramycin (71%) and 17 of the 27 patients receiving
cefuroxime (63%) were treated entirely as out-patients. Four of
the patients treated with cefuroxime as out-patients had persistent
coagulase-negative staphylococcal peritonitis for several weeks
before responding promptly to vancomycin. All the patients treated
at home with vancomycin/tobramycin responded promptly.
Three of the patients treated with cefuroxime developed
colitis due to Clostridium difficile which was successfully treated
with oral vancomycin. No adverse effects were noted in the
patients treated with vancomycin and tobramycin.
Serum Concentrations of Vancomycin and Tobramycin
These were each measured in six patients after five to 14
days' treatment. Vancomycin concentrations ranged from 8 to
12 mg/1 (mean 10.1) and tobramycin concentrations from 3.1 to
4.8 mg/1 (mean 3.6).
Discussion
Cefuroxime was the most popular antibiotic for the initial
treatment of CAFD peritonitis in the United Kingdom, at least until
the end of 1982 (Gokal and Marsh, 1984). There are no data to
indicate whether or not this situation has changed. However, the
present study confirms in vivo the impression already gained in
vitro that cefuroxime is not a suitable antibiotic for the initial
treatment of CAPD peritonitis. Only about half the infections were
cured without recourse to other antibiotics, and three patients
developed CI. difficile colitis. Other authors have reported
similar results. Gokal and others (1982) successfully managed only
62% of episodes with cefuroxime alone. They also reported that CI.
difficile colitis developed in 13 of their cefuroxime treated
patients, of whom two survived only after total colectomy and one
died. Raman and Knight (1985) found that cefuroxime cured only 55%
of 29 episodes of CAPD peritonitis.
Hie outstanding in vitro activity of vancomycin against Gram
positive organisms was mirrored by its success in eradicating all
but one coagulase-negative staphylococcus and two diphtheroids in
the 27 episodes involving Gram positive organisms (89%).
Furthermore, all eight of the episodes caused by coagulase-negative
staphylococci which did not respond to cefuroxime were cured by
vancomycin. Another promising account of the use of
intraperitoneal vancomycin has recently been published (Gray et al,
1985). Doses of 50 mg/1 of vancomycin and 50 mg/1 of ceftazidime,
a new cephalosporin, were added to each bag of dialysate. The less
appropriate antibiotic was stopped when the causative organisms
were identified and treatment was continued for seven to 14 days.
Sixty-three of 64 episodes of CAPD peritonitis were cured including
all those caused by Gram positive bacteria. Krothapalli and others
(1983) reported that vancomycin lg given intravenously once weekly
for four weeks successfully cured 82% of 62 episodes of CAPD
peritonitis. However, theirs and the present study are not
strictly comparable. Fifty-seven per cent of their episodes were
caused by Staph, aureus and only 25% by coagulase-negative
staphylococci compared with 3% and 63% respectively in the present
study.
Treatment of Gram negative infections with tobramycin was
less successful. As only nine such infections were treated with
tobramycin during the study, we were unable to determine whether it
was more effective than cefuroxime. However, all but one of the
Gram negative isolates were sensitive to tobramycin whereas
several, including the P. aerugoinosa isolates, were totally
resistant to cefuroxime. At the very least, therefore, tobramycin
emerged as an effective antibiotic for holding at bay most Gram
negative infections until culture and antibiotic sensitivity
results were known.
Since 1982, various other ways of treating CAPD peritonitis
have been recommended (Fenton, 1982; Editorial, 1982; Vas, 1983).
However, few authors have presented for scrutiny the results of
their treatment. Adequate assessment is thus impossible. The
studies of cefuroxime have been presented above. Glasson and Favre
(1984) used intraperitoneal cotrimoxazole to treat 45 episodes of
peritonitis, of which 85% were cured. However, our study of
isolates of coagulase-negative staphylococci suggests that it is
highly unlikely that such a good result could have been achieved in
our patients. Maskell and Crump (1985) used cephradine 500 mg six
hourly by mouth for seven days as their standard treatment of 168
episodes. Only 68% responded and "intractable peritonitis",
requiring catheter removal, developed in 14%. Their poor results
can be readily explained. Firstly, cephradine has poor activity
against many strains of coagulase-negative staphylococci (p 78) and
is inactive against many Gram negative bacteria including
Enterobacter, Serratia and P. aeruginosa (Garrod et al, 1981).
Secondly, although cephradine is usually well absorbed when taken
by mouth, its penetration into the peritoneal cavity may be less
satisfactory, particularly when the peritoneal membrane is not
acutely inflamed. To my knowledge, there are no published studies
of the intraperitoneal penetration of oral cephradine in patients
with CAPD peritonitis (Gruer, 1985). My own pilot study of
treatment of CAPD with oral Augmentin (amoxycillin plus clavulanic
acid) was similarly unsuccessful (Gruer et al, 1983a). This
antibiotic combination has a spectrum of activity substantially
wider than that of cephradine. I concluded then that there was no
oral antibiotic which could be confidently used for the initial
treatment of CAPD peritonitis.
The serum concentrations of vancomycin did not exceed 12 mg/1
in any of our patients and hence were well below the concentrations
of greater than 50 mg/1 which are believed to be potentially
ototoxic. However, serum concentrations of tobramycin were between
3 and 5 mg/1 in all patients. As previously discussed (p 45), such
concentrations may be toxic in some patients, particularly if
maintained for long periods, or attained repeatedly in patients
requiring multiple courses of treatment. The following question
thus arises: can the use of the aminoglycoside be modified, to
reduce the serum levels attained without compromising the efficacy
of the treatment?
The majority of patients successfully treated themselves with
vancomycin and tobramycin at home. However, the 12 day regimen
proved rather poorly adapted to this purpose. If both antibiotics
are added to all bags for three days followed by one antibiotic for
a further nine days, 60 separate injections are required.
Vancomycin is only available in ampoules of 500 mg diluted in
20 mis. Exactly 1.2 ml of this solution must be withdrawn to
ensure a dose of 30 mg. Tobramycin is available as a solution of
40 mg/ml and hence 16 mg will be provided by 0.4 ml. Hence, the
regimen demands considerable diligence and accuracy from the
patient. A second question thus arises. Can the treatment be
simplified without compromising its efficacy?
An attempt to resolve these two questions is presented in the
following section.
Chapter 6
The Treatment of CAPD Peritonitis with Once-Daily Vancomycin and
Gentamicin*
Summary: One hundred episodes of CAPD peritonitis were treated by
adding antibiotics to the overnight dialysate only for nine days.
Treatment was started with vancomycin and gentamicin and continued
with the more appropriate agent once culture results were known.
Eighty-eight episodes were cured by a single course of treatment.
All but two of the 70 infections caused by Gram positive organisms
were cured by these antibiotics alone. However, other antibiotics
were required in eight of the 19 infections involving Gram negative
bacteria. The intraperitoneal catheter had to be temporarily
removed only twice. Seventy-six episodes were treated entirely at
home and on only eight occasions did the patient spend more than
one night in hospital because of peritonitis. Serum vancomycin
concentrations during treatment were below 12 mg/1. Serum
gentamicin concentrations were usually around 3 mg/1 but
occasionally higher. Two cases of gentamicin induced ototoxicity
have since occurred using this treatment. An effective alternative
to the aminoglycosides is required.
* A summary of these results has been published as a letter in the
Lancet. See Appendix 4.
Introduction
In Chapter 5, we showed that the vancomycin/tobramycin
regimen was an effective means of treating most episodes of CAPD
peritonitis. However, the need for frequent, accurately prepared
injections made it impractical for self-administration.
Furthermore, serum concentrations of tobramycin sometimes attained
potentially ototoxic levels. It struck us that the regimen could
be readily simplified by decreasing the frequency of injections but
increasing the unit dose. The causative organisms would thereby be
exposed intermittently to higher concentrations of antibiotics.
During the undosed periods, previously absorbed antibiotics would
slowly diffuse back into the peritoneal cavity. This would ensure
both that the bacteria were still being exposed to antibiotics,
albeit in low concentrations, and that some elimination of the
antibiotics occurred. Thus, serum antibiotic concentrations would
follow a wavelike rather than a flat curve. Substantiation of this
idea came from Manchester, where Professor G E Mawer (unpublished
observations) developed a computer model of the pharmacokinetics of
intraperitoneal gentamicin, based upon the data of De Paepe and
others (1981) and Pancorbo and Comty (1981). From these, he
deduced that a once-daily intraperitoneal dose of 1 mg/kg
bodyweight would lead to peak and trough serum concentrations of
5 mg/1 and 2 mg/1 respectively. In 1982, Baird and Jones published
a short report of the use of 10 mg/1 of intraperitoneal gentamicin
or netilmicin given twice daily. They found this regimen was
bacteriologically satisfactory in most cases of CAPD peritonitis
and led to maximum serum antibiotic concentrations of 2.9 mg/1 in
the one patient studied.
Encouraged by this information, we established a simplified
regimen whereby 100 mg of vancomycin and/or 40 mg of gentamicin
were added to the overnight bag of dialysate only, for nine days.
Gentamicin was used because at the start of the study it had become
appreciably cheaper than tobramycin. The antibiotics were added to
the overnight bag to ensure a dwell time of at least seven hours.
The doses of antibiotics were chosen both to ensure satisfactory
intraperitoneal and serum concentrations and to take account of the
commercially available ampoule sizes.
In this chapter, I describe the results of the use of this
regimen in the treatment of 100 consecutive episodes of CAPD
peritonitis. Serum and dialysate concentrations of vancomycin and
gentamicin obtained in selected patients are also presented, and
the cost of this and the previous regimen are compared.
Patients and Methods
The study included all patients with CAPD peritonitis
presenting at the Queen Elizabeth Hospital from 1 February 1983
until 100 episodes had been treated. The diagnosis of peritonitis
was made and samples of dialysate were taken and processed as
previously described (p 60).
Treatment: After dialysate samples had been taken, vancomycin
100 mg (one-fifth of an ampoule) and gentamicin 40 mg (one ampoule)
were added to the first fresh bag of dialysate and thereafter to
each overnight bag only. Patients who were systemically ill were
admitted to hospital. In addition to the first intraperitoneal
dose, such patients also received single intravenous doses of
vancomycin, 500 mg and gentamicin, 80 mg. Patients with severe
abdominal pain were treated with peritoneal lavage until the pain
improved. Other patients were treated at home and normally seen at
the CAPD out-patient clinic after two and nine days of treatment.
If the dialysate was very turbid, heparin 1,000 units was added to
each bag of dialysate for 48 hours. The administration tubing was
changed after two days of treatment in all cases.
When the results of culture and antibiotic sensitivity were
known, treatment was continued as follows:
1. Vancomycin sensitive organisms: vancomycin 100 mg added
to the overnight bag only;
2. Vancomycin resistant, gentamicin sensitive organisms:
gentamicin 40 mg added to the overnight bag only;
3. Organisms resistant to both vancomycin and gentamicin:
another appropriate antibiotic added to all bags;
4. If no organism was cultured, despite a firm clinical
diagnosis of peritonitis, vancomycin 100 mg and
gentamicin 40 mg were added to the overnight bag only.
Treatment was normally continued for nine days. Each ampoule
of vancomycin provided five doses and hence a full course of
vancomycin required two ampoules. Ampoules were kept at 4°C while
in use.
Treatment failure: Treatment was considered to have failed if
the causative organism was not eradicated after the course of
treatment or if peritonitis due to the same organism recurred
within 28 days of the end of treatment.
Antibiotic concentrations: Serum and dialysate effluent




























































































































Serum samples were taken between 10.00 and 13.00 hours to ensure
peak or near peak concentrations were measured. Dialysate effluent
samples were collected on days 2, 5 and 9 of treatment. All
samples were stored at -70°C until assayed. Concentrations were
measured as previously described (p 99).
Results
The 100 episodes were treated between 1 February 1983 and 31
March 1984. During this period, 79 patients underwent CAPD for a
total of 560 patient months. The causative organisms and the
results of their treatment are shown in Table 6.1. All the Gram
positive isolates were sensitive to vancomycin. Sixty-six of the
70 infections involving Gram positive organisms (94%) were cured by
the once daily treatment. One infection caused by coagulase-
negative staphylococci relapsed once, another twice and a third was
cured only by temporary catheter removal. One Staph, aureus
infection was cured only when oral flucloxacillin was given to
treat a concurrent exit-site infection.
Five of the 19 Gram negative isolates were resistant to
gentamicin. These and three other isolates failed to respond to
gentamicin. Two gentamicin resistant Pseudomonas spp responded to
cefotaxime. An Acinetobacter calcoaceticus was only sensitive in
vitro to latamoxef. Treatment with this agent was unsuccessful and
temporary catheter removal was required. The two infections
involving Bacteriodes fragilis (clinically appendicitis and
diverticulitis respectively) were successfully treated with
metronidazole. Two infections caused by gentamicin-sensitive
Pseudomonas spp relapsed after gentamicin was stopped. A severe
infection involving E. coli, Strep, pyogenes and Strep, faecalis
was successfully treated with gentamicin, vancomycin and
cefuroxime.
The sixteen culture negative episodes all responded rapidly
to the once daily treatment. In two of the 16 cases, no sample was
sent for culture; in one, the sample was only cultured after two
days; in three, the patient had received antibiotics shortly before
the sample was taken. In the remaining ten cases, there was no
obvious explanation for the negative cultures.
Home or hospital treatment: Seventy-six of the 100 episodes
were treated entirely at home. On seven occasions, the patient
arrived at the hospital late at night and remained in hospital
until the following day. On four occasions, the patient remained
in hospital for reasons other than peritonitis (pneumonia,
investigation of pulmonary infiltrates, drug induced arthropathy
and retraining in CAPD technique). Five episodes developed in
hospital, four of them within five days of the insertion of the
intraperitoneal catheter. On only eight occasions was the
peritonitis severe enough to require hospital admission. The
organisms responsible for these severe episodes are shown in Table
6.2. Only one episode, caused by Acinetobacter calcoaceticus had
been unsuccessfully treated at home. On the other seven occasions,
the patient's clinical condition had been severe enough to warrant
treatment in hospital from the outset.
Antibiotic concentrations: The mean vancomycin concentrations
in serum and dialysate effluent samples from five patients are
shown in Table 6.3. The highest recorded serum vancomycin
TABLE 6.2
CAUSATIVE ORGANISMS AND TREATMENT OF EIGHT EPISODES OF CAPD PERITONITIS
REQUIRING HOSPITAL ADMISSION
Causative Organisms Other Treatment Used
Acinetobacter anitratus Catheter removed
Coagulase negative staphylococcus Catheter removed
Staphylococcus aureus Intermittent peritoneal dialysis
E. coli + Strep, pyogenes +
Strep, faecalis
Intermittent peritoneal dialysis
E. coli + B. fragilis Metronidazole + cefotaxime
Viridans streptococcus None
Viridans streptococcus None




(rog/1) IN SERUM AND DIALYSIS EFFLUENT
Day 2 Day 5 Day 9
Serum 6.1 5.9 6.7
Dosed effluent 14.5 14.5 29.3
Undosed effluent 1.6 2 2.4
concentration in any patient was 12.0 rag/1. The vancomycin
concentration in the dosed effluent appeared higher on day 9 than
on days 2 and 5, although the differences were not statistically
significant. This may reflect a reduction in vancomycin absorption
as the peritoneal membrane became less inflamed. Very little
vancomycin diffused into the undosed dialysate.
Mean serum gentamicin concentrations were 2.5 mg/1 (SD +
1.2 mg/1) after nine or ten days treatment in seven patients. The
highest recorded serum gentamicin concentration was 5.0 mg/1. The
mean gentamicin concentration in 18 bags of dosed effluent from
nine patients during their first three days of treatment was
4.6 mg/1 (range 2.4 - 11.6 mg/1). Gentamicin was undetectable in
most bags of undosed effluent with the highest recorded
concentrations being 2.2 mg/1.
No adverse effects attributable to the antibiotics were
observed.
Total dosage and cost of treatment: Table 6.4 compares the
total dose of antibiotic administered and the cost of the two
vancomycin/aminoglycoside regimens. This shows that both total
dose of antibiotic and cost were substantially reduced by the once-
daily treatment, which also usually required only 13 injections
compared with the 60 given previously.
Discussion
The addition of vancomycin and/or gentamicin to only the
overnight bag proved to be no less effective than the addition of
lower doses of vancomycin and tobramycin to all bags. The once-
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TABLE 6.4
TOTAL DOSAGE AND COST OF TREATMENT OF CAPD PERITONITIS WITH ONCE-DAILY
















Full course vancomycin 1,000 1,940
25.04 50.68
+ 3 days gentamicin 120 272
3 days vancomycin 300 860
19.41 39.56
+ full course gentamicin 400 848
1 vancomycin 100 mg/bag
gentamicin 40 mg/bag
10 day course
2 vancomycin 500 mg and gentamicin 80 mg IV x 1
then vancomycin 30 mg/bag, gentamicin 16 mg/bag, 12 day course
3 Current NHS prices: vancomycin 500 mg - £11.09
(1983) gentamicin 80 mg - £1.70
daily regimen cured 87% of episodes compared with the 82% success
achieved by its all-bag predecessor. Furthermore, only two of the
100 episodes treated by the once-daily regimen required temporary
catheter removal.
The treatment of infection caused by Gram positive organisms
was, once again, extremely successful. As before, all the Gram
positive isolates were sensitive to vancomycin. In only one of the
70 episodes was another antibiotic used and in only one case was
the intraperitoneal catheter removed. Whether or not the
aminoglycoside given during the first two or three days contributes
to these good results remains to be established. However, many of
the staphylococci were extremely sensitive to gentamicin and
tobramycin. Vancomycin and gentamicin or tobramycin act
synergistically against many staphylococci and streptococci,
including strains resistant to the aminoglycoside alone (Garrod et
al, 1981). Aminoglycosides are also rapidly bactericidal in
peritoneal dialysate whereas vancomycin acts more slowly (Bint et
al, 1980; Loeppsky et al, 1983; Ziezler et al, 1956; Wilcox et al,
1985). The initial combination may thus be an important factor in
ensuring the success of the once-daily treatment of Gram positive
organisms.
Treatment of Gram negative infections was less successful.
Only six of the 14 infections caused by Gram negative organisms
were cured by the once-daily treatment. Four of the failures were
caused by Pseudomonas spp, organisms which other workers have also
found difficult to eradicate from the peritoneum (Vas, 1985).
Temporary catheter removal was, however, required only once, for an
infection caused by a multiply resistant Acinetobacter
calcoaceticus. These results lend weight to the idea that CAPD
peritonitis caused by Enterobacteriaceae, Pseudomonas spp and
Acinetobacter calcoaceticus might be best treated by a combination
of synergistic antibiotics, once the results of culture and
sensitivity are known.
Only eight patients had to spend more than one night in
hospital because of peritonitis and all but the most severe
episodes were treated without changing the patient's dialysis
routine. As the once-daily dose was either a single 40 mg ampoule
of gentamicin or one-fifth of a 500 mg ampoule of vancomycin,
patients found the treatment simple and agreeable to use. The
success of home treatment was also warmly welcomed by the staff of
the renal unit. Indeed, the rapid expansion of the CAPD service at
the Queen Elizabeth Hospital (described in Chapter 8) could not
have occurred without it.
Successful home treatment also leads to major financial
savings. The cost of treatment has, however, rarely been
considered in the published debate on CAPD peritonitis.
Beardsworth and Goldsmith (1982) found that the annual cost per
CAPD patient of re-admission to hospital was £2,856 in 1979 and
only £528 in 1981. They attributed a large part of this reduction
to the introduction of a policy of home treatment of peritonitis
where possible. Rubin and others (1980) calculated that in 1979
the average cost of treating an episode of CAPD peritonitis was
$1,605. Atkins and others (1981c) found that the cost of each
episode varied from $1,085 to an astonishing $6,885 when caused by
multiply resistant Staph, aureus. The present study has shown that
most episodes of peritonitis can be treated for about £25 ($30)
plus the cost of syringes and laboratory investigations.
Our study of antibiotic concentrations in dialysate and serum
revealed large inter-patient variations for both vancomycin and
gentamicin. This variation has been noted by other workers for
vancomycin (Pancorbo and Comty, 1982; Bunke et al, 1983),
gentamicin (Pancorbo and Comty, 1981), tobramycin (Bunke et al,
1982) and netilmicin (Keogh et al, 1983; Grefberg et al, 1984).
Studies of the peritoneal clearance of vancomycin or aminoglycoside
given intravenously also substantiate our findings that these
antibiotics diffuse rather unpredictably from the blood stream into
the peritoneal cavity. Glew and others (1982) found that after
intravenous administration, dialysate concentrations of vancomycin
ranged from 0-96% of simultaneous serum concentrations, with an
average value of 27%. Bunke and others (1982 and 1983) calculated
that on average only 15-20% of an intravenous dose of either
vancomycin or tobramycin was cleared by CAPD.
The reasons for the wide variations in peritoneal absorption
and clearance of vancomycin and the aminoglycosides remain poorly
understood. Such variations have been observed both in patients
with peritonitis (Glew et al, 1982; Magera et al, 1983; Keogh et
al, 1984) and in those without (Pancorbo and Comty, 1981 and 1982;
Bunke et al, 1982 and 1983; Paton et al, 1983). As our results for
vancomycin suggest, it is possible that the degree of inflammation
of the peritoneal membrane influences diffusion, but this does not
seem to be the major determinant. The importance of factors such
as the surface area and micro-circulation of the peritoneal
membrane has yet to be assessed.
Given the relatively unpredictable absorption of these
antibiotics, it does not seem very useful to employ dosage
schedules based on body-weight, as some authors have recommended
(Bunke et al, 1982 and 1983). Such an approach greatly complicates
treatment and will inevitably lead to mistakes and wastage of
antibiotics. A fixed dose regimen is preferable, provided that it
delivers sufficient antibiotic to the site of infection to
eliminate all infective organisms but insufficient to the eighth
cranial nerve to poison the patient. The present regimen appeared
to meet the first requirement in most cases as judged by the
clinical results. We also found that concentrations of vancomycin
and gentamicin in the dialysate exceeded the minimum inhibitory
concentration against most organisms throughout the overnight
dialysis period. The second requirement was also certainly
satisfied for vancomycin. Serum concentrations of vancomycin never
exceeded 12 mg/1, well below the potentially toxic range (Farber
and Moellering, 1983). Our data for gentamicin were, however, less
reassuring: some patients developed serum gentamicin concentrations
of 4-5 mg/1. Although none of the patients in this study developed
symptoms of ototoxicity, other published data strongly indicate
that such concentrations are potentially ototoxic (Mawer et al,
1974; Lerner et al, 1983).
Confirmation that ototoxicity can result from our once daily
regimen came several months after completion of the present study.
Two patients who had received several courses of once-daily
intraperitoneal gentamicin in quick succession developed clinically
apparent vestibular toxicity. Fortunately, however, symptoms
gradually subsided once the gentamicin had been stopped. Serum
gentamicin concentrations were not measured.
Given the rather mediocre performance of gentamicin and
tobramycin in our two studies plus their potential toxicity, what
are the alternatives? Netilmicin is believed to be less ototoxic
than either gentamicin or tobramycin (Lerner et al, 1983) and is
more active against many staphylococci and some strains of Gram
negative bacilli (Moellering, 1983). Two studies of its use in
the treatment of CAPD peritonitis have been published. Keogh and
others (1984) treated 14 episodes of peritonitis with continuous
intraperitoneal netilmicin in doses ranging from 5-20 mg/1 of
dialysate. There were only five Gram negative isolates and two of
these were resistant to netilmicin. Vestibular toxicity developed
in one patient receiving 20 mg/1 of netilmicin (an imprudently high
dose, in my view). Her serum netilmicin concentrations reached
15 mg/1 after only two days of treatment. Grefberg and others
(1984) treated 23 episodes in 18 patients. They added 30 mg of
netilmicin to each of the first eight 2 litre bags and then 30 mg
to each overnight bag thereafter for a further six days. Twenty-
three episodes were treated; five were "un-evaluable" and 16 were
cured. All four episodes caused by Gram negative organisms were
cured. Commendably, all 18 patients were tested audiometrically as
soon as possible after admission and one and three months
thereafter. Auditory function remained unchanged in all patients
but, on the last day of treatment, one patient developed severe
vertigo which lasted for two months. These studies are too limited
to suggest whether or not netilmicin is more effective than
gentamicin or tobramycin in treating Gram negative CAPD
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peritonitis. They make it clear, however, that, like all available
aminoglycosides, netilmicin is potentially ototoxic.
The most promising candidate among the new cephalosporins is
ceftazidime which has excellent activity against most Gram negative
bacilli, including, importantly, P. aeruginosa (Gozzard et al,
1983). It has, however, less activity against several other
species of Pseudomonas and Acinetobacter and the staphylococci
(Gould and Wise, 1985). A study of the use of ceftazidime and
vancomycin has recently been published (Gray et al, 1985). In a
series of 64 cases of CAPD peritonitis, seven of the eight episodes
known to have been caused by Gram negative bacteria were cured by
intraperitoneal ceftazidime. These promising results have prompted
my colleagues in the renal unit at the Queen Elizabeth Hospital to
embark upon a prospective study using intraperitoneal vancomycin
and ceftazidime.
Other possibilities for the future include members of the
quinolone family of antibiotics such as pefloxacin and norfloxacin.
These agents have a spectrum of activity similar to that of
ceftazidime although streptococci are relatively resistant. They
appear to have few side effects (although clinical experience is
limited) and they do not induce the development of resistant
strains as readily as the new cephalosporins (Editorial, 1984;
Gould and Wise, 1985).
In conclusion, this study has shown for the first time that
most episodes of CAPD peritonitis can be effectively and safely
treated at home by the once-daily addition of antibiotics to the
dialysate. However, the aminoglycoside remains an imperfect choice
for which a substitute should be sought. Furthermore, it is
essential that the use of this, and any other, treatment of CAPD
peritonitis should be kept under constant scrutiny to ensure that
its effectiveness is being maintained.
Chapter 7
Disinfection of the Hands and Tubing of CAPD Patients*
Summary: The effectiveness of two methods of handwashing before the
bag exchange was studied over a three month period in 31 patients
using CAPD. A defined, double rinse with 70% ethanol was found to
be more convenient and much more effective than povidone iodine
detergent alone or povidone iodine followed by 70% ethanol.
Spraying the tubing around the bag connector with 70% ethanol
reduced the number of adherent skin organisms and hence the
likelihood of bacteria being drawn into the dialysate. Although
there was no difference in the overall incidence of peritonitis in
the two study groups, there was an unexpected drop in the incidence
of peritonitis caused by coagulase-negative staphylococci. This
was attributed to an increased overall awareness of the importance
of handwashing and aseptic procedures during the bag exchange.
Patients whose catheter exit sites were colonised with Staph,
aureus or Acinetobacter spp were found to be likely to develop
peritonitis due to these organisms.
* The data presented in this chapter has been published in the
Journal of Hospital Infection. See Appendix 4.
Introduction
Since CAPD was first introduced, it has been universally
agreed that bacterial contamination of the dialysate occurs most
readily during the dialysis exchange. Organisms present on the
patients' hands, on the connector itself or in the surrounding air
are thought to enter the system while the connector is
disconnected. All patients are therefore trained to wash their
hands thoroughly before each bag exchange (Clayton et al, 1981).
An antiseptic detergent is generally recommended, the commonest
being povidone iodine (Betadine), and chlorhexidine (Hibiscrub).
Although the effects of these agents have been studied on the hands
of health-care personnel (Ayliffe, 1980), their effect on the
resident flora of patients' hands has not been evaluated. At the
start of the study, all our patients were using povidone iodine.
We have therefore compared its effectiveness as a hand disinfectant
with that of 70% ethanol, another widely used skin disinfectant.
We also looked at decontamination of the connector and the adjacent
tubing and of the skin around the catheter exit site and recorded
the incidence of peritonitis during the study.
Materials and Methods
The study took place during a three month period between
February and May 1983. The 31 patients practising CAPD at the
Queen Elizabeth Hospital, Birmingham, were each randomly allocated
to one of two groups. Group A contained 16 patients and Group B
15. The groups were found to be matched in terms of age, sex, time
on CAPD, previous episodes of peritonitis and proportions of
diabetics to non-diabetics. All patients used the "Travenol IIR"
system, and carried out three or four exchanges per 24 hours.
Skin disinfection before bag exchange: Hands were disinfected
before preparation of the surface, administration set and bag, and
immediately prior to exchange. Group A patients continued to use
the existing method, consisting of a thorough handwash with povi¬
done iodine detergent ("Betadine" surgical scrub) followed by an
application of 5 ml of 70% ethanol containing 1% glycerol as an
emollient. Group B patients applied 5 ml of 70% ethanol and 1%
glycerol to the cupped hands and gently rubbed until dry. The
process was then repeated. A defined procedure was taught to
ensure all surfaces of hands were covered (Ayliffe, Babb and
Quoraishi, 1978). Group A used a non-medicated soap and Group B 4%
chlorhexidine detergent ("Hibiscrub") for general handwashing.
Group A cleaned the catheter exit site with povidone iodine
detergent and Group B with chlorhexidine detergent. Both groups
wore masks during the exchange and Group B also sprayed the outer
surface of the bag connector and adjacent tubing with 70% ethanol.
Bacteriological sampling: Samples were taken from the hands,
the catheter exit site and the administration tubing at monthly
intervals where possible, or in most cases two to four times during
the study.
Samples were taken from the hands before and after
disinfection using the two methods.
(1) Broth sampling. The tips of the fingers and thumb of
one hand were gently kneaded for one minute on the
bottom of a Petri dish containing 10 ml of recovery
medium. The recovery medium contained nutrient broth
(No 2, Oxoid Ltd, Basingstoke) with a 0.75% lecithin-
tween mixture and 1% sodium thiosulphate to neutralise
residual povidone iodine or chlorhexidine. Neat and
ten-fold dilutions were then drop-pipetted on to the
surface of blood and phenolphthalein disodium phosphate
(PPD) agar plates. The agar (Oxoid No 2) was enriched
with 1% horse serum.
(2) Finger streaks. This method was used to estimate the
number of bacteria readily detachable from each finger
tip. The fingers and thumb of the other hand were
streaked across the surface of a nutrient agar plate
(PPD).
The skin of the abdominal wall immediately adjacent to the
exit site was sampled using (1) a contact plate (25 cm^) containing
either PPD or blood agar, (2) a swab moistened in Ringer's
solution which was then plated directly on to blood and PPD agar.
Swabs moistened in Ringer's solution were used to sample both
the bag and peritoneal catheter connectors and also the tubing for
4-5 cm on each side of the connectors. A further sample was taken
from Group B patients from the bag connector and adjacent tubing
following disinfection with alcohol.
Swabs moistened in Ringer's solution were taken from the
anterior nares and cultured immediately on PPD agar.
In the event of a CAPD patient presenting with a bag
containing turbid fluid which was found to have more than
100 leukocytes/mm^, the dialysate was cultured as follows: 20 ml
were centrifuged and the deposit plated out on blood and cystine
lactose electrolyte deficient (CLED) agar plates; 60 ml were added
to a 100 ml medical flat bottle containing 20 ml of sterile
nutrient broth (Oxoid No 2) at four-times normal strength, the
addition of the dialysate thereby diluting the broth to the correct
concentration.
All plates and broth cultures were incubated aerobically at
37°C for 18 hours. Plates were re-incubated for 24 hours at room
temperature to assist with identification of coagulase-negative
staphylococci and counts were made where appropriate. Strains were
identified by conventional tests and the API system was used for
all Gram negative bacilli and selected coagulase-negative
staphylococci from patients with peritonitis.
Statistical analysis: The difference of means and the Chi-
squared test with Yates' correction were used where appropriate.
Results
In Group A, one patient was transferred to haemodialysis
before he could be sampled, dnd another was unable to attend the
sampling clinic. The 14 remaining patients were sampled on a total
of 36 occasions. The 15 patients in Group B were sampled on 49
occasions.
Hand sampling: The number of resident skin bacteria
recoverable from the fingers by the broth sampling method before
skin disinfection varied considerably from patient to patient in
both groups (range: 1.8 x 10^ - 7.2 x 10^ CFU). However, median
counts in the two groups were very similar (1.6 x 10^ and 3.3 x 10^
CFU).
Using the broth sampling technique, there was an increase in
the mean bacterial counts following the use of povidone iodine
alone and povidone iodine followed by alcohol. These increases
were 107% and 51% respectively. There was, however, a mean
reduction in the bacterial count of 69% in the defined double
alcohol wash group. Thus, the defined alcohol wash led to a
significantly greater reduction than either povidone iodine alone
or povidone iodine plus alcohol (p < 0.001). More resident
bacteria were recovered after than before washing with povidone
iodine alone on 16 of 29 occasions (55%) and on 12 of 36 occasions
(33%) with povidone iodine and alcohol. On five occasions, the
bacterial count after povidone iodine and alcohol increased more
than five-fold. On only five of the 47 occasions (11%) did the
bacterial count rise following the defined alcohol wash, the
greatest increase being 3.6 fold.
Table 7.1 shows that with the finger streak sampling method,
lower bacterial counts were also obtained following the defined
alcohol wash. The alcohol wash led to significantly lower counts
being obtained from the thumb, middle and ring fingers.
Bacterial species: The bacteria isolated from the hands were
mainly coagulase-negative staphylococci. Staph, aureus was
recovered from the hands before disinfection in five Group A
patients on a total of eight occasions and from seven Group B
patients on eleven occasions. Following disinfection, Staph,
aureus could still be isolated from four of the five Group A
patients and two of the Group B patients. These differences were
not statistically significant. The following Gram negative bacilli
were recovered from 11 of the 83 samples (13%) before disinfection,
but none of the samples after disinfection: Acinetobacter spp,
TABLE 7.1





(Fingers) Counts of Fingers
After two applications No growth 60.5
of alcohol 43 1-10 33.5
(Group B) (215) 11+ 6.0
After povidone iodine No growth 39.3
Group A 29 1-10 28.3
(145) 11 + 32.4
After povidone iodine No growth 45.2
and alcohol 31 1-10 29.0
(Group A) (155) 11+ 25.8
eight samples from six patients; Proteus mirabilis, from two
patients and Escherichia coli, from one patient. On only three
occasions did the number of Gram negative bacilli recovered from a
broth sample exceed 100. A few colonies of Strep, viridans were
recovered from one of the 83 pre-disinfection samples.
Exit site and tubing: Contact plate sampling of the exit site
gave very similar counts in both the chlorhexidine and the povidone
iodine treated groups. Counts ranged from less than ten colonies
to confluent growth, but in both groups there was a moderate to
heavy growth in about 70% of samples and a very heavy or confluent
growth in 20%. Again, most of the organisms cultured were
coagulase-negative staphylococci. However, exit site samples from
three patients in Group A and four patients in Group B yielded
Staph, aureus. Staph, aureus was also grown from the hands before
disinfection and the anterior nares in all these patients. Phage
typing showed that all strains isolated from different sites in the
same patient were identical. Acinetobacter spp were isolated from
four of the six patients from whose hands they had been recovered.
Proteus mirabilis was cultured from the exit site of one patient.
The results of sampling the administration tubing before and
after spraying with 70% alcohol are shown in Table 7.2. This shows
that there was more contamination of the tubing around the
peritoneal catheter connector, which lies close to the abdominal
wall, than around the bag connector. Spraying the tubing around
the bag connector with alcohol led to a large reduction in counts,
with 82% of samples taken after disinfection showing no growth.
Peritonitis: Over the three months before the start of the
TABLE 7.2
CONTAMINATION OF THE ADMINISTRATION TUBING BEFORE AND AFTER













0 14 26 82
1 - 10 37 57 16
11 - 100 38 17 • 2
100 + 11 0 0
Sample number 84 35 49
study (period 1), there were 23 episodes of peritonitis during 94
patient-months of CAPD (one episode per 4.1 patient-months). Over
the three months of the study (period 2), there were 16 episodes
during 106.5 patient-months (one episode per 6.7 patient-months).
Seven of the 16 episodes occurred in six Group A patients and nine
in six Group B patients. The organisms isolated during the two
periods are shown in Table 7.3. The number of patients infected by
coagulase-negative staphylococci fell from 11 of 27 during period 1
to only three of 29 during period 2 (X2 = 4.39, p < 0.05) rising
again to eight of 27 during the three months following the end of
the study. The proportion of patients developing peritonitis
caused by other organisms did not change significantly.
Discussion
This is the first time that the effectiveness of the
handwashing techniques used by CAPD patients has been studied.
Most studies of handwashing techniques have been concerned with the
removal of traditional bacterial pathogens such as Staph, aureus
and Klebsiella spp which are transiently found on the hands, and
have involved health care personnel. However, CAPD peritonitis is
often caused by resident skin bacteria, notably the coagulase-
negative staphylococci, and the patients themselves usually carry
out their bag exchanges. Hence, it is important to know how
effective are the patient's disinfection procedures in reducing the
resident as well as the transient skin flora.
Our study has shown that the povidone iodine detergent, as
used by our patients, is often counter-productive. Far from
reducing the resident skin flora on the hands, it led to an
TABLE 7.3
ORGANISMS CAUSING PERITONITIS IN CAPD PATIENTS BEFORE AND DURING STUDY







Coagulase negative staphylococci 15 2
Coagulase negative staphylococci
with Staph, aureus 1 0
with Str. viridans 0 1
with diphtheroids 1 0
with Gram negative bacilli 1 0
Diphtheroids 0 1
Staph, aureus 0 3
Str. viridans 0 4
Acinetobacter spp 2 1




increase on more than half the occasions. The use of 70% alcohol
immediately after povidone iodine somewhat improved disinfection
but in many instances the counts were still higher than before
disinfection. The defined double alcohol wash was significantly
more effective, with a mean count reduction of 69%. Nevertheless,
on a few occasions, counts were still higher after the alcohol wash
than before.
There are probably three main reasons for the greater
effectiveness of the defined double alcohol wash. First, the
povidone iodine preparation, unlike 70% alcohol, is a detergent as
well as a disinfectant. Its detergent action brings to the surface
bacteria lodged in pores and creases. Second, 70% alcohol kills
bacteria more rapidly than povidone iodine (Ayliffe, 1980). Third,
the defined wash means that there is less chance that any part of
the fingers will avoid disinfection. The finger streak samples
showed that the difference between the two methods was greatest on
the thumb, middle and ring fingers. Previous work has shown that
these areas are often missed during handwashing (Taylor, 1978).
Despite the superiority of the double alcohol wash over
povidone iodine and a single application of alcohol, we were unable
to show any difference between the two groups in the incidence of
peritonitis during the short period of the study. We did, however,
observe an unexpected reduction in the overall incidence of
peritonitis caused by coagulase-negative staphylococci, with three
episodes during the three months of the study compared with 18
episodes during the three months before the study. Because the
coagulase-negative staphylococcus is the most likely contaminant of
the bag connector, the incidence of coagulase-negative
staphylococcal peritonitis is probably a good indicator of the
adequacy of bag exchange technique. Although Group A patients were
not specifically instructed in handwash techniques during the
study, they inevitably became aware that this was what we were
studying. Consequently, patients in both groups may well have paid
more attention to their exchanges with less contamination of the
bag connector as a result. Indeed, current connector design should
ensure that the bag exchange can be carried out aseptically, even
with dirty hands, provided technique is meticulous.
The alcohol wash was generally preferred by patients. It
could be carried out without using a wash-hand basin making it very
suitable for travellers and holiday makers. Once learned, the
technique was quicker than using povidone iodine detergent. The
alcohol, being almost colourless, did not stain clothes or
jewellery. With the added glycerol, it was found by some patients
to be gentler to the skin than povidone iodine. All patients were
thus switched to the defined double alcohol wash once the results
of the study were known. Despite this, the incidence of coagulase-
negative staphylococcal peritonitis rose sharply again. Was this
because some patients had returned to their old slack ways?
The fallability of the handwash procedures would seem to
provide a good argument for the use of sterile gloves during the
bag exchange. In practice, the benefits of gloves are unlikely to
be great. Donning the gloves without contaminating them requires
care and dexterity. The patients who would use gloves properly
would probably be those with a good exchange technique and hence a
low risk of peritonitis. Less competent patients would be less
likely to use the gloves to advantage. Given the considerable
expense of supplying sterile gloves for every exchange, their use
cannot be recommended at present.
Each of the three episodes of Staph, aureus peritonitis was
caused by organisms identical to isolates previously cultured from
the patient's nose, hands and exit site. Those patients who had
Staph, aureus on their hands but not on the exit site did not
develop Staph, aureus peritonitis during the study. This perhaps
favours the exit site as a focus of colonisation from which direct
spread along the outside of the catheter later occurred. Sewell
and others (1982) also found a very significant relationship
between nasal or skin carriage of Staph, aureus and subsequent
Staph, aureus peritonitis. Carriers of Staph, aureus accounted for
seven of the eight episodes they studied and three of the four
persistent carriers developed Staph, aureus peritonitis during the
13 months of their study.
Acinetobacter peritonitis occurred in two of the four
patients carrying the organism on their exit site as well as on
their hands. A similar strain was found on the face-flannel of one
of these patients. Colonisation of the exit site by potential
pathogens occurred despite reported daily cleansing of the exit
site with either povidone iodine or chlorhexidine detergent. Both
these agents thus seem inadequate for the purpose. It may be that
the detergent has a damaging effect on the skin which favours
colonisation.
Our study showed that Strep, viridans is almost never found
on the hands or exit site of CAPD patients. The most likely route
to the peritoneum taken by these oral organisms is via the blood
stream. Two of the four episodes of Strep, viridans peritonitis
during the study period occurred in the only splenectomised patient
in the group. We have subsequently seen four patients all of whom
developed Strep, viridans peritonitis shortly after developing an
oral lesion or undergoing dental treatment (Kiddy et al, 1985). We
thus recommend that CAPD patients should use a soft bristle
toothbrush to minimise damage to the gums, and attend to oral
lesions promptly. Any dental treatment involving the gums should
be covered by antibiotic prophylaxis, using the same regimen
advised for patients at risk of infective endocarditis (Working
party, 1982). Furthermore, as we found no evidence that oral
organisms contaminate the bag connector during the exchange, we
have dispensed with the mask, thus simplifying the bag changing
routine and increasing its social acceptability.
Hand disinfection emerges from this study as a ritual that is
at best of limited value and at worst distinctly counter¬
productive. A defined double alcohol wash is probably the most
practical method. Until the foolproof bag exchange is developed, a
meticulous aseptic technique will remain the best insurance against
infection. In the Epilogue, I shall discuss the progress that is
being made towards the ideal exchange.
Chapter 8
Four Years of CAR) Peritonitis
Summary: During 1981-1984, 131 patients were trained to use CAPD at
the Queen Elizabeth Hospital, Birmingham. Four patients died while
on CAPD but only one from peritonitis. The overall incidence of
peritonitis was one episode every 5.1 patient-months, being lowest
in 1983 but increasing again in 1984. By the end of 1984, 43
patients had used CAPD for more than one year; only seven of these
had not had peritonitis and six had had at least ten episodes.
CAPD was permanently discontinued following seven of the 319
episodes of peritonitis (2.1%). The intraperitoneal catheter was
temporarily removed following a further 5.6% of episodes including
8.8% of those in 1984. As a result, the antibiotic treatment of
peritonitis has recently been re-assessed. Peritonitis remains the
main threat to the CAPD prograimie at the Queen Elizabeth Hospital.
Introduction
The antibiotic regimens I have described on the preceding
pages have, with certain reservations, proved to be suitable for
treating most episodes of bacterial CAPD peritonitis. However, if
peritonitis is frequent, then failure to cure even a small
percentage of cases can lead to the failure of CAPD for a
significant number of patients. In this chapter, I assess the
impact of peritonitis on the CAPD programme at the Queen Elizabeth
Hospital (QEH) by considering the incidence of peritonitis over
four years and the rate of failure of CAPD due to peritonitis.
These results are then compared with those obtained in other
centres.
Patients and Methods
All patients trained in CAPD at the QEH between 1981 and 1984
were included in the analysis. All episodes of peritonitis and all
temporary and permanent interruptions of CAPD were noted. The
peritonitis rate was first calculated simply as "episodes per
patient-months of treatment". Then, to allow more accurate
comparisons between the peritonitis rate in different populations
and at different times, the probability of developing a first
episode of peritonitis was calculated by standard life-table
analysis (Pierratos et al, 1982; Bradford Hill, 1977). The
significance of differences between probability curves was
determined by the log-rank test using a Hewlett-Packard
programmable calculator. The technique survival of CAPD was
calculated by the method of Kaplan and Meier (1958) with patients
who stopped CAPD because they died or received a renal transplant
being considered "lost to follow-up" from the date of death or
transplantation.
Results
During the period January 1981 to December 1984, 131 patients
were trained to use CAPD at the QEH. Figure 8.1 compares the
increase in the number of patients using CAPD at the hospital
during this period with the world-wide increase that occurred in
1979-82. By the end of 1984, patients at the QEH had been using
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Figure 8.1 Number of patients on CAPD at the end of each three month
period at the Queen Elizabeth Hospital, Birmingham,
1981 - 84, and in the world, 1979 - 1982 ( )
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CAPD for a mean of 12.4 months. However, Figure 8.2 shows that
only one-third of the patients had used CAPD for more than 12
months and only 16 patients had had more than two years'
experience. The average age of the patients was 42.4 years (range
15-70). Fourteen patients were aged over 60 years but only two
over 65. Ninety patients were male and 41 female; 31 patients were
diabetic. During the four years, 30 of the 131 patients received a
renal transplant after an average period of 10.2 months of CAPD.
Four of the 131 patients died while using CAPD; three from
ischaemic heart disease (two within one month of starting CAPD) and
one fron peritonitis (see below).
Peritonitis
During the total of 1,631 patient-months of CAPD, there were
319 episodes of peritonitis giving an overall incidence of one
episode every 5.1 patient-months. The number of patient-months per
episode was 3.2 in 1981, 3.9 in 1982, 6.1 in 1983 and 5.4 in 1984.
The probability of developing a first episode of peritonitis
against time is shown in Figure 8.3. This shows that patients
trained in 1983 took significantly longer to develop their first
episode of peritonitis than those starting in 1982, whereas in 1984
the peritonitis-free interval shortened again. Figure 8.4 shows
that only seven of the 43 patients using CAPD for more than a year
had not had peritonitis whilst six had had at least ten episodes.
Only one patient, a 57 year old man, died as a result of
peritonitis. This fatal episode was treated in a hosptial outside
Birmingham and neither the causative organism nor the treatment
given are known. In seven of the 319 episodes (2.1%), peritonitis
led to the permanent removal of the intraperitoneal catheter and
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Number of episodes of peritonitis
The number of episodes of peritonitis experienced by
patients who had used CAPD for more than one year
discontinuation of CAPD. In a further 18 episodes (5.6%), the
catheter was temporarily removed because of peritonitis but
successfully replaced one to three months later. The causative
organisms in these 25 cases are shown in Table 8.1 which also shows
that in most cases the catheter was removed because of recurrent
rather than acute infection. In only two cases did peritonitis
lead to the failure of the peritoneum as a dialysis membrane, and
in both of these a combination of pyogenic bacteria was
responsible. The likelihood of catheter removal did not seem to be
related to the patient's age or sex or to the presence of diabetes
mellitus. Table 8.2 shows that the frequency with which the
intraperitoneal catheter was temporarily removed rose sharply in
1984.
The effect of peritonitis on the long-term success of CAPD is
shown in Figure 8.5. Seven per cent of patients had discontinued
CAPD because of peritonitis after one year and 16.6% after two
years. Of the 11 occasions when CAPD has failed during the first
four years of the programme, seven have been due to peritonitis.
Discussion
The remarkably rapid rise in the number of patients using
CAPD worldwide between 1979 and 1982 is mirrored in the increase in
the number of patients using CAPD at the QEH (Figure 8.1). CAPD
patients at the QEH have been younger on average than those in most
other centres, with an average age of 42.4 years compared with an
average age of 49.5 years in the 3,784 patients on CAPD throughout
Europe at the end of 1982 (Moore et al, 1984). Only two patients
TABLE 8.1
THE CAUSATIVE ORGANISMS RESPONSIBLE FOR PERITONITIS LEADING TO





Due to recurrent infection
Coagulase-negative staphylococci 6 1
Diphtheroids 2 0
Aerobic sporing bacillus 2 0
Staph, aureus 1 1
Agrobacterium sp. 0 1
Due to severe acute infection
Yeast 2 0
Enterobacter cloacae 1 0
P. aeruginosa 1 0
Strep, viridans 1 0
Acinetobacter anitratus 1 0
Pseudomonas sp. + Citrobacter freundii 0 1
E. coli + B. fragilis 0 1




PATIENT-MONTHS OF CAPD FOR EACH TEMPORARY OR PERMANENT
CATHETER REMOVAL
1982 1983 1984
Temporary catheter removal 136 153 61
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Figure 8.5 Percentage failure rate of CAPD due to
(1) peritonitis and (2) all causes
(numbers above steps indicate number of
patients still using CAPD at start of each
period)
at the QEH were aged over 65 years, compared with about 17% of all
patients on CAPD throughout Europe. The relative youth of the
patients at the QEH may explain in part why their overall survival
at two years was about 96.4% (three deaths) compared with only 72%
overall throughout Europe (Moore et al, 1984).
The incidence of peritonitis at the QEH and its impact on the
CAPD programme remain unacceptably high. The probability of
developing peritonitis within the first year of CAPD was 100% in
patients starting in 1982 and 1984 (Figure 8.3). Only in 1983 did
it drop to 60% to compare more favourably with the results of the
most successful centres. The National Institutes of Health
reported a probability of 70% in the United States as a whole
(Friedman, 1984); in Toronto the figure was 64% (Pierratos, 1982);
in Montpellier, using a filter system, 30% (Slingeneyer et al,
1982); and in Milan using a novel disinfectant system, a remarkable
22% (Maiorca et al, 1983). (These latter two systems will be
considered in the Epilogue.) The overall incidence of peritonitis
at the QEH of one episode every 5.1 patient-months was also much
higher than that reported in many centres. Hie average incidence
in the United States during the period 1981-83 was one episode
every 7.5 months but a number of experienced centres there have
recently reported one episode only every 11-14 months (Multicenter
Study Group, 1985). In the United Kingdom, a recent survey found
that eight of the 41 contributing units had a peritonitis rate of
better than one episode every 12 patient-months. At the other
extreme, however, ten centres reported rates of one episode every
four months or less (Gokal and Marsh, 1984).
Why have the peritonitis rates at the QEH remained so high
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when the techniques and equipment used there appear to be the same
as those of units where peritonitis is less frequent? Because
peritonitis can so readily result from poor patient technique and
personal hygiene, its prevention currently depends heavily upon the
training given to patients and their supervision thereafter
(Clayton et al, 1981). As already described in Chapter 7, the
incidence of CAPD peritonitis caused by coagulase-negative
staphylococci fell sharply when close attention was paid to
patients' bag-exchange technique (Gruer et al, 1984b). Most units
have experienced a high incidence of peritonitis in the initial
months of their CAPD programme, followed by an improvement as staff
become more experienced in training and supervising their patients.
This appeared to happen at the QEH between 1982 and 1983 but the
situation clearly deteriorated again in 1984. At the QEH in early
1983, the 20-30 CAPD patients were trained and supervised by two
full-time nurses. By the end of 1984, the number of patients had
increased to nearly 90, but only one more part-time nurse had been
assigned to their care. No extra medical staff had been taken on
since the CAPD programme had begun. All patients continued to be
seen in the same small room (4.5 m x 3 m) that had been allocated
for CAPD in 1981. Then it was envisaged that the number of
patients in the programme would not exceed ten! Consequently, the
amount of time that nursing and medical staff could devote to each
patient has dropped progressively and their working facilities have
become less adequate. I believe this situation largely accounts
for the rise in the incidence of peritonitis at the QEH between
1983 and 1984.
Although efforts to reduce the incidence of peritonitis at
the QEH have been unsuccessful, its treatment has been
comparatively satisfactory. None of the 318 episodes treated at
the QEH was fatal. This compares with a case-fatality rate of 1.9
to 3.4% in the years 1977-82 in the pioneering centres at Toronto
(Fenton et al, 1983). Whilst half the 18 patients who died of
peritonitis in Toronto were aged over 60 years, the others were in
the age groups from which most of the QEH patients were drawn.
This suggests that the absence of fatal episodes at the QEH cannot
simply be explained by the relative youth of its CAPD population.
Peritonitis led to the permanent discontinuation of CAPD in
1.4% of episodes of peritonitis at the QEH in 1982, and 2.7% in
1983 and 1984. This compares with case-failure rates of 5.7 to
7.5% in Toronto during 1977 to 1982 (Wu et al, 1983), 9.5% in
Newcastle (Bamos et al, 1983) and 12% in Mississippi (Rubin et al,
1983). In part, this difference between the QEH results and those
of other centres may reflect more appropriate antibiotic treatment.
It may also lie in the current readiness at the QEH to remove the
catheter temporarily if antibiotics have failed to eradicate the
infection. This strategy has proved to be effective in aborting
both severe acute infections and milder recurrent ones (Table 8.1).
A notable feature of the 1984 results was the marked increase
in the number of temporary catheter removals (Table 8.2). Nine of
the 13 temporary removals in 1984 were in response to recurrent
infections caused by Gram positive bacteria. This has led to a
recent re-assessment of the effectiveness of the once-daily
vancomycin regimen. It does now appear that this regimen is
sometimes insufficient to eradicate all apparently sensitive
bacteria. Consequently, vancomycin is again being added to each
bag of dialysate to ensure that the infective organisms are
constantly exposed to antibiotics. The total daily dose of
vancomycin has also been doubled to 200 mg. Work is also in
progress to see whether any of these recurrent infections are
caused by vancomycin-tolerant organisms.
Only two of the 131 patients had to discontinue CAPD because
peritonitis had so damaged the peritoneal membrane as to make
dialysis inadequate (Table 8.1). In both cases the infection had
been caused by a combination of pyogenic organisms. On the other
hand, several patients have had many episodes of peritonitis
without a major deterioration in peritoneal dialysis function.
However, Rubin and others (1983b) have shown that a high rate of
peritonitis is associated with a small but significant decline in
peritoneal dialysis function compared with patients with a low rate
of peritonitis. Much still needs to be learned about the response
of the peritoneal membrane to infection (Diaz-Buxo, 1984). For
example, can anything be done to mitigate the effect of
peritonitis, other than promptly treating the infection with
appropriate antibiotics? Should the peritoneum be periodically
rested to promote its regeneration, or will this increase the risk
of adhesions? Hie relative youth of CAPD means that we simply do
not know whether the peritoneal membrane can withstand repeated
infective and other insults and support patients for over two
decades - as haemodialysis has done (Coles, 1985).
In conclusion, peritonitis remains the major threat to the
CAPD programme at the QEH. It seems unlikely that the peritonitis
rate will decrease significantly unless:
1) the staff-to-patient ratio and hence the quality of
patient training and supervision can be increased;
or 2) technical developments which reduce the risk of
peritoneal contamination can be introduced.
In the final section, I shall discuss such technical
developments and their promise.
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Epilogue
Can VE Eliminate C£PD Peritonitis?
Introduction
It is clear that the rapid diagnosis and treatment of
peritonitis are indispensable to the safety of CAPD as it has been
practised until now. Might we not envisage, however, a time when
technical improvements had led to the virtual elimination of the
risk of peritonitis? Over the past four years, intensive efforts
have been directed towards achieving this end.
The most vulnerable feature of the standard CAPD system is
the connector between the bag of dialysate and the administration
tubing. Most attention has therefore been focussed on ways of
modifying the connector, either to make contamination less likely,
or to ensure that contaminating organisms are destroyed in situ.
This closing section begins by briefly reviewing the developments
which have shown most promise. These involve the use of
intraluminal filters, intraluminal disinfectants, ultra-violet
irradiation and the "sterile weld" bag exchanger.
A radically different approach to the prevention of
peritonitis is based on the premise that the natural defences of
the peritoneum against infection are compromised by the presence of
large volumes of dialysate. The peritoneum cannot therefore
respond adequately to the micro-organisms it encounters. The
chapter concludes with a review of research in this area which
offers the prospect of future preventive measures.
1. Intraluminal Filters
If it is certain that most episodes of peritonitis follow
contamination of the bag connector, the logic of fitting a
bacterial filter in the tubing between the connector and the
peritoneal cavity is irreproachable. As discussed earlier (p 17),
the first advocates of the in-line filter were Slingeneyer and his
colleagues in Montpellier, France. The design of their system is
shown in Figure P.2 (p 18). Each patient normally used each filter
for 10-14 days. In two papers, Slingeneyer and his colleagues
(1981, 1982) reported that the average peritonitis rate in their
CAPD patients, all of whom used the filter system, was one episode
per 31 patient-months when they excluded episodes caused by
accidental disconnection of the tubing from the Tenckhoff catheter.
These rates were substantially lower than those reported by other
centres. They cultured the upstream and downstream sides of used
filters and found that 25% of 114 filters cultured were
contaminated on the upstream side only, whilst only 3% were
contaminated on the downstream side. This provided further
evidence that the filter was effectively preventing organisms from
entering the peritoneal cavity. Unfortunately, this group did not
compare peritonitis rates in their CAPD patients with and without
the filter. Indeed, their comparative trial of patients using
intermittent peritoneal dialysis with and without a filter showed
no difference in the peritonitis rates of the two groups. A
suspicion therefore remained that the very low peritonitis rates
associated with filter use could be due to other factors.
Furthermore, the filters were expensive and bulky. Consequently,
few other centres took to their use.
More recently, the Millipore Co have developed the Peridex
filter, specifically designed for use in CAPD and much more compact
than the earlier model used in Montpellier. The main
bacteriological weakness of both models is that micro-organisms can
circumvent the filter by growing down the outlet by-pass tube and
through the check valve. Poole-Warren and others (1984) tested
seven Peridex filter sets for 30 days in conditions designed to
duplicate normal CAPD routine, except that the first bag of
dialysate used in five of the seven sets had been inoculated with
106 CFU of Serratia marcescens. They found that the organisms
successfully by-passed the filter via the outlet tube on Day 19 in
three sets and Day 23 in one. They concluded that the system would
be likely to afford protection if changed every two weeks.
However, given that they only tested five sets and one orgamism,
their conclusions seem premature. Ash and Winchester (1984)
studied 33 patients both with and without the Peridex filter. They
were all said to have a higher than average rate of peritonitis
before they began using the filter. The overall rate of
peritonitis fell from one episode every 7.5 patient-months to one
every 15.6 patient-months (p < 0.01). Like Slingeneyer and others,
they found that dialysate upstream to the filter was more often
culture positive. The principal weakness of this study was that
the patients acted as their own historical controls. At least some
of the improvement could have been due to the fact that many
patients tend to have less peritonitis once they are well
established on CAPD (Multicenter study group, 1985). Nevertheless,
the results do suggest that the filter can be useful. 'However, the
main disadvantage of the technique is the fact that each filter
costs at least £50 (Ash and Winchester, 1983). If the filter is
changed every fortnight, the annual cost per patient of filters
alone will be £1,300. If most episodes are treated at home as we
recommend, for a cost of around £50 per episode, on cost grounds
alone the filter could not possibly be justified except in patients
with frequent, life-threatening peritonitis.
2. Ultraviolet Light
Ultraviolet light of sufficient intensity rapidly kills most
bacteria and yeasts. Travenol Inc, a company which has played a
major role in the development of CAPD, has recently introduced a
portable, battery-powered ultraviolet source designed to sterilise
the bag-tubing connector at each exchange. The fresh bag and
tubing connectors are partially coupled, leaving the seal of the
bag intact. The connector is then placed within the irradiation
chamber of the apparatus. Irradiation at 1500 mW/sec/cm^ is
maintained for 3-5 minutes, a dose known to produce complete
disinfection, even after gross contamination with organisms that
are relatively resistant to ultraviolet light, such as Candida
albicans (Holmes et al, 1984). After irradiation, the male and
female portions of the connector are fully coupled, breaking the
bag seal and allowing the dialysate to be run into the peritoneal
cavity.
This system has recently been subjected to a well designed
controlled, randomised, multi-centre trial (Multicenter study
group, 1985). One hundred and sixty-seven patients all initially
performed CAPD without the u-v system for at least four months.
Thereafter, 93 patients were randomly allocated to a control group
and 74 to the test group. After a period of retraining of both
groups, the comparative trial lasted for nine months. The results
showed that there were no significant differences between the
peritonitis rates in the pretrial and trial period in either group
or between those of the two groups in either period. Nor were
there any major differences in the proportion of episodes caused by
the different bacterial species. There was thus no evidence that
the u-v system reduced the risk of peritonitis in these patients.
The authors attempted to explain these disappointing results
on the following grounds. They noted that the overall peritonitis
rates in both test and control group patients was, at one episode
every 11-14 patient-months, only about half their national average.
They thus postulated that most of the patients had excellent bag
exchange technique and that the incidence of peritonitis resulting
from connector contamination was already low. They found that some
patients had much less peritonitis while using the u-v system than
before (although, ipso facto, others must have had more peritonitis
than before). They therefore concluded that the u-v system might
be reserved for use by selected patients with high rates of
peritonitis thought due to connector contamination. They further
suggested that their study showed that the role of contamination of
the connector had perhaps been overstressed and that attention
should now be turned to other sources of infection, such as the
catheter exit site and the intestine.
3. Intraluminal Disinfection of the Connector
Another approach to the problem of contamination of the
connector is to bathe in disinfectant the interior of the connector
and the adjacent tubing. The principal disadvantage of this method
is the risk of toxicity should the disinfectant be allowed into the
peritoneal cavity. Two promising variations on this theme have
recently been reported. Buoncristiani and others (1983) developed
a Y-tube system (Figure E.1) in which arms A and B are filled with
dilute sodium hypochlorite solution between each dialysis exchange.
During the bag exchange, an empty bag is attached to arm B and the
fresh bag to arm A. The waste dialysate is drained into the empty
bag. Fresh dialysate is then run from the new bag into the waste
bag to remove remaining disinfectant. The main clamp is then
opened and the remaining fresh dialysate is run into the peritoneal
cavity. Finally, the main clamp is closed and fresh disinfectant
solution is run into the two arms via arm B. Both bags are then
removed and replaced with sterile caps until the next bag exchange.
The first results of this method (Buoncristiani et al, 1983)
were promising, but the non-randomised study design was too weak to
allow firm conclusions to be drawn. Maiorca and others (1983) then
published the results of a prospective randomised controlled trial
in which 32 patients using the standard Travenol spike connector
were compared with 32 patients using the Y-tube system. The
peritonitis rate in the control group was one episode per 11.3
patient-months compared with one episode per 33 patient-months in
the test group (p < O.OOl). The only adverse effect of the
technique was transient severe abdominal pain which occurred on the
eleven occasions (out of over 40,000 exchanges) when the
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Figure E.l The Y-tube system
hypochlorite solution was accidentally allowed into the peritoneal
cavity. The pain was said to be relieved rapidly by peritoneal
lavage and no long term consequences of the incidents were noted.
A simpler approach has been advocated by Parsons and others
(1983). Using the conventional Travenol II connector, they simply
sprayed a small amount of povidone iodine 5% into the female part
of the connector. Thus, when the connection is made, the male
portion also becomes bathed in the disinfectant. They reported
that after introducing this modification, the peritonitis rate fell
from one episode every 4.5-5 patient-months to one episode every
34 patient-months. Further evidence that this simple manoeuvre can
effectively prevent peritonitis has been published by Beardsworth
and others (1984). Using the Travenol II connector without
povidone iodine instillation, the peritonitis rate was one episode
every 4.6 months. Povidone iodine instillation was associated with
a fall in the rate to one episode every 21.4 patient-months, with
the probability of developing a first episode of peritonitis being
very significantly reduced (0.001 < p < 0.002).
Both the bacterial filter and the u-v light system seem to
work well in the laboratory. It is therefore somewhat perplexing
that the intraluminal disinfectant systems should give apparently
better results. Does this simply reflect different study designs?
If not, to what can the differences be attributed? Only further
research and, in particular, well designed comparative trials will
provide answers to these questions.
Although intraluminal disinfectants can apparently reduce the
incidence of peritonitis, their use must be subjected to constant
scrutiny. For inevitably, the disinfectant will sometimes be
carried into the peritoneal cavity with the attendant risk of
toxicity. That this risk is real is shown in a recent paper from
Glasgow (Junor et al, 1985). They describe 11 patients who
developed sclerosing peritonitis, a severe and irreversible form of
peritonitis characterised by the development of a dense layer of
fibrous tissue on the peritoneum. All these patients were members
of a group of 54 patients who had been spraying the inside of the
bag connector with 0.5% chlorhexidine in 70% alcohol. Sclerosing
peritonitis did not develop in any of the 107 patients who used 5%
povidone iodine in alcohol instead. In vitro studies suggested
that the chlorhexidine-alcohol mixture reacts with the intraluminal
plastic to produce a suspension of tiny plastic particles. It is
not yet clear, however, whether it is the particles or the
disinfectant itself which lead to the peritoneal reaction.
4. The Sterile Meld Bag Exchanger
All the systems discussed above require the patient to
disconnect and connect their dialysis bags manually. The interior
of the connector is thereby exposed to the risk of contamination by
skin- and air-borne organisms. Hamilton and others (1983a, b) have
described a "sterile weld" system in which the tube leading from
the dialysate bag is continuous with the administration tubing. To
carry out an exchange, the peritoneum is drained into the waste bag
and some of the air in the bag is squeezed back into the first part
of the administration tubing. The tubing is then placed within the
welding apparatus alongside the tubing of the fresh bag (Figure







Figure E.2 The Sterile Weld Connector
(adapted from Hamilton et al, 1983)
the tubing of both the new and the used bags and simultaneously
killing any micro-organisms present. The movable tubing carrier
then shifts the melted ends and alligns the new bag and the
administration tubing, welding them together. The weld is said to
have at least 90% of the strength of the original tubing. Without
supplying many details, the authors indicate that various tests of
the device's bacteriological safety proved satisfactory. At
present, the system is undergoing clinical trials. Provided it is
reliable, safe and acceptably priced, it may well prove to be the
answer to the CAPD maiden's prayer.
5. Preventing Other Sources of Spread
Considerable progress has therefore been made towards
rendering the bag exchange free from the risk of contamination. It
is clear, however, that in a proportion of episodes of peritonitis,
the organism's portal of entry is elsewhere. Those which follow
colonisation or infection of the exit site may be prevented by
improvements in the design of the intraperitoneal catheter. Those
which follow haematogenous spread from the mouth (viridans
streptococci) or spread from the intestine or the female genital
tract will be more difficult to prevent. At the Queen Elizabeth
Hospital, we have encountered several cases of viridans
streptococcal peritonitis in patients with oral lesions or who have
had recent dental treatment (Kiddy et al, 1985). We have therefore
stressed the importance of dental hygiene and recommended that CAPD
patients undergoing dental treatment involving the gum should
receive the same prophylactic antibiotics as are currently
advocated for patients with cardiac valve lesions (Gruer et al,
1984b; Kiddy et al, 1985). Peritonitis as a complication of
diverticulitis is particularly likely in elderly patients. For
example, in one study of a CAPD population with an average age of
60 years, 9% of cases of peritonitis were attributed to
diverticulitis (Slingeneyer and Mion, 1982). Some authors have
therefore recommended that Barium studies should be carried out
before starting CAPD: the presence of severe diverticular disease
could weigh against accepting the patient for CAPD (Wu et al,
1983). A less problematic approach is to encourage all CAPD
patients to take a high residue diet with the aim of avoiding
constipation (Wu, 1983).
6. Strengthening Intraperitoneal Defence
A quite different preventive strategy has been suggested by
studies of the natural defence mechanisms of the peritoneum. The
reports of Slingeneyer and his colleagues showed that after 10-14
days of use, the upstream surface of in-line filters was
contaminated wth micro-organisms in 25% of cases. Assuming that
these organisms would reach the peritoneum in patients not using a
filter, it appears that most organisms entering the peritoneum are
eliminated by local defence mechanisms. Might, therefore, some
patients develop peritonitis more often than others because their
intraperitoneal defences are less effective? If this were so,
could anything be done to enhance natural defences of the
peritoneum?
One obvious approach is to use prophylactic antibiotics.
However, it is virtually inevitable that the continuous use of
antibiotics would lead to the selection of resistant bacteria.
Furthermore, it is unlikely that ordinary doses of oral antibiotics
could be relied upon to achieve adequate concentrations in the
dialysate. In the only study of prophylactic antibiotics in CAPD
so far published, Lowe and his colleagues (1980) studied 25
patients given cephalexin 500 mg twice daily for a total of 80
patient-months. This had no effect on the incidence of
peritonitis. More recently, several groups of workers have taken a
more fundamental approach, studying the behaviour of micro¬
organisms and the immune system in dialysate. The most interesting
of their findings are discussed below.
Fresh dialysate does not support the growth of most bacteria
causing CAPD peritonitis (Flournoy et al, 1983) and may be
bactericidal for some strains (Diskin et al, 1983). However, both
groups of workers found that after only a short period within the
peritoneum, the dialysate sustained the growth of many species.
The addition to fresh dialysate of serum of albumin, but not urea,
had the same effect (Diskin et al, 1983). Diskin noted, however,
that the dialysate effluent from four of twelve patients was
bactericidal against the single coagulase-negative staphylococcus
tested. The effluent from one patient was also bactericidal
against a light inoculum of one of the two test strains of E. coli.
This patient's effluent contained significantly greater quantities
of IgA than effluent from others and was the only one in which
complement C3 was detected. Here, therefore, was preliminary
evidence that the intraperitoneal environment might be more hostile
to bacteria in some patients than others.
As discussed earlier, Vas and his colleagues (Vas et al,
1981; Duwe et al, 1981) showed that the phagocytosis of bacteria by
polymorphonuclear leukocytes is markedly inhibited by fresh
dialysate. This appears due to the low pH and high osmolality of
the fresh dialysate. Phagocytosis is also compromised early in the
dialysis dwell time because the numbers of both phagocytes and
bacteria are low and hence the likelihood that the two will meet is
small. In summary, therefore, these studies suggest that fresh
dialysate suits neither the infective agent nor the host's
defences. As time passes and dialysate-blood equilibration occurs,
the intraperitoneal environment appears to become more favourable
to both.
More recently, workers in Minnesota have studied the
phagocytic activity of macrophages and polymorphs against strains
of Staph, epidermidis and E. coli isolated from infected dialysate
(Verbrugh et al, 1983; Keane et al, 1984). They found that, in the
presence of normal pooled human serum, both cell types effectively
phagocytosed Staph, epidermidis and E. coli. When heated serum was
used, only Staph, epidermidis continued to be opsonised, indicating
that the E. coli opsonin was a heat labile substance, probably
complement. Phagocytes and bacteria were then incubated in
dialysis effluent from 21 CAPD patients. Heat-stable opsonic
activity against Staph, epidermidis was detected in five of the
effluent samples but at titres about 100-fold lower than in serum.
None of the dialysate samples opsonised E. coli, however. They
found that there was a significant correlation between the opsonic
activity of the dialysate against Staph, epidermidis and its IgA
content. Subsequent studies have suggested that the principal
opsonin for Staph, epidennidis in both serum and dialysate is an
antibody against the peptidoglycan moiety of the staphylococcal
cell wall (Keane and Peterson, 1984). These workers have also
found that patients with low levels of heat stable opsonins in
their dialysis effluent have a significantly higher incidence of
peritonitis due to Staph, epidermidis than those with high levels.
Since the opsonic activity of dialysate can be substantially
increased by adding normal pooled human serum, they suggest that
Staph, epidermidis peritonitis (and perhaps other forms) might be
prevented by adding serum to fresh dialysate.
This interesting hypothesis remains to be tested. However,
the technical advances discussed earlier in the chapter should lead
to a reduction in the frequency of external contamination and hence
to less staphylococcal peritonitis. Consequently, even if "passive
immunisation of the peritoneum" is successful, its place in the
prevention of peritonitis in the future may be limited.
At the time of completing this thesis (mid-1985), there is
good reason to believe that improved techniques and a better
understanding of intraperitoneal immunology will make CAPD
peritonitis a much rarer condition. What remains in doubt is the
long term durability of the peritoneal membrane, which is being
required to perform a task for which it clearly was not designed.
At present, the failure rate of CAPD remains high and the long term
morbidity and mortality rates appear poorer for CAPD patients than
for comparable patients on home haemodialysis (Coles, 1985). Is
CAPD going to make a lasting contribution to the treatment of
chronic renal failure, or is it going to be rendered obsolete by
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the arrival of fully portable haemodialysis units or some other, as
yet unknown, approach? Time alone will tell.
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APPENDIX 1
EXAMINATION OF PERITONEAL FLUIDS FROM PATIENTS ON PERITONEAL
DIALYSIS WITH SUSPECTED PERITONITIS PRESENTING OUTSIDE NORMAL
LABORATORY HOURS - DISCUSSION PAPER
When CAPD patients present with suspected peritonitis outside
normal laboratory hours, it is current practice for the duty renal
houseman or registrar to call in the duty bacteriology technician
to examine a sample of dialysis effluent. The technician will
perform a white cell count, and gram stain, set up culture plates
and place culture bottles in the incubator. At present, out-of-
hours calls for PD fluid examinations number about ten per month,
of which one to two per month are requested between midnight and
8.00 am. This represents 14% of all emergency out-of-hours
bacteriology calls and one-third of after midnight calls for
samples from Queen Elizabeth Hospital and Maternity Hospital
patients.
In practice, the emergency examination of ED fluid rarely, if
ever, alters the immediate management of the patient. The
development of cloudy effluent is a clear indicator of the onset of
peritonitis and the naked-eye appearance of the fluid correlates
well with the white cell count. In less than ten per cent of cases
of acute CAPD peritonitis are organisms seen on the gram stain and
even then the picture can be misleading: in some instances,
organisms seen on gram stain are not those which are ultimately
cultured; in cases of peritonitis with mixed organisms, only one
organism may be seen on gram stain, but more than one subsequently
grown. Consequently, our current antibiotic policy should be
adhered to, irrespective of the initial gram stain.
Thus, emergency PD cell counting and gram staining contribute
little, if anything, to immediate patient management. It is
essential, however, that the PD fluid inoculated into culture
bottles be incubated immediately to permit early growth. On the
other hand, PD fluid in universal containers can be refrigerated
for 24 hours without invalidating the white cell count. Thus, a
system which could guarantee that specimens were incubated and
refrigerated in the hospital and then taken to the laboratory the
following morning would not, as a rule, diminish the usefulness of
the laboratory service but would obviate the need to call out the
laboratory technician.
Exceptionally, patients are admitted with severe peritonitis
and systemic disturbance. In these cases the laboratory technician
should be called in to process the fluid. Thereafter, if concern
remains, the renal medical staff should not hesitate to contact the
medical bacteriologist on-call to discuss whether anything further
can be done to hasten the diagnosis or improve treatment.
A routine out-of-hours system might be as follows. Specimens
are taken and logged into a book in the CAPD room. The culture
bottles are then taken by a member of the ward staff to the out-of-
hours incubator. The universal container is placed in the ward
refrigerator. It is then the responsibility of the CAPD nursing
staff to ensure that the following morning the log book is checked
and any samples taken promptly to the laboratory. The laboratory
staff should be notified of the arrival of such specimens. The
white cell count will be made and this and any provisional
microscopy or culture results 'phoned to the duty renal registrar
or the CAPD sister at the end of the morning.
Dr Laurence Gruer
APPENDIX 2
SUMMARY OF PROCEDURES FOR THE MICROBIOLOGICAL EXAMINATION OF
DIALYSATE FROM CAPD PATIENTS WITH SUSPECTED PERITONITIS
A Renal Chit Staff
1) Normally, only cloudy dialysate should be sent.
2) Carefully wipe infection port of dialysate bag with a
sterile alcohol swab.
3) Remove 80 mis of dialysate from dialysate bag via
infection port using a sterile syringe and needle.
4) Change needle.
5) Inject 60 mis into a dialysate culture bottle and
20 mis into a sterile plastic universal cotainer.
6) If laboratory is open, dispatch properly labelled
specimens immediately.
7) If laboratory closed, put culture bottle in the out-of-
hours incubator and universal container in a
refrigerator. Ensure that samples are sent as soon as
the laboratory opens.
B Laboratory Staff
1) Normally, only cloudy dialysate samples should be
processed.
2) Place dialysate culture bottle in standard incubator at
37°C.
3) Gently shake dialysate in universal container before
removing a few drops to perform white cell count in
189
haemocytometer.
4) Centrifuge dialysate in universal container at
3,000 rpm for 15 minutes. Pour off all but one drop of
supernatant. Prepare a smear for Gram stain and use
remaining deposit to inoculate sheep blood and CLED
agar for aerobic incubation.
5) Remove culture bottle from incubator after 18-24 hours.
If growth is visible, perform a Gram stain and
inoculate appropriate solid media. Report positive
Gram stain findings to clinical microbiological staff.
6) If no growth is visible in culture bottle, inoculate
sheep blood agar plates for aerobic and anaerobic
incubation. Replace culture bottle in incubator.
Examine bottles daily for signs of growth.
7) Identify isolates using normal methods.
8) Gram positive isolates should be initially tested for
sensitivity to flucloxacillin, vancomycin, gentamicin
and ampicillin. Gram negative isolates should be
initially tested against gentamicin, ampicillin and
cefuroxime.
9) Report identification and antibiotic sensitivity
results to clinical microbiological staff. Record
results of white cell count, culture and antibiotic
sensitivity in CAPD peritonitis book.




DIAGNOSTIC BACTERIOLOGIQUE PES PERITONITES DE DPCA
CRITERES DE DIAGNOSTIC
Typiquement, une peritonite de DPCA ddbute par 1'apparition d'un liquide de
dialyse trouble. Secondairement, aprds quelques heures ou mdmes quelques
jours, apparaissent les signes cliniques.
Le diagnostic se repose sur la mise en Evidence dans le liquide de dialyse
3
de plus de 100 polynucldaires neutrophiles par mm : un tel chiffre correspond
h une turbidity de liquide et h une pdritonite. La culture bactdriologique
est alors indispensable.
En revanche, il est ddsormais inutile d'analyser systdmatiquement au cours
des visites le liquide de dialyse. A un liquide clair s'associe l'absence
de pdritonite, un faible nombre de polynucldaires et aucune valeur de toute
culture bactdrienne.
METHODES DE PRELEVEMENT POUR CYTOLOGIE ET CULTURE
Pour permettre le diagnostic bacteriologique, le volume du liquide mis en
culture doit dtre important, car le nombre de bactdries par millilitre de
liquide de dialyse peut dtre faible. Le site d'injection du sac de liquide
usd est nettoyd prdalablement avec de l'alcool. Ensuite, 105 ml de liquide
usd sont retirds avec une seringue stdrile. 50 ml sont injectds avec une
nouvelle aiguille dans chacun des deux flacons spdciaux (l'un avec un bouchon
noir, l'autre vert), en les remplissant jusqu'h la ligne. rouge. 5 ml sont
mis dans un poudrier stdrile pour la numdration des globules blancs, au
laboratoire de cytologie.
Les prdldvements sont adresses immediatement aux laboratoires pendant leurs
heures d'ouverture. Sinon, le poudrier est h garder au frigidaire, et les
flacons de culture sont h mettre rapidement dans une etuve h 37°. Les
prdldvements seront adressds secondairement aux laboratoires au moment de
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Sir,—Dr Knight and his colleagues (Dec. 11, p. 1301) report
success in treating peritonitis in patients on continuous ambulatory
peritoneal dialysis (CAPD) with oral antibiotics. Cephradine was
their drug of choice but erythromycin, co-trimoxazole and
'Augmentin' (amoxycillin and clavulanic acid) were also used.
Cephradine has a narrower spectrum than that of cefuroxime, the
first-choice treatment of CAPD peritonitis in several units in the
U.K. Dr Gokal and others (Dec. 18, p. 1388) report a success rate of
58% in treating 1 36 episodes ofCAPD peritonitis with ccfuroxime.
Our experience is similar. In the first half of 1982 we successfully
treated 9 of 13 episodes of peritonitis with intraperitoneal
cefuroxime alone (75 mg/l). During the next three months only 5 of
1 3 episodes were cured by cefuroxime, giving a success rate over
nine months of 54%. Most of these later failures were due to strains
ofStaphylococcus epidermidis (a/bus) which had reduced sensitivity to
cefuroxime on routine disc testing and which were only partly
suppressed clinically, leading to a persistent or relapsing peritonitis.
We therefore abandoned cefuroxime in favour of vancomycin, to
which isolates ofStaph, epidermidis have been consistently sensitive,
and tobramycin, both given intraperitoneal^.
We have since studied the sensitivity to cefuroxime and
cephradine of forty-one distinct isolates ofStaph, epidermidis from
29 episodes of CAPD peritonitis. The MIC50 (50% of isolates
inhibited) for cefuroxime was 2 mg/l whilst that for cephradine was
8 mg/l. The MIC90 (90% of isolates inhibited) for both antibiotics
was 32 mg/l. These high MICs indicate that oral cephradine would
be no more successful in our situation than was cefuroxime. We
suggest that the use ofcephalosporins, including oral cephradine, in
CAPD peritonitis is likely to be limited in the long term by the
emergence of resistant Staph, epidermidis.
We have also treated CAPD peritonitis with oral augmentin,
which we selected for its stability to/Mactamases produced by both
gram-positive cocci and aerobic gram-negative bacilli. We treated
ten patients, all of whom had early peritonitis without major
systemic disturbance. Each patient received two augmentin tablets
(amoxycillin 500 mg, clavulanic acid 250 mg) with food 30 min
before each dialysis exchange. Only three of the ten patients
responded satisfactorily. Of the remaining patients, two had an
augmentin resistant Klebsiella; in two, nausea and vomiting led to
discontinuation of the antibiotic; in three, the organism (Staph,
epidermidis) was not eradicated despite in vitro sensitivity.
Antibiotic concentrations in the dialysate eHluent were measured in
four patients. Amoxycillin levels were between 20 and 39 mg/l but
clavulanic acid levels ranged from only 0-25 to 3 mg/l. The low
concentration of clavulanic acid in the dialysate may well have
played a part in the failure of augmentin to eradicate apparently
•sensitive organisms.
We thus consider oral cephradine and augmentin to be unsuitable
for the routine treatment of CAPD peritonitis in our patients.
Despite the potential advantages oforal therapy, we know ofno oral
antibiotic with a spectrum of activity and stability sufficient to
warrant its use in preference to parenteral agents in this condition.
Department of Medical Microbiology,
Medical School,
University of Birmingham,
Birmingham BI5 2TJ L. D. Gruer
R. S. C. Rodger
Department of Renal Medicine,
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Species identification and antibiotic sensitivity of coagulase-negative
staphylococci from CAPD peritonitis
Laurence D. Gruer, Roberta Bartlett and Graham A. J. Ayliffe
Department ofMedicalMicrobiology, Birmingham Medical School, Birmingham Bl 5 2TJ,
England
Forty-three strains of coagulase-negative staphylococci were obtained from
dialysis effluent during 41 episodes of CAPD peritonitis. Eighty per cent of these
were found to be Staphylococcus epidermidis but several other species also
occurred. A recurrent infection lasting 15 weeks was caused by Staph, haemolyti-
cus. Multiple antibiotic resistance was found to be common. Of 13 antibiotics
tested, only vancomycin was active against all strains although most strains were
also sensitive to rifampicin, netilmicin and cefamandole. Vancomycin was chosen
for the initial treatment ofCAPD peritonitis caused by coagulase-negative staphy¬
lococci and eradicated the organism in 29 of 30 episodes.
Introduction
Peritonitis is the main serious complication of continuous ambulatory peritoneal
dialysis (CAPD). All major published studies of CAPD peritonitis report that it is
most commonly caused by coagulase-negative staphylococci (Rubin et al., 1980;
Chan eta/., 1981; Knight et al., 1982; Gokal et al., 1982; Vas, 1983). Such organisms
are frequently resistant to many antibiotics, and may thus prove difficult to eradicate
(Chan et al., 1981; Vas et al., 1981; Atkins et al., 1981). During the first nine months
of 1982, coagulase-negative staphylococci were responsible for 44% of the 45
episodes of CAPD peritonitis occurring at the Queen Elizabeth Hospital,
Birmingham, including 10 of the 12 episodes which were not cured by the first course
of antibiotics.
We therefore collected all coagulase-negative staphylococci isolated from the
dialysis effluent ofCAPD patients with peritonitis. Our aim was to characterize these
organisms more precisely and to identify the antibiotics to which they were most
consistently sensitive. We hoped this would permit us to select antibiotics which
could be used with confidence to treat CAPD peritonitis caused by coagulase-
negative staphylococci from the time of first presentation.
Materials and methods
Initial isolation and identification
A sample of 80 ml of dialysis effluent was collected aseptically from every CAPD
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patient presenting with acute peritonitis to the CAPD unit at the Queen Elizabeth
Hospital, Birmingham. Twenty ml were placed in a sterile universal container. The
remaining 60 ml were injected via a fresh sterile needle into a standard 100 ml medi¬
cal flat bottle containing 20 ml of sterile nutrient broth (Oxoid No. 2) at four times
normal strength, thereby diluting the broth to the correct concentration.
In the laboratory, a few drops of dialysate were removed from the universal con¬
tainer for a white cell count (Vas, 1983). Bacterial peritonitis was considered present
if more than 100 neutrophil polymorphs/mm1 were seen. The rest of the 20 ml was
centrifuged and the deposit plated on to blood and CLED agar for aerobic incubation
at 37°C for 24 h. The culture bottle was incubated aerobicaily at 37°C and sub-
cultured on to blood agar after 24 h or if growth was detected visually at any time
during the next nine days.
All isolates of Gram-positive cocci resembling staphylococci were purified on
Columbia agar base (Oxoid Ltd) by twice plating out from a single colony. Isolates
were subjected to the following primary identification tests: catalase, coagulase and
oxidation or fermentation of glucose (Hugh & Leifson, 1953). All catalase-positive,
coagulase-negative, fermentative isolates were then characterized further.
API Staphylococcus identification galleries (API, Montalieu, Vercien, France)
were used according to the manufacturer's instructions. Tests included in the
galleries were the fermentation of glucose, fructose, mannose, maltose, lactose,
trehalose, mannitol, xylitol, melibiose, raffinose, xylose, saccharose, a-methyl gly¬
coside and /V-acetyl-glucosamine; the reduction of nitrate to nitrite; the production
of acetyl-methyl-Carbinol (V-P test); and the production of alkaline phosphatase,
arginine hydrolase and urease. On the basis of the results each isolate was assigned
a numerical profile which could then be used to identify the isolate from an index
provided by the manufacturer and based on the classification of Kloos & Schleifer
(1975).
Biotyping using conventional methods and phage-typing (de Saxe el al.. 1981) was
carried out by the Central Public Health Laboratory (CPHL), Colindale, London.
The tests used were the fermentation of fructose, maltose, lactose, trehalose, manni¬
tol, xylitol, xylose, arabinose, ribose and sucrose; the reduction of nitrate to nitrite;
and the production of acetoin and alkaline phosphatase. Each isolate was then
assigned a biotype according to a modification of the Baird-Parker classification
which could then be converted to the Kloos & Schleifer classification (Marples, 1981;
Marples & Richardson, 1982).
Antibiotic sensitivity testing
Thirteen antibiotics with known anti-staphylococcal activity were tested. The mini¬
mum inhibitory concentration (MIC) of each antibiotic for each isolate was found
by a standard agar plate dilution method (Waterworth, 1978) with Iso-Sensitest agar
(Oxoid, Ltd). Control strains of coagulase-negative staphylococci were provided by
the Antibiotic Research Laboratory, Dudley Road Hospital, Birmingham and were
included on each plate. All MICs were determined after 24 h incubation except for
flucloxacillin, cefuroxime and cefamandole where the determination was made at
48 h.
A short antibiogram was obtained for each isolate using five antibiotics (gentami-
cin, erythromycin, clindamycin, flucloxacillin and fusidic acid) to each of which
Coagulase-negative staphylococci from CAPD peritonitis
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resistance was common and apparently independent. The production of/Mactamase
was detected by the method of Park, Lopez & Cook (1978).
Results
A total of 61 isolates of coagulase-negative staphylococci were obtained from 52
specimens of dialysis effluent during the period 1 May 1982 to 30 April 1983. These
specimens were collected during 41 episodes of acute peritonitis in 25 patients. A
coagulase-negative staphylococci was twice cultured concurrently with an acineto-
bacter, once with a Staph, aureus and once with an a-haemolytic streptococcus. On
seven occasions, two or three colonial types of coagulase-negative staphylococci were
obtained from a single specimen. On five of these occasions further characterization
showed that they were all colonial variants of the same strain, but on two occasions
the isolates had different biotypes and antibiograms.
Table I. Speciation of 43 distinct strains of
coaguiase-negative staphylococci from patients
with CAPD peritonitis
Method ofbiotypingOrganism Ap[ Conventf0Pnaf,
Staph, epidermidis 36 34
Staph, haemulyticus 2 2
Staph, warneri 1 2
Staph, cohnii 1 1
Staph, capitis 1 0
Staph, simulans 0 2
Staph. Iiominis 1 2
Untypeable 1 0
•Tests carried out by Central Public Health Labora¬
tory, Colindale.
Identification
After considering the source, biotype, phage type and antibiotic sensitivity of each
of the 61 isolates, we were able to distinguish only 43 strains. These are classified
according to species in Table I which shows that most were Staph, epidermidis.
There was close agreement between API and CPHL biotyping as to which strains
were Staph, epidermidis but several of the other strains were speciated differently
by the two methods.
The same strain was isolated more than once from each of nine patients. In five,
all the isolates were cultured during the initial course of antibiotics and were not
re-isolated thereafter. In three, the same strain was re-isolated between one and three
weeks after the first course of treatment but did not recur after the second course.
In one patient the same strain of Staph, haemolylicus was isolated from the dialysate
on four different occasions over a period of 15 weeks. On each of these occasions
the patient had peritonitis and no other organism was isolated.
During the 12 months of the study, four patients had two separate episodes of
580 L. D. Gruer et al.
Table II. Percentage of isolates of coagulase-negative staphylococci resistant to five antibiotics
in various studies
CAPD peritonitis Richardson & Marsik & Smith et al. Gemmell &
Antibiotic isolates Marpies (1982) Brake (1982) (1982) Dawson (1982)
(n = 43) (n = 532) (n = 203) (n = 191) (« = 100)
Gentamicin 40 27 8 24 0
Erythromycin 42 31 41 43 —
Clindamycin 12 — 36 36 0
Methicillin 35 37 66 39 0
Fusidic acid 9 25 — — 0
peritonitis caused by different strains of coagulase-negative staphylococci, three
patients had three and two had four.
Phage typing
Only 26 of the 59 isolates tested showed lysis by one or more phages and lysis was
often weak. On two occasions, phage typing clearly differentiated isolates from the
same patient which had identical biotypes and antibiograms. Phage typing also
sometimes confirmed that isolates cultured on different occasions from the same
patient were identical.
M/C50 and MICm
All but six of the 43 distinct strains produced /^-lactamase. The MICs of each of
the 13 antibiotics for 50% and 90% of the strains are shown in Table III. Also in¬
cluded in the Table are the antibiotic concentrations which can be readily but safely
achieved in dialysis fluid and blood. Only six of the 13 antibiotics—vancomycin,
rifampicin, netilmicin, cefamandole, fusidic acid and clindamycin achieved an
adequately low MIC,,,. All strains were sensitive to 1 or 2 mg/1 of vancomycin and
only one strain was resistant to rifampicin. All but two strains were sensitive to
netilmicin and cefamandole at 2 and 4 mg/1, respectively, but the MICs of both these
antibiotics varied between strains by a factor of up to 64 suggesting that strains
with greater resistance might readily emerge. There were few strains resistant to
clindamycin (all > 32 mg/1) and four to fusidic acid (> 8 mg/1).
We concluded that vancomycin appeared to have the most consistent activity of
all the antibiotics tested. Rifampicin, netilmicin and cefamandole also seemed
worthy of further consideration for clinical use.
Antibiograms
Sixteen of the 61 isolates tested were sensitive to all five antibiotics but each of the
other 45 isolates was resistant to between one and four. Table II shows the percent¬
ages of strains which were resistant to each of the five antibiotics compared with
those from four other recent studies of coagulase-negative staphylococci isolated
from a variety of clinical specimens.
There were 14 different patterns of resistance to the five antibiotics among our
isolates, several patterns being unique to isolates from a single patient. On all but
one occasion, isolates with identical phage types also had identical antibiograms.
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Table III. MIC50 and MICW of 13 antibiotics for strains of coagulase-
negative staphylococci from patients with CAPD peritonitis com¬












Vancomycin 41 2 2 15 20
Rifampicin 41 0 004 0-008 — 5t
Netilmicin 41 0125 1 6 4
Cefamandole 39 1 4 30 10
Fusidic acid 41 0125 2 25 20
Clindamycin 42 006 0-125 25 5
Flucloxacillin 43 2 >32 50 10
Cephradine 35 16 32 — I0f
Cefuroxime 35 16 >32 30 10
Erythromycin 42 0125 >32 — l-5t
Gentamicin 41 0125 16 4 4
Tobramycin 35 0125 > 16 4 4
T rimethoprim 35 > 16 > 16 — 3t
'Approximate mean inter-dose level following standard intra-peritoneal
dose (Oreopoulos el at.. 1981).
(Approximate mean inter-dose level following standard intravenous dose
(or oral dose where marked) suitable for patient with severe renal impairment
(Garrod, Lambert & O'Grady, 1981).
(Given orally.
Conversely, only twice did an isolate have a different phage type but the same
antibiogram. Thus, phage typing and the antibiogram had similar usefulness.
Discussion
The analyses of the bacteria causing CAPD peritonitis which have appeared to-date
do not distinguish between Staph, epidermidis and other coagulase-negative staphy¬
lococci. In therapeutic terms this probably does not matter, but it means that certain
epidemiological features of coagulase-negative staphylococci peritonitis have been
obscured. Studies on normal human skin have shown that Staph, epidermidis com¬
prise only 23% of the coagulase-negative staphylococci on the skin (KIoos &
Schliefer, 1975). In contrast, studies of clinical isolates of coagulase-negative staphy¬
lococci show that from 63 to 81% are Staph, epidermidis (Marsik & Brake, 1982;
Gemmell & Dawson, 1982; Sewell el ai, 1982) whilst as many as 93% of clinically
significant coagulase-negative staphylococci infections may be caused by Staph, epi¬
dermidis (Sewell el al., 1982). The present study of 43 distinct strains of coagulase-
negative staphylococci, all of which were thought to be clinically significant, showed
that about 80% were Staph, epidermidis. Thus, the apparently greater pathogenicity
of Staph, epidermidis sensu slricto compared with other coagulase-negative staphy¬
lococci includes a greater ability to cause CAPD peritonitis. Nevertheless, the infec¬
tion can also be caused by other coagulase-negative staphylococci. Most notably,
Staph, haemolyticus was responsible for a recurrent infection lasting 15 weeks.
582 L. D. Gruer et al.
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We found that biotyping was helpful in determining which isolates represented
persisting and which fresh infection. As other authors have found, the API Staph
system gave results which correlated well with those of conventional methods, yield¬
ing numerical profiles which could be readily compared (Marples & Richardson,
1982; Gemmell & Dawson, 1982; Ellner & Myrick, 1982). Further differentiation
of some strains was made possible by phage typing or antibiotic sensitivity testing,
but both approaches had disadvantages. The phage-typing system could type only
50% of isolates and extensive antibiotic sensitivity testing is too laborious for routine,
clinical use. The short antibiogram, on the other hand, proved capable of differen¬
tiating some strains, as well as providing clinically useful information.
Resistance to fiucloxacillin, cefuroxime, cephradine, gentamicin, tobramycin,
trimethoprim and erythromycin was sufficiently frequent among our isolates
coagulase-negative staphylococci to make these agents unsuitable for routine use.
Although apparently not universal, resistance to these and other antibiotics is wide¬
spread (Table II) and may be increasing. Richardson & Marples (1982) hav,e noted
that the proportion of gentamicin-resistant strains of coagulase-negative staphylo¬
cocci has risen from 7% in 1976-77 to 33% in 1980.
Cefamandole and netilmicin were both notably more active than the other cepha¬
losporins and aminoglycosides we tested, a feature recently noted elsewhere (Smith
el al., 1982; D. C. E. Speller, personal communication). However, their MICs varied
greatly from strain to strain suggesting that a progressive decrease in the sensitivity
of coagulase-negative staphylococci to both antibiotics might occur if they were used
extensively. Despite the excellent activity of rifampicin against all but one strain we
felt that its special role in treatment of tuberculosis precluded its routine use in
CAPD peritonitis.
Vancomycin-resistant strains of coagulase-negative staphylococci are rarely found
at present (Vas el al., 1981; Atkins et al., 1981; Smith el al.. 1982) and did not occur
in our study. Vancomycin therefore emerged as the best of the antibiotics tested in
vitro and was thus chosen for the initial treatment of coagulase-negative staphylo¬
cocci peritonitis in our patients. From October 1982 to July 1983, we treated 30
episodes of coagulase-negative staphylococci peritonitis with intraperitoneal vanco¬
mycin for 10-12 days. In only one case was the organism not eradicated and no ad¬
verse effects of the antibiotic were observed. We therefore conclude that vancomycin
is the best antibiotic currently available for the treatment ofCAPD peritonitis caused
by coagulase-negative staphylococci.
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of these compounds on chlamydial DNA
synthesis.
MICs and MLCs of ciprofloxacin and nor¬
floxacin already reported in conventional tests
(Mcier-Ewert el al., 1983, 1984; Heesen &
Muytjens, 1984; Ridgway el al., 1984) are
approximately four-fold lower than our figures.
Our results show that ofloxacin is more active
than other quinoline carboxylic acids tested in
vitro against Cltlam. trachomatis to date. They
also suggest that IF stains may be more sensi¬
tive (and hence give slightly higher MICs and
MLCs) than iodine or Giemsa when anti¬
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Vancomycin in (he treatment of CAPD
peritonitis
Sir,
Dr Gruer and his colleagues (Gruer. Bartlett
& Ayliffe. 1984) conclude that vancomycin
should be the drug of choice for the initial treat¬
ment of CAPD peritonitis caused b> coagulasc-
negative staphylococci. May we make two brief
comments?
An episode of CAPD peritonitis requires
empirical treatment until the causative organ¬
ism is known - this may be as soon as 24 h from
the onset of symptoms, but is usually 48 h or
longer, with antibacterial sensitivities not avail¬
able until a day later. In most of the studies
cited by Gruer Gram-negative organisms have
accounted for at least one third of the episodes.
Initial empirical treatment must therefore take
this into account, and vancomycin alone would
be inappropriate.
Secondly, the source of infection is, with rare
exceptions, the skin, and incorrect or careless
handling of the apparatus the cause of peri¬
tonitis. As the addition of an antibiotic to the
dialysis bag provides yet another opportunity
for contamination of the system, we investi¬
gated the efficacy of empirical oral treatment
(Knight et al., 1982). We chose cephradine for
this purpose, in view of its reasonably wide
Gram-negative and Gram-positive spectrum;
oral cephradine is now used here for the
first line treatment of CAPD peritonitis. The
majority ofstrains ofcoagulasc-ncgalive staphy¬
lococci continue to be sensitive to cephradine in
vitro (50 of the 72 isolates since January 1983).
Episodes which fail to respond require different
treatment when the organism is known, and
we agree that vancomycin is a useful agent
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Species identification and antibiotic sensitivity of
coagulase-negative staphylococci from CAPD
peritonitis. Journal of Antimicrobial Chemotherapy
13, 577-83.
Knight. K. R.. Polak. A.. Crump. J. & Maskcll. R.
(1982). Laboratory diagnosis and oral treatment of
CAPD peritonitis. Lancet ii. 1301 -4
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This letter has been shown to Dr Gruer whose
reply follows
Sir,
The aim of our paper was not to describe
our policy for the initial treatment of CAPD
peritonitis: this will be covered in a future
publication. Our aim was to examine the
antibiotic sensitivities of coagulase-negative
staphylococci causing CAPD peritonitis. In
our patients, these were the organisms most
frequently isolated, most often resistant to
many antibiotics and hence most difficult to
treat. Deciding on the best antibiotic for
trcatingcoagulase-ncgativestaphylococcal peri¬
tonitis thus seemed an essential first step
in formulating an initial treatment policy.
Vancomycin emerged as the most reliable anti¬
biotic (0% resistance). On the other hand, more
than half the strains we tested were resistant to
cefuroxime (previously our antibiotic of choice)
and cephradine, making them unsuitable first
line agents. Resistance to cephradine in Ports¬
mouth is, at 30%, lower than in Birmingham
but still seems an unsatisfactory level for a first-
line antibiotic.
Further study of other organisms isolated
from infected dialysate showed that satisfac¬
tory initial cover could not be provided by a
single antibiotic. Vancomycin was the best
agent for Gram-positive and an aminoglyco¬
side for Gram-negative isolates. Thus, for the
past two years, the renal unit at the Queen
Elizabeth Hospital, Birmingham has used intra¬
peritoneal vancomycin and gentamicin for
initial treatment, dropping the inappropriate
agent or, very rarely, changing to another
antibiotic when sensitivities arc known.
I believe that Maskell and Crump's advocacy
of oral antibiotics is ill-founded. Unless very
advanced, CAPD peritonitis is a localised
infection and bacteraemia is extremely rare. It
seems inappropriate to rely on unpredictable
enteral absorption leading to usually rather low
intraperitoneal antibiotic concentrations Injec¬
tion of antibiotics into the fresh dialysale bag
via the injection port delivers high concentra¬
tions of antibiotic immediately to the site of
infection. I have never encountered secondary
CAPD peritonitis due to the use of intra¬
peritoneal antibiotics and am unaware of any
published evidence for this.
To make treatment easier to carry out at
home and to reduce the risk of accumulation of
potentially ototoxic antibiotics, we now add
lOOmg vancomycin and/or 40 mg gentamicin
to the overnight bag only, for ten days. This
ensures a dwcll-timc of at least six hours and
allows some peritoneal clearance of antibiotics
during the rest of the day. This approach has
proved surprisingly successful. Of the first 100
episodes thus treated, 88 were cured by the ten
day course and four by an extended course of
vancomycin. Other antibiotics were required in
six episodes, all for gentamicin-resislant Gram-
negative organisms. In only two cases did the
catheter have to be temporarily removed. Only
eight patients had to be hospitalised for more
than one night because of their infection.
Scrum antibiotic levels were satisfactory with
maximum scrum concentrations of 12 mg/1 and
3 mg/l for vancomycin and gentamicin respec¬
tively. No clinical side effects of the treatment
were observed. No vancomycin-resistant Gram-
positive organisms have been encountered and
refractory coagulase-ncgativc staphylococcal
peritonitis has ceased to be a major problem.
LAURENCEGRUER
Lahoratoirc dc Baeteriologie Virologic.
Faculte dc Medecine Alexis Carrel.
Rue Guillaume Paradin.
69373 Lyon Cedcx 2. France
Susceptibility of Clostridium difficile strains to
new antibiotics: quinolones, efrolomvcin,
teicoplanin and imipenem
Sir.
The recent influx of new antibacterial agents,
many of which appear in high concentration in
faeces promoted us to examine 23 epidemiolo-
gically unrelated strains of Clostridium difficile
isolated from different wards and the com¬
munity in Cambridge. Cultures were grown in
brain heart infusion broth (incubated anaerobi-
cally for 48 h), then an inoculum was made by-
diluting each tenfold with the same broth and
applying approx 0 002 ml to plates containing
Iso Sensitest agar with 5% lysed horse blood
and dilutions of the antibiotics. The inocula
contained ca 10s cells, and the plates were read
after 24 h incubation in an anaerobic cabinet
(Whitley).
The agents which were kindly donated by the
makers were: ofloxacin (Hoescht), pefloxacin
(May & Baker), norfloxacin (Merck, Sharpc &
Dohme). ciprofloxacin (Bayer), and enoxacin
(Warner Lambert); other agents included
cfrotomycin. imipenem (Merck. Sharpe and
Dohme). and teicoplanin (Mcrrell). Vanco¬
mycin was used as a reference drug.
The results arc shown in Tabic I; excluding
those for norfloxacin (64 mg/1). enoxacin
( > 32 mg/1) and ofloxacin (8 mg-'l) for w hich all
the strains gave the identical values given in
brackets. Several points of interest emerge.
Efrolomvcin and tcicoplanin arc obviously
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Summary: During a 1 month study the effectiveness of two methods of
handwashing was assessed in a group of 31 patients undergoing continuous
ambulatory peritoneal dialysis. A defined, double rinse with alcohol, prior to
bag exchange, was found to be more convenient and significantly more
effective than povidone-iodine alone or povidone-iodine followed by alcohol.
Spraying the tubing around the bag connector with 70 per cent ethanol
reduced the numbers of adherent skin organisms so reducing the likelihood of
bacteria being drawn into the dialysate. Although there was no difference in
the overall incidence of peritonitis in the two groups of patients studied, there
was an unexpected drop in the incidence of peritonitis caused by coagulase-
negative skin staphylococci. This was attributed to an overall awareness of
the importance of handwashing and aseptic procedures during bag exchange.
Monitoring the bacteriology of the catheter exit site may give some prior
indication as to the likelihood of subsequent peritonitis especially with
Staphylococcus aureus and Gram-negative bacilli.
Introduction
Peritonitis is the main reason for failure of continuous ambulatory
peritoneal dialysis (CAPD) (Gokal et al., 1982). The bacteria causing
peritonitis are commonly resident skin flora, e.g. coagulase-negative
staphylococci, but may include transient Gram-negative bacilli (Editorial,
1982). The organisms may enter the system via either of the two connectors
between the dialysate bag and catheter, or along the track of the catheter
from the abdominal wall (Parsons et al., 1983). Infection may arise from the
patient's hands or the skin of the abdomen adjacent to the catheter exit site.
Patients are generally instructed in techniques of handwashing and care of
the exit site. A variety of disinfectants are used and include povidone-
iodine, chlorhexidine and alcohol. Although the effects of these agents have
been studied on the hands of staff (Ayliffe, 1980), they have not been
evaluated on the resident flora of patients' hands.
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In this study, two methods of disinfection of the hands are compared and
the incidence of peritonitis recorded. Decontamination of the connector and
associated tubing and the skin adjacent to the catheter exit were also
investigated.
Materials and methods
The study took place during a 3 month period between February and May
1983. The 31 patients practising CAPD at the Queen Elizabeth Hospital,
Birmingham, were each randomly allocated to one of two groups. Group A
contained 16 patients and Group B 15. The groups were found to be
matched in terms of age, sex, time on CAPD, previous episodes of
peritonitis and proportions of diabetics to non-diabetics. All patients used
the 'Travenol IIR' system, and carried out three or four exchanges per 24h.
Skin disinfection before bag exchange
Hands were disinfected before preparation of the surface, administration set
and bag, and immediately prior to exchange. Group A patients continued to
use the existing method consisting of a thorough handwash with povidone-
iodine detergent ('Betadine' surgical scrub) followed by an application of
5 ml of 70 per cent ethanol containing 1 per cent glycerol as an emollient.
Group B patients applied 5 ml of 70 per cent ethanol and 1 per cent glycerol
to the cupped hands and gently rubbed until dry. The process was then
repeated. A defined procedure was taught to ensure all surfaces of hands
were covered (Ayliffe, Babb and Quoraishi, 1978). Group A used a non-
medicated soap and Group B 4 per cent chlorhexidine-detergent
('Hibiscrub') for general handwashing.
Group A cleaned the catheter exit site with povidone-iodine detergent
and Group B with chlorhexidine-detergent. Both groups wore masks
during the exchange and Group B also sprayed the outer surface of the bag
connector and adjacent tubing with 70 per cent ethanol.
Bacteriological sampling
Samples were taken from the hands, the catheter exit site and the
administration tubing at monthly intervals where possible, or in most cases
two to four times during the study.
Samples were taken from the hands before and after disinfection using
two methods.
(1) Broth sampling. The tips of the fingers and thumb of one hand were
gently kneaded for 1 min on the bottom of a Petri dish containing
10ml of recovery medium. The recovery medium contained nutrient
broth (No. 2, Oxoid Ltd, Basingstoke) with 0 75 per cent lecithin-
tween mixture and 1 per cent sodium thiosulphate to neutralize
residual povidone-iodine or chlorhexidine. Neat and 10-fold
dilutions were then drop-pipetted on to the surface of blood and
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phenolphthalein disodium phosphate (PPD) agar plates. The agar
(Oxoid No. 2) was enriched with 1 per cent horse serum.
(2) Finger streaks. This method was used to estimate the number of
bacteria readily detachable from each finger tip. The fingers and
thumb of the other hand were streaked across the surface of a nutrient
agar plate (PPD).
The skin of the abdominal wall immediately adjacent to the exit site was
sampled using (1) a contact plate (25cm2) containing either PPD or blood
agar, (2) a swab moistened in Ringer's solution which was then plated
directly on to blood and PPD agar.
Swabs moistened in Ringer's solution were used to sample both the bag
and peritoneal catheter connectors and also the tubing for T5cm on each
side of the connectors. A further sample was taken from Group B patients
from the bag connector and adjacent tubing following disinfection with
alcohol.
Swabs moistened in Ringer's solution were taken from the anterior nares
and cultured immediately on PPD agar.
In the event of a CAPD patient presenting with a bag containing turbid
fluid which was found to have more than 100 leucocytes/mm3, the dialysate
was cultured as follows: 20ml were centrifuged and the deposit plated out
on blood and cystine lactose electrolyte deficient (CLED) agar plates; 60ml
were added to a 100 ml medical flat bottle containing 20 ml of sterile
nutrient broth (Oxoid No. 2) at four-times normal strength, the addition of
the dialysate thereby diluting the broth to the correct concentration.
All plates and broth cultures were incubated aerobically at 37°C for 18 h.
Plates were re-incubated for 24 h at room temperature to assist with
identification of coagulase-negative staphylococci and counts were made
where appropriate. Strains were identified by conventional tests and the
API system was used for all Gram-negative bacilli and selected coagulase-
negative staphylococci from patients with peritonitis.
Results
In Group A, the treatment of one patient was changed to haemodialysis
before he could be sampled, and another was unable to attend the sampling
clinic. The 14 remaining patients in Group A were sampled on a total of 36
occasions. The 15 patients in Group B were sampled on 49 occasions.
The number of resident skin bacteria recoverable from the fingers by the
broth sampling method before skin disinfection varied considerably from
patient-to-patient (range: 1 8 x 102-72 x 106). The median counts in the
two groups were, however, very similar (16 x 104 and 3 3 x 104).
Using the broth sampling technique, there was an increase in the mean
bacterial counts following the use of povidone-iodine alone and povidone-
iodine followed by alcohol. These increases were 107 per cent and 51 per
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cent respectively. There was, however, a mean bacterial count reduction of
69 per cent in the defined double alcohol treatment group. Thus, the
defined double alcohol treatment resulted in a significantly greater
reduction than either povidone-iodine alone or povidone-iodine plus
alcohol (/><0 001). On 16 of 29 occasions (55 per cent) more resident flora
were recovered after than before washing with povidone-iodine alone, and
12 of 36 (33 per cent) occasions after povidone-iodine plus alcohol. On five
occasions the bacterial count after povidone-iodine plus alcohol increased
more than five-fold. On only five of the 47 occasions (1 1 per cent) did the
bacterial count rise following the defined double alcohol wash, the greatest
increase being 3 6-fold.
Table 1 shows that with the finger-streak sampling method lower
bacterial counts were obtained following the double alcohol treatment than
with the other products. Significantly lower counts of resident flora were
also obtained from the thumb, middle and ring fingers after using a defined
alcohol wash procedure.
Organisms isolated from the hands were mainly coagulase-negative
staphylococci. Staphylococcus aureus was recovered from the hands before
disinfection in five Group A patients on a total of eight occasions and from
seven Group B patients on 11 occasions. Following disinfection, Staph,
aureus could still be isolated from four of the five Group A patients and two
of the Group B patients. These differences were not statistically significant.
The following Gram-negative bacilli were recovered from 1 1 of the 83
samples (13 per cent) before disinfection, but none of the samples after
disinfection: Acinetobacter spp., eight samples from six patients; Proteus
mirabilis from two patients and Escherichia coli from one patient. On only-
three occasions did the number of Gram-negative bacilli recovered from a
broth sample exceed 100. A few colonies of Streptococcus viridans were
recovered from one of the 83 pre-disinfection samples.








After two applications No growth 60-5
of alcohol 43 1-10 33 5
(Group B) (215) 11 + . 60
No growth 39-3
After povidone-iodine 29 1-10 28 3
Group A (145) 11 4- 32-4
After povidone-iodine No growth 45-2
and alcohol 31 1-10 290
(Group A) (155) 1 1 + 25-8
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Contact plate sampling of the exit site gave very similar counts in both the
chlorhexidine and the povidone-iodine treated groups. Counts ranged from
less than 10 colonies to confluent growth, but in both groups there was a
moderate to heavy growth in about 70 per cent of samples and a very heavy
or confluent growth in 20 per cent. Exit site samples from three patients in
Group A and four patients in Group B showed Staph, aureus.
Staphylococcus aureus was also grown from the hands before disinfection in
all of these patients. Acinetohacter spp. were isolated from the exit site of
four of the six patients from whose hands they had been recovered. Proteus
mirabilis was cultured from the exit site of one patient.
The results of sampling the administration tubing before and after
spraying with 70 per cent ethanol are shown in Table II. This shows that
there was more contamination of the tubing around the peritoneal catheter,
which lies close to the abdominal wall, than around the bag connector.
Spraying the tubing around the bag connector with alcohol led to a large
reduction in counts, with 82 per cent of samples taken after disinfection
showing no growth.
Table II. Contamination of the administration tubing before and after disinfection ivith 70%
alcohol
Pre-disin fecion Post-disinfection
samples (%) samples (%)
Bacterial counts Peritoneal catheter
in range connector Bag connector Bag connector
0 14 26 82
1-10 37 57 16
11-100 38 17 2
100 + 11 0 0
Sample number 84 35 49
Over the 3 months before the start of the study (period 1) there were 23
episodes of peritonitis during 94 patient-months of CAPD (one episode per
41 patient-months). Over the 3 months after the start of the study (period
2) there were 16 episodes during 106 5 patient-months (one episode per 6-7
patient-months). Seven of these 16 episodes occurred in six Group A
patients, and nine in six Group B patients. The organisms isolated during
the two periods are shown in Table III. This shows that the number of
episodes of peritonitis caused by coagulase-negative staphylococci fell
substantially during period 2, i.e. 11 of 27 patients during period 1 and in
only three of 29 patients during period 2, a significant difference (P<0 02).
The proportion of patients developing peritonitis caused by other
organisms did not change significantly.
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Table III. Organisms causing peritonitis in CAPD patients
Number of isolates in
Period 1 Period 2
Organism (study period)
(27 patients) (29 patients)
Coagulase-negative staphylococci 15 2
Coagulase-negative staphylococci
with Staph, aureus 1 0
with Str. viridans 0 1
with diphtheroids 1 0
with Gram-negative bacilli 1 0
Diphtheroids 0 1
Staph, aureus 0 3
Str. viridans 0 4
Acinetohacter spp. - 2 1





Most evaluations of ward handwashing techniques have been concerned
with the removal of potentially pathogenic bacteria, e.g. Staph, aureus and
Klebsiella spp, which are transiently found on the hands of nurses and
medical staff. As CAPD peritonitis is often caused by coagulase-negative
staphylococci, and as it is the patient himself who usually carries out the bag
exchanges, it is important to know how effective are the skin disinfection
procedures on the resident as well as the transient skin flora.
Our study has shown that the povidone-iodine detergent, as used by our
patients, is often totally ineffective in reducing the resident skin flora on the
fingers. Possibly this is due to inadequate contact time. The mean count
following povidone-iodine detergent showed an increase in counts on more
than half the occasions. This increase is probably the result of the detergent
bringing to the surface bacteria lodging in pores and skin creases. The use of
70 per cent ethanol after povidone-iodine slightly improved disinfection,
but in many instances the counts were still higher than before disinfection.
The defined double alcohol wash was significantly more effective, with a
mean count reduction of 69 per cent. Nevertheless, on a few occasions
counts were still higher after the alcohol wash than before.
There are probably two main reasons for the greater effectiveness of the
defined double alcohol wash. First, 70 per cent alcohol kills bacteria more
rapidly than povidone-iodine. Secondly, the defined wash means that there
is less chance that any part of the fingers will avoid disinfection. The finger-
streak samples showed that the difference between the two methods was
most pronounced on the thumb, middle and ring fingers. Previous work has
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shown that these areas are often missed during handwashing (Taylor, 1 978).
The alcohol wash was generally preferred by patients, and it could be
carried out without using a handwash-basin making it very suitable for
travellers and holiday makers. Once learned, the technique was quicker than
using povidone-iodine detergent. The alcohol, being almost colourless, did
not stain clothes or jewellery and, with added glycerol, was found by some
patients to be gentler to the skin than povidone-iodine. The use of
chlorhexidine-detergent, instead of non-medicated soap, for routine hand
treatment showed no obvious benefit.
Despite the superiority of the double alcohol wash over povidone-iodine
and a single application of alcohol, we were unable to show any difference
between the two groups in the incidence of peritonitis during the short
period of the study. We did, however, observe an unexpected reduction in
the overall incidence of peritonitis caused by coagulase-negative
staphylococci, with three episodes during the study as against 18 episodes
during the same period before the study. Although Group A patients were
not specifically instructed in handwash techniques during the study they
inevitably became aware that this was what we were studying.
Consequently, patients in both groups may well have paid more attention to
their exchanges with less contamination of the bag connector as a result.
Indeed, recent connector design should ensure that the bag exchange can be
carried out aseptically even with dirty hands, provided the technique is
meticulous.
Each of the three episodes of Staph, aureus peritonitis was caused by
organisms identical to isolates previously cultured from the patient's nose,
hands and exit site. Those patients who had Staph, aureus on the hands but
not on the exit site did not develop Staph, aureus peritonitis during the
study. This perhaps favours the exit site as a focus of colonization from
which spread to the peritoneum later occurred. Similarly, acinetobacter
peritonitis occurred in two of the four patients with the organism on the exit
site as well as on the hands. A similar strain was found on the face-flannel of
one of these patients. Colonization of the exit site by potential pathogens
occurred despite reported daily cleansing of the exit site with either
povidone-iodine or chlorhexidine detergent. Both these agents thus seem
inadequate for the purpose. It may be that the detergent has a damaging
effect on the skin which favours colonization.
Our study showed that Str. viridans are almost never found on the hands
or exit site of CAPD patients. A much more likely route into the peritoneum
is from the mouth via the bloodstream. This hypothesis is strengthened by
the fact that two of the four episodes of Str. viridans peritonitis during the
study period occurred in the only splenectomized patient in the group.
While further work is required to confirm this hypothesis, we believe the
evidence is sufficient to recommend prompt attention to gingivitis and
prophylactic erythromycin when traumatic dental treatment is being
undertaken; CAPD patients should also be advised to use a soft toothbrush.
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Our failure to isolate oral flora from the skin or tubing indicates that direct
spread from the mouth is an unlikely route of spread. We have, therefore,
dispensed with the mask, further simplifying the bag changing routine and
increasing its social acceptability.
If the incidence of CAPD peritonitis is to be reduced, the bag exchange
must be made a more foolproof procedure. Disinfection of the connection
site between the administration set and the bag using a povidone-iodine
spray (Parsons et al., 1983) or flushing with a hypochlorite solution has been
shown to be effective (Maiorca et al., 1983).
Nevertheless, an effective aseptic procedure would be preferable and
CAPD unit staff should aim constantly to encourage a meticulous exchange
technique. A defined double alcohol wash may be the best available means
of hand disinfection but the importance of hand disinfection per se should
not be overvalued.
We wish to thank Sister J. Curley and the staff and patients of the CAI'D Unit at the Queen
Elizabeth Hospital, Birmingham, for their enthusiastic co-operation.
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Letters to the Editor
Sir,
CAPD Peritonitis
In their interesting leading article, Spencer & Fenton (1984) referred to
several unsatisfactory culture techniques and suggested that the pour-plate
technique used in their laboratory (Fenton, 1982) is the method of choice.
This requires that the specimen must be handled from the outset in the
laboratory by technical staff. We prefer a simpler method which can be
initiated in the clinical area and which does not necessitate calling in staff
out of hours. Dialysate (2-3 ml) is aspirated from the bag and inoculated
into thioglycollate broth with 5% CO, under vacuum (Gibco Ltd), which is
then sent to the laboratory for appropriate subculture. Using this technique
we isolated organisms from 84% of specimens (Knight et al., 1982); since
then this method has given a consistently high positive culture rate (87%)
which compares well with the 79% reported by Fenton (1982).
We would also like to mention our experience with treating peritonitis
with oral cephradine. Encouraged by a preliminary study (Knight et al.,
1982) we went on to treat 58 episodes of peritonitis alternately with oral
cephradine or intraperitoneal cefuroxime for 7 days. The primary
resolution rate was not significantly different in the two groups (66% with
oral cephradine, 55% with cefuroxime). We have since adopted a 7-day
course of oral cephradine 500 mg 6-hourly as our standard empirical
treatment. We have, to date, treated 168 episodes in this way with a clinical
response in 101 (60%). There was secondary success with an alternative
drug in 43 episodes (26%); intractable peritonitis leading to catheter loss
occurred in 24 (14%). We have had no episodes of cephalosporin-related
diarrhoea, possibly because we restrict the course to 7 days. We agree with
Spencer & Fenton (1984) that the optimum length of treatment remains still
to be determined, but in a condition caused by endogenous infection with
commensal flora, it seems logical to aim for the shortest course which is
clinically effective, thus causing minimal interference with the balance and
antimicrobial sensitivity of the potential pathogens.
Prevention of peritonitis is obviously the desirable objective. Gruer and
his colleagues (1984) report that they were able to reduce the incidence of
peritonitis due to coagulase-negative staphylococci by a double alcohol
handwash before bag changing. Perhaps the time has come for a trial of
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Sir,
Peritonitis in CAPD patients
Raman & Maskell (1985) incorrectly state that we found the incidence of
CAPD peritonitis was reduced by a double-alcohol wash before bag
changing. The double-alcohol wash was indeed much more effective than
povidone-iodine in reducing the resident flora of the hands. The incidence
of peritonitis caused by coagulase-negative staphylococci did fall during the
study period. However, the reduction was common to both the alcohol and
the povidone-iodine using groups. After the study, the incidence of
coagulase-negative staphylococcal peritonitis rose quickly to pre-study
levels—although by then all patients were using the double-alcohol wash!
We suspect the temporary improvement occurred because patients were
aware their bag changing technique was under scrutiny during the study
and therefore became more diligent. We await the development of a truly
secure method of bag-changing which keeps hands and connectors well
apart. The recently described sterile weld system looks promising
(Hamilton et al., 1983).
I agree with Raman & Maskell (1985) that the pour-plate culture
technique described by Fenton (1982) fails, as does filtration, because it
requires the presence of skilled laboratory staff from the outset. At the
Queen Elizabeth Hospital, Birmingham, a simple bottle culture technique,
similar to that described by Raman & Maskell (1985), is used. Once
inoculated, the bottles were treated like blood cultures. Over the first 2
years, organisms were cultured by this method in 89% of 148 episodes of
CAPD peritonitis. Simultaneous plate culture of a centrifuged deposit was
useful only for isolating certain strict aerobes such as Agrobacterium spp,
and raised the total isolation rate to 95% of episodes.
Laurence Gruer Laboratoire de Bacteriologie-Virologie,
Faculte de Medecine Alexis Carrel,
Rue Guillayne Oaradub,
69373 Lyon Cedex 2,
France.
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ONCE-DAILY ANTIBIOTIC TREATMENT OF CAPD
PERITONITIS
Sir,—Peritonitis remains the main threat to successful
continuous ambulatory peritoneal dialysis (CAPD). We have
attempted to develop a treatment policy that has a sound
microbiological base, but which can be used easily by the patient
treating himself at home. A study of the antibiotic sensitivities of
organisms isolated from infected dialysis specimens over one year
showed that the most reliable initial treatment would be a
combination of vancomycin1 and an aminoglycoside.
The treatment policy adopted was as follows. After samples of
dialysate fluid have been taken for microscopy and culture, 100 mg
vancomycin and 40 mg gentamicin are added to the next bag of
dialysis fluid. Patients who are not seriously ill are then allowed
home with instructions to add 100 mg vancomycin and 40 mg
gentamicin to subsequent overnight bags only. When the results of
culture are known (generally after 48 h), it is usually possible to
continue with one antibiotic only. Treatment is continued for 10
days. Patients with significant systemic evidence of infection are
also given an initial intravenous dose of vancomycin 500 mg and
gentamicin 40 mg.
Results of treatment of the first 100 consecutive episodes were:
— No
Bacteriological findings:
Culture positive episodes 83
Gram-positive strains(100% vancomycin sensitive) 74
Grant-negative strains(66% gentamicin sensitive) 18
Cure achieved tvith:
Once-daily treatment only 88
Extended course ofvancomycin 4
Other antibiotics 6
After cat heter removal 2
llonie/hosfntal neatmem
Episode treated entirely at home 79
Overnight stay only 7
Admission because ofperitonitis 8
Admission for ot her reasons 6
Most patients successfully treated themselves at home without
altering their dialysis routine. Only two patients required a
temporary removal of the peritoneal catheter. No clinical side-
effects of the antibiotics were seen. Peak serum levels were 5 • 5 to 12 •
mg/l for vancomycin and less than 3 mg/l for gentamicin. The
adoption of this policy has greatly simplified our treatment of
peritonitis, increasing our cure rate and decreasing the incidence of
antibiotic-associated colitis, which had been a feature of our
previous treatment regimen with cephalosporins. The simplified
regimen has been welcomed by patients and stalTalike.
I .. D. Gruf.r*
Departments of Clinical Microbiology KiDDY
md Nephrology, n Anil
Queen Elizabeth Hospital,
Birmingham Bl5 2TH J- MtCHAF.I.
•Present address: Hdpual Cardiologique, I.yon, France.
I. Gruer l.D, Bartlett r, AylilTe GAJ Species identification and antibiotic sensitivity of
coagulase negative staphylococci from CAPD peritonitis. J Atuimicrob Chemother
1984; 13: 577-83.
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Vancomycin and Tobramycin in the Treatment of CAPD Peritonitis
L.D. Gruer. J.H. Turney. J. Curley. J. Michael. D. Adu
Renal Unit, Queen Elizabeth Hospital, Birmingham, UK
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Abstract. Seventy-five episodes of continuous ambulatory peritoneal dialysis (CAPD) peritonitis were studied
during a I year period at the Queen Elizabeth Hospital, Birmingham. When two simple culture methods were used in
parallel, the causative organisms were identified in sjjK'o of cases. Nearly two thirds of episodes of peritonitis were
caused by coagulase-negative staphylococci (C-NS), many of which were multiply antibiotic-resistant. On the basis of
detailed antibiotic sensitivities, intraperitoneal vancomycin and tobramycin were chosen for the initial treatment of
CAPD peritonitis. With this regime, a cure was achieved in 32 of 38 episodes, compared with 15 of 27 episodes when
cefuroxime was used. All but I of 24 episodes caused by C-NS were cured by vancomycin.
Introduction
Infective peritonitis remains the major complication
of continuous ambulatory peritoneal dialysis (CAPD)
[1-6]. Most centres report two obstacles to effective treat¬
ment. Firstly, the causative organism cannot be identified
in 15-40% of episodes. Secondly, multiply antibiotic-re¬
sistant organisms are commonly encountered. Using a
novel method of culture, we have been able to identify the
causative organism in almost all cases. We describe an
antibiotic policy based on an analysis of the antibiotic
sensitivities of isolates obtained over a l-vear period and
show how its use has led to a reduction in morbidity from
CAPD peritonitis.
Patients and Methods
This sludy included all episodes of peritoniiis occurring in 39
patients on CAPD at the Queen Elizabeth Hospital between March
1,1982 and February 28,1983. The age range of the patients was from
16 to 65 years, with a mean of 39( ± SD) 13 years. There were 26 males
and 13 females. Ten of the 39 patients were diabetics. All the patients
were on 3 or 4 exchanges of dialvsate/dav.
Microbiolngical Inve.uigaiinns
Eighty millilitres of dialysis effluent were removed asepticallv
from the waste bag. Twenty millilitres were placed in a sterile
universal container. The remaining 60 ml were injected via a fresh
sterile needle into a standard 100-ml medical flat bottle containing
20 ml of sterile nutrient broth (Oxoid No.2) at 4 times normal
strength, thereby diluting it to the correct concentration. During
normal working hours all samples were then sent directly to the
laboratory. At other times, the universal container was kept in a
refrigerator at 4 :C and the dialysate culture bottle in an icubator at
37 'C until the laboratory opened Bacterial peritonitis was consid¬
ered to be present if more than 100 neutrophil polymorphs/mm1
were seen. The fluid in the universal container was centrifuged and
the deposit used to prepare a gram-stained film and to inoculate
blood and CLED agar plates for aerobic incubation. The culture
bottle was incubated aerobically and subcultured after 24 h onto
blood agar for both aerobic and anaerobic incubation, or if growth
was detected visually, at any time during the next 9 days Isolates
were identified using conventional techniques. Antibiotic sensitivi¬
ties were determined using the Stokes disc diffusion method [7). In
addition, a standard agar plate dilution method [8] was used to
determine the minimum inhibitory cencentration (MIC) of 13 anti¬
biotics against isolates of coagulase-negative staphylcocci (C-NS).
Initial Antibiotic Therapy
Two regimes were used in the course of the study. In each case,
treatment was started as soon as bacteriological samples had been
taken.
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Regime I (March-Seplember 1982): An initial dose of ctfurox-
ime 500 mg intravenously followed by cefuroxime 75 mg/l of
dialysate for 12 days. If isolates were resistant to cefuroxime, an¬
other appropriate antibiotic was used.
Regime 2 (October 1982-February 1983): an initial dose of van¬
comycin 500 mg intravenously followed by vancomycin 15 mg/l of
dialysate and tobramycin 8 mg/l of dialysate. After 48-72 h, the
antibiotic treatment was adjusted in the light of the bacteriological
results as follows: (l)vancomycin-sensitive organisms: vancomycin
15 mg/l of dialysate for 12 days: (2) vancomycin-resistant, tobramy-
cin-sensitive organisms: tobramycin 8 mg/l for 12 days: (3) organ¬
isms resistant to both vancomycin and tobramycin: another appro¬
priate antibiotic for 12 days: (4) if no organism was cultured in the
face of a clinical diagnosis of peritonitis, both antibiotics were
continued for 12 days.
In all except 6 epidodes of peritonitis the patients were treated at
home; they continued, their usual dialysis schedule and added
antibiotics to their dialysate. Six patients were admitted because
they were clinically unwell with a peritonitis. These patients were
treated with intermittent peritoneal dialysis for 72 h, using an
automatic cycler. Antibiotics were added to the dialysate in the same
doses as in those patients on CAPD.
Antibiotic Concentrations
Serum vancomycin concentrations were assayed using an Ab¬
bott TDX immunoassay system (Abbott Diagnostics Division,
Queensborough. Kent, UK). Serum tobramycin concentrations
were assayed using an EMIT immunoassay system (Syva UK. Ltd.
Maidenhead, Berks., UK).
Statistics
The statistical significance of differences was tested by the x: test
w ith Yates correction.
Results
Microbiology of the Effluent
During the 12 months from March 1,1982 to February
28, 1983, 75 episodes of acute peritonitis occurred during
286 patient-months of CAPD. Organisms were isolated
from the effluent in 71 of the 75 episodes (95%). One
species was cultured on 66 occasions and two on 5 occa¬
sions. Table 1 shows that C-NS were isolated on 44
occasions (62%), whereas no other organism was cultured
on more than 4 occasions.
In 71 of the 75 episodes, both bottle and plate methods
were used, and organisms were isolated on 69 occasions
(97%). In the other 4 episodes, only the plate method was
used and organisms were cultured on 2 occasions. Eigh¬
teen (24%) of organisms were isolated by the bottle
method alone, and 10 (13%) by the plate method alone.
The bottle method isolated significantly more C-NS than
the plate method (41:31,p < 0.01), whilst 7 gram-negative
bacilli (Acinetobacter anitratus, Proteus mirabilis. Agrobac-
Table I. Bacteria isolated from dialysis effluent during 71 epi¬


















Other aerobic gram-negative bacilli 3
Total 76
terium sp., Enterobacter cloacae, and 3 unidentified aer¬
obic gram-negative bacilli) were cultured only by.the
plate method. The two methods thus seemed comple¬
mentary.
Antibiotic Sensitivities
Coagulase-Negaiive Staphylococci. Full details of the
antibiotic sensitivities of the strains of C-NS isolated
during the study have been published elsewhere [8]. Only
vancomycin was active against all strains. Netilmicin,
rifampicin and cefamandole were active against at least
95% of strains. Flowever, 16 of the 41 strains tested (40%)
were highly resistant to cefuroxime (M1C>32 mg/l).
Oilier Gram-Positive Organisms. Only those 4 antibiot¬
ics consistently active against the C-NS were tested
against the 10 other gram-positive (table I). Vancomycin
and rifampicin were active against all 10 isolates, cefa¬
mandole was active against all except the Streptococcus
faecalis isolates, netilmicin was active only against the
Staphylococcus aureus and diphtheroid isolates.
Overall activity of the 4 antibiotics against gram-posi¬
tive isolates was therefore: vancomycin 100%, rifampicin
98%, cefamandole 91% and netilmicin 85%.
Gram-Negative Organisms. Of the 4 antibiotics most
active against gram-positive organisms, only netilmicin
was also consistently active against gram-negative organ-
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Table II. Overall sensitivities of 76 isolates from effluent from CAPD patients with peritonitis
Antibiotic Number of sensitive isolates Number of resistant isolates Sensitive isolatess, %
Vancomycin and netilmicin 73 3 96
Vancomycin and gentamicin/tobramycin 72 4 95
Netilmicin 65 II 86
Cefamandole 56 20 74
Cefuroxime 36 40 47
isms, inhibiting all but 3 of the 22 isolates, Klebsiella
aerogenes, Agrobacterium sp. and an unidentified aerobic
gram-negative bacillus. Other antibiotics which were
found to be active against most isolates were gentamicin
and tobramycin (18 of 22) and cefotaxime (16 of 22).
Cefuroxime and cefamandole were only active agaisnt 7
of 22 isolates.
Overal Antibiotic Sensitivites. These are shown in table
II. The best single agent was netilmicin, active against
860/o of isolates. However, combinations of vancomycin
and netilmicin and vancomycin and tobramycin/gen-
tamicin were active against 96 and 95% of isolates, re¬
spectively. Cefuroxime, our drug of choice at the start of
the study, was active against only 47% of isolates.
Antibiotic Treatment
During the first 7 months of the study, 15 of 27 ep¬
isodes of CAPD peritonitis (56°o) were successfully-
treated with cefuroxime alone. Only 6 of the 14 episodes
caused by C-NS responded. Eleven of the 12 unrespon¬
sive.infections were subsequently successfully treated
with either vancomycin or tobramycin. In 1 case, the
patient only recovered after removal of the intraperito¬
neal catheter.
In the light of these results and the antibiotic sensitiv¬
ity data which had accumulated during the first 6 months
of the study, we changed our initial treatment from cefu¬
roxime to a combination of vancomycin and tobramycin.
During the final 5 months of the study, 32 of 38
episodes (84%) were successfully treated with vancomy¬
cin and tobramycin. Twenty-three of the 24 episodes
caused by C-NS responded to vancomycin compared
with 6 of 14 treated with cefuroxime (pcO.OOl). The
organisms causing the 6 episodes which did not respond
to vancomycin and tobramycin were K. aerogenes; P.
mirabilis; Pseudomonas aeruginosaand S. aureus;Agrobac-
terium sp.: a diphtheroid; and a C-NS. These infections
did not respond to other antibiotics and were only cured
by removal of the intraperitoneal catheter.
Vancomycin and Tobramycin Concentrations
Serum vancomycin and tobramycin concentrations
were each measured in 6 patients after 5-14 days treat¬
ment. Vancomycin concentrations ranged from 8 to
12 mg/1 (mean 10.1 mg/l) and tobramycin concentrations
from 3.1 to 4.8 mg/l (mean 3.6 mg/l).
Discussion
In most published surveys of CAPD peritonitis, a
causative organism could not be isolated in at least 15% of
cases [1-5]. Until now, only Vas et al. [6] using expensive
and complicated filtration techniques, have reported an
isolation rate of over 90%. The methods we have de¬
scribed are simple and cheap and have the added advan¬
tage that samples do not need to be processed outside
normal laboratory hours. CAPD dialysate is not a good
culture medium and hence any bacteria present may be
both few in number and in poor condition. The bottle
culture method allows a large volume of fluid to be
cultured without subjecting the organisms to the addi¬
tional stresses of centrifugation or filtration. It appears to
be particularly suitable for isolating C-NS.
We isolated C-NS from 62% of 71 culture-positive
samples. This is a higher proportion than that reported in
other series [1-6], and may in part reflect the sensitivity of
our culture methods. C-NS were also responsible for
several prolonged episodes of peritonitis despite treat¬
ment with cefuroxime, our antibiotic of choice at the start
of the study. Our efforts to formulate a policy for the
initial treatment of CAPD peritonitis therefore centred
on this group of organisms.
Only vancomycin was active against all the C-NS
isolates tested. Several other authors also report that
C-NS causing CAPD peritonitis are consistently sensi¬
tive to vancomycin but often resistant to many other
antibiotics [2, 9-11]. Vancomycin and rifampicin were
also consistently active against the other gram-positive
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isolates from our patients but several streptococci were
resistant to netilmicin and cefamandole. Setting aside
rifampicin because of its status as an anti-tuberculous
drug and because rifampicin-resistant mutants can readi¬
ly occur [12], vancomycin emerged as clearly the best
antibiotic for treating gram-positive organisms. On the
other hand, the aminoglycosides - netilmicin, tobramy¬
cin and gentamicin - had the most consistent activity
against the gram-negative isolates. There was therefore
no single antibiotic which could be used with confidence
in the initial treatment of CAPD peritonitis but a combi¬
nation of vancomycin and an aminoglycoside appeared
to provide nearly total cover. Despite the slightly wider
activity of netilmicin, we felt that its use was best res¬
tricted, since it is more expensive than tobramycin or
gentamicin and useful as an antibiotic reserved for treat¬
ing serious infections caused by gram-negative bacilli
resistant to gentamicin and tobramycin. We therefore
chose to use tobramycin, which at that time was cheaper
than gentamicin.
During the first 7 months of the study we attempted to
treat CAPD peritonitis with cefuroxime at a dose of
75 mg/l of dialysate. Only 15 of 27 (56%) episodes of
peritonitis were cured with this treatment. It could be
argued that the dose of cefuroxime used was too low to be
effective. However we found that 40% of the C-NS tested
were highly resistant to cefuroxime with MIC. > 32 mg/l.
In other studies using cefuroxime in doses of up to
200 mg/I of dialysate, a similar failure rate was observed
[2, 4], During the final 5 months of our study, vancomycin
and tobramycin successfully cured 84% of 38 episodes of
peritonitis, including all but 1 of 24 episodes caused by
C-NS.
The use of vancomycin and tobramycin has thus led to
a substantial improvement in the results of our treatment
of CAPD peritonitis. Both drugs, however, carry the risk
of ototoxicity. If they are to be generally used for treating
CAPD peritonitis, it is essential that this risk be mini¬
mised. Current preparations of vancomycin have been
associated with a very low incidence of ototoxicity and
then only when serum levels exceed 80 mg/l [13]. Our
regime led to serum levels around 10 mg/l, which are
unlikely to be hazardous. On the other hand, we found
that serum tobramycin levels were generally between 3
and 5 mg/l. Similar results have been reported elsewhere
[14, 15]. Tobramycin and gentamicin appear equally oto¬
toxic ij^ humans [16]. Meter \\1] has provided evidence
that the risk of ototoxicity increases markedly when the
product of the.mean serum trough concentration of gen¬
tamicin (mg/l) and duration of treatment exceeds 45.
This figure undoubtedly was exceeded in some of our
patients, although ototoxicity was not clinically appar¬
ent. Consequently, we are studying the use of intermittent
doses of intraperitoneal vancomycin and aminoglyco¬
sides in a attempt to reduce antibiotic concentrations
whilst preserving antimicrobial efficacy.
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